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ABSTRACT 
 
From Nano to Micro: Versatile Strategies for Near-Infrared Light-controlled Nitric Oxide 
Delivery and Their Therapeutic Applications 
 
by 
 
Po-Ju Huang 
 
Nitric oxide (NO) has attracted considerable attention due to its promising 
applications in cancer treatment. The therapeutic effect of NO pro-drugs greatly depends on 
the concentration, duration and the specific site of NO delivered. Photochemical delivery 
can control the timing, dosage and location of NO release by administering the intensity and 
location of light irradiation. However, there are key challenges associated with using such 
photo-activated NO releasing molecules ("photoNORMs"). One is to activate these 
precursors with tissue penetrating near infrared (NIR) light, while another is to deliver these 
precursors directly to inflammatory sites, including tumors. Here, we describe two different 
NIR light-activated NO releasing composites with nano and micron size, and demonstrate 
their delivery strategies to cancer cells and tumor spheroids by using cell penetrating 
peptides (CPPs) and macrophages mediation respectively. 
 For the nano-delivery, we developed new nano-carriers with graphene quantum dots 
(GQDs) as photo-active cores, lipophilic domains and a surface modified with cell-
penetrating peptides. The lipophilic domains in the CPP-nano-carriers can be loaded with 
  
ix 
hydrophobic photoNORMs. Such CPPs can overcome the barrier of cellular membranes and 
efficiently deliver our nano-carriers inside the cell. Moreover, GQD is able to absorb 794 
nm photon and transfer energy to trigger NO release from the NO precursors in lipophilic 
domains. We showed NO photo-release in HeLa cancer cells under 794 nm laser irradiation 
can be visualized by using a fluorescent NO probe dye (DAF-FM-2DA). 
For the micro-delivery, we applied bone marrow macrophages (BMMs) as "Trojan 
horses" to deliver biocompatible polymer micro-particles incorporating photoNORMs and 
upconversion nanoparticles (UCNPs) to breast cancer spheroids. Both components are 
activated by tissue penetrating NIR light allowing for simultaneous therapeutic NO delivery 
and photoluminescence (PL) imaging capabilities with a single NIR laser source. By varying 
light source intensity, we were able to garner control over NO release rates reducing hypoxia 
inducible factor 1 alpha (HIF-1α) levels with low doses of NO while demonstrating direct 
cytoxicity to spheroids with high doses of NO. 
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Chapter I. Introduction  
A. Nitric Oxide  
Nitric oxide (NO), one of small molecule bioregulators (SMBs), is endogenously 
generated from L-arginine via the enzyme nitric oxide synthase (NOS) in mammalian 
physiology1 and plays pivotal roles in diverse biological processes such as vasodilation,1 
platelet aggregation and adhesion,1 the immune response to infection,2,3 wound repair,4 
cancer biology and pathology5. Due to its integral role in human physiology, many disease 
states have been attributed to deficiencies in NO biosynthesis.6 Therefore, developing 
strategies for conveying NO to specific disease sites hold promise to many biomedical 
applications such as cardiovascular regulation,7–9 antimicrobial therapies2,10,11 and 
tumoricidal treatments12,13. However, depending on oxygen concentration and distance from 
vessel, NO has short extravascular half-life which is in a range of 0.09 to over 2 second,14 
and, its intravascular half-life is down to 2 ms.15 
Therefore, in order to achieve controlled NO delivery, different types of NO donors have 
already been investigated and synthesized. These include organic nitrates16, nitrites16, metal–
NO complexes17–25, chromium dinitrito (CrONO)26–33, nitrosamines16, N-diazeniumdiolates 
(NONOates)34–38, and S-nitrosothiols (RSNOs)39–46. In the Ford group, we are focusing on 
light sensitive metal-NO complexes and CrONO derivatives for photochemical NO delivery. 
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B. Photo-triggered NO Delivery 
In addition to reactivity and delivered sites of NO, precise dosage-control for NO 
delivery is another critical factor to influence the efficacy of such photochemical NO 
therapy.47,48 For example, at nanomolar concentrations, NO is a vasodilator49 and is 
cytoprotective50, while at micromolar concentrations, NO can suppress tumor growth5 and is 
a radiation sensitizer when administered in tandem with γ-radiation.51 Photochemical 
delivery can control the timing, dosage and location of NO release by administering the 
intensity and location of light irradiation. However, there are several key challenges 
associated with this approach in biological systems. One is the need to trigger NO release 
from photo-activated NO releasing moieties ("photoNORMs") using tissue-penetrating 
wavelengths (ideally NIR light),48 and the second is to develop targeting strategies for 
delivery to specific sites in vitro or in vivo. 
Most photoNORMs such as Ru-NO complexes require UV or visible light at 
wavelengths that do not deeply penetrate tissue to uncage NO.24,25 However, the optimal 
wavelength for light transmission through tissue is approximately 700 nm to 900 nm (the 
therapeutic window)52,53 where water, tissue and blood have low absorbance. Some research 
groups have worked on the synthesis of NIR light sensitive photoNORMs to address this 
issue.54,55 Others have already applied different types of NIR photosensitizers to indirectly 
trigger NO release via energy transfer between NO donors and the sensitizers in hybrid 
composites. Ford et al. have already utilized up-converting nanoparticles (UCNPs) as 
antennas to photosensitize the release of NO23,56 and of carbon monoxide (CO)57 from 
various precursors. The earlier proof-of-concept studies with UCNPs23,56,58 utilized Yb:Er- 
or Yb:Tm-doped NaYF4 nanocrystals as photosensitizers with 980 nm irradiation. However, 
  
3 
water has significant absorption after 900 nm wavelength. Therefore, Nd:Yb:Er- and 
Nd:Yb:Tm-doped nanocrystals59–62 or 100 % Er doped NaErF4 nanomaterials63 to serve as 
photosensitizers that operate with the 800 nm excitation have been considered to avoid 
overheating effect, since they should lead to less collateral damage to tissue. 
In addition to UCNPs, hollow gold nanoparticles (HGNs) and carbon dots (CDs) as 800 
nm photosensitizers were used in the photo-triggered NO delivery. Ford and his co-workers 
reported the first example of utilizing gold nanoparticle platforms for NO delivery with NIR 
external stimuli.64 The plasmonic HGNs can locally generate high temperature upon 
irradiation with biocompatible near infrared light (~800 nm) to further thermally decompose 
thiolated cupferron attached on the surface of HGNs to release NO. 
For CDs applications in NO photo-release, carbon nanomaterials are effective two-
photon absorbers that have been utilized in NIR photo-delivery for NO release based on 
their high two-photon cross-sectiones.65 Additionally, CDs have also been used as NIR 
photosensitizers to uncage carbon monoxide (CO)66, another SMB, and NO67 from their 
nano-composites via photocatalyic and photothermal decomposition, respectively.  
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C. NIR Photosensitizers 
C-1. Lanthanide-doped Upconversion Nanoparticles (UCNPs) 
Upconversion is a nonlinear optical process which converts absorbed two or multi-
photons at long wavelength to emit a single photon at shorter wavelength. Lanthanide-doped 
nanomaterials have long lifetimes of excited states and a ladder-like energy levels system to 
achieve such optical property.68 These so-called upconverting nanoparticles (UCNPs) 
usually consist of a crystalline host with lanthanide ions as dopants.69 The partly filled 4f 
orbital of lanthanide ions (Ln3+) has 4f - 4f electronic transitions that primarily contribute the 
unique photophysical properties and luminescence spectra are further influenced by the 
inorganic host material, the organic ligands, and surface quenching effects.70  
Typically, host materials are fluoride composites such as NaYF4 or NaGdF4.71 Ln3+ 
cations are substitutionally doped into these host composites to replace the trivalent cations. 
Electric dipole transitions in the anisotropic crystal field surrounding a dopant site are 
forbidden and strictly prohibited only in a spherically symmetric environment.70 Therefore, 
host materials such as hexagonal β phase of NaYF4 and NaGdF4 can have emission an order 
of magnitude greater than cubic α phase of NaYF4 owing to less symmetric lanthanide 
dopant sites in hexagonal structure.72,73 
Additionally, lanthanide dopants in UCNPs can serve as either photon absorbers or 
photon emitters by accepting energy from another species via energy transfer (ET). 
Therefore, varying the composition of lanthanide ions in such heterostructures can greatly 
influence their excitation and emission wavelengths as well as upconverting efficiency.70 
For general upconversion mechanism, Yb3+ and Nd3+ as NIR photon absorbers can be 
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excited at 980 nm and 800 nm respectively, and transfer energy to the emitters such as Tm3+, 
Er3+ and Ho3+ to correspondingly generate blue, orange and green emission if considering a 
single doping system.74 However, Almutairi and her co-workers recently show Er3+ ion 
possesses interesting energy levels that can absorb 800 nm and 980 nm photons, and have 
downshifted emission at 1550 nm as well as upconversion emission at 540 nm and 650 
nm.63 Therefore, in this case, Er3+ can not only serve as a NIR photon absorber but also act 
as an upconversion emitter. Particularly, they reported 100 % Er doped core-shell 
nanoparticles (NaErF4@NaLuF4) have upconversion emission intensity higher than the 5-
50% Er doped core-shell nanoparticles. However, unshelled 100 % Er doped core 
nanoparticles have totally opposite results.  So, the reason is that high dopant concentrations 
of UCNPs have predominant quenching process due to the energy migration to surface not 
the cross-relaxation between dopants. Thus, inert epitaxial shell growth on the surface of 
highly doping core UCNPs can prevent surface quenching to afford higher emission 
intensity. This research works will inspire scientists to work on heavily lanthanide-doping 
UCNPs for high upconversion efficiency. 
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C-2. Carbon Dots (CDs) 
Fluorescent carbon dots (CDs) were first discovered in 2004 as impurities of single-
walled carbon nanotube.75 Based on preparation method and solid morphology, carbon dots 
can be classified into three categories76,77: carbon quantum dots (CQDs), graphene quantum 
dots (GQDs) and polymer dots (PDs). CQDs are graphite or graphite-like nanoparticles 
while GQDs are graphene nano-fragments. PDs are made not only by several organic 
molecules with some functional groups such as thiol, hydroxy, carboxylic acid and amine 
but also synthetic or natural polymers under hydrothermal process.78–82  
Typically, GQDs have dimensions in the size range from 3 nm to 20 nm diameter that 
cause excitonic quantum confinement effect.83 Such carbon nanomaterials have been 
prepared by top-down fragmentation such as Hummers’ oxidation,84 electrochemical 
exfoliation,85–87 ultrasonic exfoliation88,89 and solvothermal cutting90–92 of graphene sheets 
or graphite materials. Because of their superiority in chemical inertness, biocompatibility,93 
low toxicity,94 high fluorescent quantum yield (QYf) up to 65%)95 and high two-photon 
absorption cross sections (up to 48000 Göppert-Mayer (GM) units)96,97, GQDs have 
potential applications in bioimaging, biosensor and biomolecule/drug delivery. Moreover, 
through surface passivation and modification, GQDs can either have enhanced 
photoluminescence property95 or exhibit photothermal effect67.   
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D. Versatile Strategies for Targeted NO Delivery  
The long-term goal of photochemical NO delivery is to develop versatile strategies to 
address the challenges described in Section B: application of appropriate wavelength to have 
deeper tissue penetration52,98 and avoid over-heating effect60 as well as development of 
methods for precise delivery47. Therefore, we are applying NIR sensitive photoNORMs and 
composites containing NIR photosensitizers and NO donors for NIR light triggered NO 
release. Additionally, two different targeted delivery strategies are designed and developed 
for precise NO therapeutics: macrophage-mediated micro-delivery and peptide-modified 
nano-delivery. 
For macrophage-mediated micro-delivery described in Chapter III, we applied polymer 
microemulsion technique to encapsulate a 794 nm sensitive manganese nitrosyl complex as 
a photoNORM54 and Nd3+ doped upconverting nanoparticles (Nd-UCNPs) as bioimaging 
agent59–62 into biocompatible poly(lactide-co-glycolide) (PLGA) spherical microparticles 
with ca. 1 micron size.99–101 Both components can be activated by tissue penetrating NIR 
light allowing for simultaneous therapeutic NO delivery and photoluminescence (PL) 
imaging capabilities with a single NIR laser source. Since tumors can send out signals to 
immune system and recruit monocytes/macrophages to comprise upto 50-70% tumor mass 
based on wound healing process,102 the microparticles engulfed by macrophages can be 
delivered into tumors and release NO upon NIR laser irradiation. 
For peptide-modified nano-delivery, we utilized GQDs as a 794 nm light responsive 
photosensitizer to photothermally trigger NO release67 from a new chromium (III) dinitrito 
complex (CrONO). GQDs with carboxylic acid can be covalently bonded with oleylamine to 
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generate hydrophobic oleyl GQDs via amide coupling and further assemble with 
biotinylated amphiphilic polyethylene glycol (PEG) lipids via entanglement of long aliphatic 
chains and van der Waals force to afford 55 nm (avg.) nano-carriers containing lipophilic 
domains. Hydrophobic CrONO can infuse into these domains58 and the surface of nano-
carriers can be modified with biotinylated cell penetrating peptides (CPPs) via biotin- 
streptavidin-biotin assembly to enhance penetrating ability to cancer cells.103  
Through these proof-of-concept investigations, we want to demonstrate NO can be 
carried into tumor and cancer cells by using designed carriers with different size and 
versatile delivery strategies. Moreover, we are able to tune the intensity of light to control 
specific concentration of NO release inside tumors for diverse therapeutic purposes. 
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Chapter II. The Synthesis  
A. Materials 
Section C&D: Benzylideneacetone (98%) was purchased from Alfa Aesar. 
Ethylenediamine (anhydrous) was purchased from TCI. Potassium carbonate (anhydrous) 
was purchased Fisher Scientific. Sodium borohydride, 1-(triphenylphosphoranylidene)-2-
propanone, 3-nitrobenzaldehyde, chromium(III) chloride tetrahydrofuran complex (1:3), 
sodium nitrite and sodium tetraphenylborate were purchased from Sigma-Aldrich. Sodium 
tetrafluoroborate (technical grade) was purchased from Baker&Adamson. 
Section E: Sodium tetraphenylborate, sodium trifluoroacetate, sodium oleate, ammonium 
fluoride, lanthanide chlorides (99.9+%), oleic acid (OA) (90%), 1-octadecene (ODE) (90%) 
were purchased from Sigma-Aldrich. 
Section G: Poly(vinyl) alcohol (PVA, Mw: 13000-23000), 4-morpholineethanesulfonic 
acid (MES, low moisture content, 99+%), immunoglobulin G (IgG from mouse serum), N-
(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDCHCl, commercial 
grade), sodium hydroxide (NaOH, ACS reagent grade) were purchased from Sigma-Aldrich. 
Poly(lactic-co-glycolic acid) (5050 DLG 8A, acid terminated) was purchased from 
Lakeshore Biomaterials. N-hydroxysuccinimide (NHS) was purchased from Pierce. 
Section H: Potassium permanganate (reagent grade) was purchased from 
Baker&Adamson, reagent). Phosphorus pentoxide was purchased from Fisher Scientific. 
Sulfuric acid, hydrochloric acid, dimethylformamide, hydrogen peroxide were purchased 
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from EMD. Graphite nanoparticles and graphene nanopowder (1-5nm) were purchased from 
SkySpring Nanomaterials. 
B. Analytical Instrumentation 
Absorbance spectra were taken on a Shimadzu UV-2401PC. Infrared spectra were taken 
using a Mattson Research Series FTIR. Fluorescence spectra were measured on a PTI 
fluorimeter equipped with a Hammamatsu R928P PMT. Nitric oxide was measured using a 
General Electric Sievers Nitric Oxide Analyzer NOA 280i. Samples were photolyzed with a 
3 watt 798 nm SheauPac fiber coupled laser module (actual excitation wavelength: 794 nm) 
or a 451 nm royal blue LED. NMR spectra were obtained on Varian 400 MHz or 500 MHz 
spectrometers. ESI-MS spectra were taken on a QTOF2 mass spectrometer (Waters 
Corporation). XRD spectra were obtained on a Bruker AXS D8 Discover GADDS X-Ray 
diffractometer (XRD). TEM images were obtained on a FEI Titan 300 kV FEG 
Transmission electron microscope. SEM images were obtained on a FEI Nova Nano 650 
FEG scanning electron microscope. AFM images were obtained on an Agilent 5500 atomic 
force microscope (Agilent Technologies) in tapping mode. X-ray photoelectron 
spectroscopy (XPS) was performed on a Quantum 2000 spectrometer, and the Al-Kα line 
was used as the excitation source. 
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C. Tetraaza-macrocyclic Ligands 
C -1. Ligand Design and Synthesis 
The advantage of photo-triggered drug delivery is that biological active component can 
be released upon light exposure to achieve precisely-controlling the dosage, location and 
timing of drug release in targeted sites.1 However, if these photosensitive pro-drugs leak out 
from their carriers during the transportation in the blood circulatory system and diffuse into 
skin tissues and eyes, it may cause patients who expose to ambient light to have side effect 
due to unexpected release of photosensitive drugs. Therefore, in order to address potential 
drug leakage from the polymeric carriers we developed, a hydrophobic ligand 5,12-
dimethyl-7,14-diphenyl-1,4,8,11-tetraazacyclotetradecane (PetA, 3), was synthesized by a 
modification of a published procedure.2 Compared to 1,4,8,11-tetraazacyclotetradecane 
(cyclam)3 and 5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane (TetA)4–6, the 
PetA ligand has intrinsically higher hydrophobicity due to introduction of two phenyl rings 
on the macrocyclic structure. (Figure II-C-1) The brief synthetic procedure of PetA 
analogue involves the reaction of the E form of a α-β unsaturated ketone such as 
benzylideneacetone with ethylenediamine to form a 14-member ring tetraaza-macrocyclic 
ligand with two diimine groups. (Scheme II-C-1) This unreduced ligand (PetA-diene) is 
moisture sensitive due to ring strain in its macrocyclic structure and would irreversibly 
decompose into two fragments with more stable π-conjugated structure via retro-Michael 
reaction.7 (Scheme II-C-2) However, once these two diimines are reduced with sodium 
tetrahydroborate (NaBH4) to generate tetraazacyclotetradecane, the PetA ligand becomes 
stable toward hydrolysis. 
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NH HN
NH HN
NH HN
NH HN
NH HN
NH HN
Cyclam TetA PetA  
Figure II-C-1. Three different 14-member ring tetraazamacrocyclic ligands. 
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Scheme II-C-1. The synthetic pathway of PetA ligand (3). 
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N H2N
NH2 N
Yellow color  
Scheme II-C-2. The decomposition of PetA-diene (2). 
 
Moreover, in order to increase the variability of the products from the coupling reactions 
for PetA, different functional groups such as hydroxyl (-OH) and amine (-NH2) can be 
introduced to its phenyl ring via general synthetic strategies for various (E)-4-(substituted 
phenyl) but-3-en-2-one.8 (Scheme II-C-3) However, commercial aminobenzaldehydes are 
too expensive to be applied in large-scale synthesis. Hence, a nitro group was used as a 
precursor of amine functional group and the (E)-4-(3-nitrophenyl) but-3-en-2-one (1”) was 
prepared by Wittig reaction. (Scheme II-C-4) The 5,12-dimethyl-7,14-bis(3-nitrophenyl)-
1,4,8,11-tetraazacyclotetradecane (NitroPetA, 3”) was synthesized by following the 
procedure similar to that used for the PetA synthesis. (Scheme II-C-5) However, the 
NitroPetA-diene ligand (2”) is very unstable compared to PetA-diene (2), and it even 
decomposes in deuterium chloroform (CDCl3) in 3 min. The possible reason for the 
decomposition is that the nitro groups on the phenyl rings as electron-withdrawing groups 
can stabilize π electrons on the π-conjugated system of decomposed fragments. Therefore, if 
some electron-donating groups such as hydroxyl (-OH) and amine (-NH2) are used instead 
of nitro group (-NO2), it would greatly enhance the stability of the PetA-diene analogues and 
increase the production yield. According to the crystal structure of NitroPetA (Figure II-C-
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2), it has a symmetrical structure with R, R, S, S configuration as same as PetA ligand.9,10 
Additionally, the circular dichroism spectrum shows this molecule has no chirality. (Figure 
II-C-3) 
 
H
O
O
PPh3
CH2Cl2
Reflux
O
R R
R= -OH, -NH2, -NO2 …et al.  
Scheme II-C-3. The general synthetic strategy for (E)-4-(substituted phenyl)but-3-en-2-
one.  
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Scheme II-C-4. The synthetic pathway of (E)-4-(3-nitrophenyl) but-3-en-2-one (1”). 
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Scheme II-C-5. The synthetic pathway of NitroPetA ligand (3”). 
 
 
Figure II-C-2. The crystal structure of NitroPetA ligand (3”) 
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Figure II-C-3. The circular dichroism spectra of NitroPetA (3”) ligand in 
dichloromethane. 
 
C-2. Synthetic Procedure 
PetA-diene (2): 5,12-Dimethy-7,14 diphenyl-l,4,8,11 tetraazacyclotetradeca-4,11-diene 
(PetA-diene) was synthesized by a procedure modified from that reported by Lloyd.1 
Benzyladineacetone (5 g, 1 equiv.) was dissolved in 3:1 anhydrous cyclohexane: anhydrous 
ethyl ether (50 mL) over anhydrous potassium carbonate (3.43 g, 0.72 equiv.) and the 
resulting solution was heated to 80 oC under argon atmosphere. Anhydrous ethylenediamine 
(2.27 mL, 1 equiv.,) was added dropwise to this solution. After 2.5 h the solution was 
filtered through a medium sintered glass frit to remove all solids.  The pale yellow filtrate 
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was reduced to dryness by rotary evaporation to afford a yellow residue. Cool ethyl ether 
(10 mL) was mixed with the residue to form a white solid suspension. The white powder 
was collected by filtration and washed with ethyl ether (3 x 5 mL). The yellow filtrate was 
collected, dried by rotary evaporation and re-suspended in 5 mL cool ether to obtain more 
white solid. All white powder was dried under vacuum for at least 24 h. Yield:  5.28 g 
(82%). ESI-MS (m/z): 376. Melting point: 133-135 oC.   
 
PetA Ligand (3): Reduction of PetA-diene afforded 5,12-dimethyl-7,14-diphenyl-
1,4,8,11-tetraaza-cyclotetradecane (PetA). A sample of PetA-diene (400 mg, 1 equiv.) was 
added to 20 mL of 200 proof ethanol at room temperature and solid NaBH4 (94 mg, 2.33 
equiv.) was then added to the solution. The reaction was heated at  50 0C for 2 h. The 
solution was then filtered to remove the solid sodium borate. The filtrate was reduced to 
dryness by rotary evaporation to afford a white paste.  This paste was subsequently 
suspended in water and then extracted into chloroform.  The chloroform solution was dried 
with MgSO4, filtered and reduced to dryness by rotary evaporation to afford a white solid.  
This solid was resuspended in diethyl ether, filtered and washed with diethyl ether (3 x 3 
mL) to afford a fluffy white powder. Yield: 331 mg (77%).  ESI-MS (m/z): 380. Anal. Calcd 
for C24H36N4: C, 75.74; H, 9.53; N, 14.72. Found: C, 75.70; H, 9.54; N, 14.60. 
 
 (E)-4-(3-nitrophenyl)but-3-en-2-one (1”): 3-Nitrobenzaldehyde (3.02 g, 20 mmol) and 
1-(triphenylphosphoranylidene)-2-propanone (7.00 g, 22 mmol) were dissolved in 20 mL 
dichloromethane (DCM), and the solution was refluxed under argon atmosphere overnight. 
After refluxing, the solution was dried by rotary evaporation. Silica gel column purification 
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was performed with hexane : DCM = 15:5 (v/v) eluent to afford a yellow powder (3.82 g, 
100%) after removing the solvent by rotary evaporation. 
  
NitroPetA-diene (2”): potassium carbonate (1.16 g, 8.37 mmol) was added into a 90 mL 
mixture of anhydrous cyclohexane : anhydrous diethyl ether = 2 :1. (E)-4-(3-
nitrophenyl)but-3-en-2-one (1”, 2.00 g, 10.46 mmol) was then added, and the solution was 
heated under reflux under argon atmosphere. Once all the yellow powder fully dissolved, 
anhydrous ethylenediamine (0.73 mL, 10.98 mmol) was slowly injected into the solution. 
The solution was refluxed with stirring for 8 h and then filtrated to remove the solid 
potassium carbonate to obtain a light yellow filtrate. The filtrate was dried by rotary 
evaporation and vacuum to afford viscous yellow liquid. 5 mL cool diethyl ether was added 
to the yellow liquid to precipitate out and collect white powder. The residue ether mixture 
was dried by rotary evaporation and vacuum again, and 3 mL cool ether was added to collect 
more white powder. The white powder is crude NitroPetA-diene (0.41 g, 16.8%) and has to 
totally be dried by vacuum for 1 day before using. 
 
NitroPetA Ligand (3”): Anhydrous NitroPetA-diene (0.524 g, 1.124 mmol) was 
dissolved into anhydrous ethanol dried by Molecular Sieve 3A from 200 proof ethanol, and 
sodium borohydride (0.34 g, 8.992 mmol) was immediately added to the ethanol solution. 
Until bubbling gradually ceased, the solution was heated up to 80 0C overnight to complete 
the reaction and then dried by rotary evaporation to afford crude white powder. The crude 
white powder was mixed with DCM and filtrated out insoluble impurities to collect filtrate. 
The filtrate was dried by rotary evaporation and washed with cool diethyl ether to obtain 
pure white powder (yield: 0.246 g, 46.6%). 
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D. Trans-Chromium(III) Dinitrito Complexes (CrONO) 
D-1. Discussion for CrONO Synthesis 
CrONO analogues have a high quantum yield for NO release in visible region and can be 
synthesized from trans-[Cr(L)Cl2]Cl.11 Generally, the trans-[Cr(L)Cl2]Cl can be prepared by 
chromium insertion into tetraaza-macrocyclic ligands such as cyclam12,13, TetA14, PetA7, 
NitroPetA and tetraphenylporphyrin (TPP)15–18 in dimethylformamide (DMF) under reflux.  
However, this procedure can also produce cis-[Cr(L)Cl2]Cl which does not give the trans-
chromium dintrito complexes needed for the photochemical experiments.19 (Scheme II-D-6) 
PetA ligand has two phenyl rings can create steric hindrance favors formation of trans-
[Cr(PetA)(Cl)2]+ (Yield: 70%) over cis-[Cr(PetA)(Cl)2]+ (Yield: 10%). (Figure II-D-4) The 
pink color of cis form complex can be separated from the cis/trans mixture by flash column 
chromatography with normal phase silica gel and dichloromethane (DCM) serve as an 
eluent. Moreover, the cis form can be converted to the trans form in DCM under reflux and 
argon atmosphere.  
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Scheme II-D-6. The synthetic pathway of trans-[Cr(PetA)(ONO)2]BF4 (6). 
 
 
Figure II-D-4. The crystal structure of cis-[Cr(PetA)(Cl)2]Cl (5) 
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Figure II-D-5 shows the crystal structure of trans-[Cr(PetA)(Cl)2]Cl (4). The green spot 
in the figure is chloride and can be replaced by nitrite under dark to from trans-
[Cr(PetA)(ONO)2]BF4 salt. (Figure II-D-6) 
 
 
 
Figure II-D-5. The crystal structure of trans-[PetACrCl2]Cl (4) 
 
 
 
Figure II-D-6. The crystal structure of trans-[Cr(PetA)(ONO)2]BF4 (6) 
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The primary amine group was introduced to PetA analogue for the purpose of coupling 
with carboxyl group on targets. As described in the Section II-C, commercial 
aminobenzaldehydes are so expensive that (4-aminobenzaldehyde: $75 USD/250 mg; 2-
aminobenzaldehyde: $185.5 USD/g) that it was deemed necessary to use a different 
synthetic stratedgy. Therefore, NitroPetA (3”) was synthesized, reacted with chromium(III) 
chloride tetrahydrofuran complex (1:3) to generate trans-[Cr(NitroPetA)(Cl)2]Cl (4”) and 
reduced to trans-[Cr(AminoPetA)(Cl)2]Cl (5”) under 30 psi H2 with Pd/C as a 
hydrogenation catalyst. (Scheme II-D-7) Figure II-D-7 shows trans-[Cr(NitroPetA)(Cl)2]Cl 
(4”) has the same configuration as trans-[PetACrCl2]Cl (4) and the nitro groups on the 
phenyl rings are successfully reduced to primary amine groups without affecting its 
configuration. (Figure II-D-8) For trans-[Cr(AminoPetA)(ONO)2]Cl (6”) synthesis, trans-
[Cr(AminoPetA)(Cl)2]Cl (5”) was dissolved into 200 proof ethanol and then mixed with 
excess amount of sodium nitrite. The solution was refluxed in the dark and under an argon 
atmosphere for 2 h. (Scheme II-D-8) The crude solution was dried by rotary evaporation 
and dissolved into DCM for ESI-MS experiment. (Figure II-D-9) Based on the mass 
spectrum, the molecular ion peak shows 554 m/z consistent with that expected for trans-
[Cr(AminoPetA)(ONO)2]+. However, the pure compound can’t be successfully obtained by 
following the same procedure as the preparation of PetACrONO due to its high solubility in 
water.  
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Here, I would like to share a possible purification method to obtain pure trans-
[Cr(AminoPetA)(ONO)2]+. The purification procedure may involve drying the post-reaction 
solution by rotary evaporation and follow by extracting the solid with acetonitrile (or DCM) 
to remove excess sodium nitrite and collecting the orange filtrate. Before removing excess 
sodium nitrite, the process can’t have water involved. The volume of filtrate is reduced to 3-
5 mL after which was added 1-2 mL 18 MΩ pure water (make sure pH of water is over 7). A 
saturated sodium tetraphenylborate solution in acetonitrile is slowly added to the mixture to 
give the expected 1:1 molar ration to the crude AminoPetACrONO used. House vacuum 
overnight is used to slowly evaporate the acetonitrile to give an orange solid that could be 
suspended in water collected by filtration. This could be recrystalized from DCM against 
diethyl ether.  
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Scheme II-D-7. The synthetic pathway to trans-[Cr(AminoPetA)(Cl)2]Cl (5”). 
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Figure II-D-7. The crystal structure of trans-[Cr(NitroPetA)(Cl)2]Cl (4”) 
 
 
 
 
 
Figure II-D-8. The crystal structure of trans-[Cr(AminoPetA)(Cl)2]BF4 (5”) 
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Scheme II-D-8. The synthetic pathway to trans-[Cr(AminoPetA)(ONO)2]+ (6”). 
 
 
Figure II-D-9. The ESI-MS spectrum of crude trans-[Cr(AminoPetA)(ONO)2]+  
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D-2. Synthetic Procedure 
trans-[Cr(PetA)Cl2]Cl: trans-[dichoro(5,12-dimethyl-7,14-diphenyl-1,4,8,11-
tetraazacyclo-tetradecane)chromium(III)] chloride was synthesized by a procedure modified 
from that reported by DeRosa et al.2  The ligand PetA (150 mg, 1 equiv.) was dissolved in 
anhydrous dimethylformamide (30 mL) at 150 oC.  CrCl3(THF)3 (149.2 mg, 1 equiv.) was 
added into the PetA solution under Argon purge. The solution was refluxed for 1 h and 
monitored by UV-vis spectroscopy. After cooling, the solution was dried by rotary 
evaporation and purified by silica gel column chromatography. The eluent DCM was used to 
wash out unreacted PetA and impurities, and the PetA chromium chloride was flushed out 
by methanol (MeOH). The methanol solution was dried by rotary evaporation, and a purple 
powder was obtained. Crude yield: 149 mg (70% yield). The powder was then dissolved in a 
minimal amount of MeOH and crystalized by vapor diffusion of diethyl ether to produce 
deep purple crystals.  Crystallization yield: 120 mg (63%).  ESI-MS (m/z): 502.18 (M+).  
Uv-Vis (ε in M-1cm-1) in methanol solution: 243 nm (2543) 389 nm (43), 439 nm (sh, 20), 
562 nm (18).  Anal. Calcd for C24H36Cl3CrN4: C, 53.49; H, 6.73; N, 10.40. Found: C, 51.07; 
H, 6.66; N, 9.87. 
  
trans-[Cr(PetA)(ONO)2]BF4: trans-[(5,12-dimethyl-7,14-diphenyl-1,4,8,11-
tetraazacyclotetradecane)dinitritochromium(III)] tetrafluoroborate was synthesized by a 
procedure modified from that described by Ostrowski et al for the cyclam analog.3   Sodium 
nitrite (1373 mg, 20 equiv.) was dissolved in anhydrous ethanol (30 mL).  The resulting 
solution was transferred via cannula into a round bottom flask containing trans-
[Cr(PetA)Cl2]Cl (539 mg, 1 equiv.) under subdued light. This solution was then refluxed in 
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the dark at 80 oC for 2 h. The reaction was removed from heat and filtered hot to afford a 
deep orange filtrate, which was passed through a 0.22 µm filter and reduced to dryness 
under vacuum.  The resulting orange residue was redissolved in a minimal amount of hot 1:1 
EtOH:H2O (5 mL) and added dropwise to a warm 1:1 EtOH:H2O solution (3 mL) of sodium 
tetrafluoroborate (105 mg, 1 equiv.). The solution was cooled overnight in a freezer and then 
filtered to give an orange powder (724 mg, 82% yield). Crystals were obtained slow vapor 
diffusion of ether into a concentated 9:1 DCM:MeOH to yield small, cubic orange crystals 
from which an X-ray crystal structure was obtained.  ESI-MS (m/z): 524.22 (M+). UV-vis 
spectrum (ε in M-1cm-1) in isobutyronitrile (iBN) solution: 257 nm (3008), 337 nm (276), 
491 nm (51). Anal. Calcd for C24H36BCrF4N6O4: C, 47.15; H, 5.94; N, 13.75. Found: C, 
47.30; H, 6.08; N, 11.60.  
 
 trans-[Cr(PetA)(ONO)2]BPh4: Trans-[(5,12-dimethyl-7,14-diphenyl-1,4,8,11-tetra-aza-
cyclotetradecane)dinitritochromium(III)] tetraphenylborate was synthesized by a procedure 
modified from that described by Ostrowski et al.3 Sodium nitrite (1444 mg, 20 equiv.) was 
dissolved in a 1:1 mixture of EtOH:H2O (30 mL).  The resulting solution was cannula 
transferred into a round bottom containing trans-[Cr(PetA)Cl2]Cl (564 mg, 1 equiv.) under 
subdued light. This solution was then refluxed in the dark at 80 oC for 2 h. The reaction was 
removed from heat and filtered hot to afford a deep orange filtrate, which was passed 
through a 0.22 µm filter and reduced to dryness under vacuum.  The resulting orange residue 
was redissolved in a minimal amount of hot 1:1 EtOH:H2O (5 mL) and added drop-wise to a 
warm solution (3 mL) of sodium tetraphenylborate (358 mg, 1 equiv.). The solution was 
cooled overnight in a freezer and then filtered to give an orange powder (724 mg, 82% 
yield). ESI-MS (m/z): 524.22 (M+).  UV-vis spectrum ε (M-1cm-1) in DCM solution: 247 nm 
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(2775), 339 nm (107), 493 nm (24). Anal. Calcd for C49H59BCrN6O4: C, 68.53; H, 6.92; N, 
9.79. Found: C, 68.57; H, 6.95; N, 9.70.  
 
trans-[Cr(NitroPetA)(Cl)2]Cl: NitroPetA (83.5 mg, 0.1776 mmol) was dissolved into 80 
0C 10 mL anhydrous dimethylformamide and heated to 152 0C under argon atmosphere. 
66.5 mg purple chromium(III) chloride tetrahydrofuran complex (1:3) was added into the 
solution and stirred for 3 min. The brownish purple solution was naturally cooled down to 
room temperature, dried by rotary evaporation and washed with 1 mL cool ethanol to afford 
crude purple powder (0.112 g, 55%). The purple crystal was obtained by a vapor diffusion 
of diethyl ether to methanol solution of crude purple compound.  
 
trans-[Cr(AminoPetA)(Cl)2]Cl: trans-[Cr(NitroPetA)(Cl)2]Cl (0.7 g, 1.18 mmol) and 
Pd/C (20 mg) were added into 10 mL anhydrous ethanol, and heated up to 50 0C with 
stirring. The reaction was performed under 30 psi hydrogen atmosphere overnight. The Pd/C 
was filtrated out and the magenta filtrate was collected and dried by rotary evaporator to 
obtain magenta powder (0.435 g, 65%). Magenta crystals were obtained by vapor diffusion 
of diethyl ether into an acetonitrile solution of the as-synthesized compound. 
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D-3. Photochemistry of trans-[Cr(PetA)(ONO)2]+ 
It has been shown that the chromium (III) dinitrito complex (CrONO) undergoes 
reversible photo-induced cleavage of the CrO-NO bond to release NO instead of Cr-ONO 
bond due to the high oxygen affinity of chromium.11,14,20 The centrosymmetric CrONO 
derivatives usually have Laporte forbidden d-d absorption bands between 450 and 500 nm 
and their extinction coefficients at that range are very small (~ 40-55 M-1 cm-1). However, 
the quantum yield for NO photo-release (ΦNO) is significant high up to ~30% at visible 
range. The absorption spectrum of trans-PetACrONO+ also has the same features as most of 
CrONO analogues. Figure II-D-10 shows the ligand field band of trans-
[Cr(PetA)(ONO)2]BF4 is at 491 nm with very low extinction coefficient (51 M-1 cm-1 in 
acetonitile). The spectrum also displays a n-π* intraligand band at 337 nm (276 M-1 cm-1 in 
acetonitile) and an intense π-π* band of the phenyl ring (3008 M-1 cm-1 in acetonitile).(Table 
II-D-1)20 
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Figure II-D-10. Electronic absorption spectrum of trans-[Cr(PetA)(ONO)2]BF4 in 
acetonitrile.  
 
 
Wavelength ε in M-1 cm-1 Peak Assignment 
257 nm 3008 π-π* 
337 nm 276 n-π* 
491 nm 51 d-d (LF) 
Table II-D-1. The peak assignment for electronic absorption spectrum of trans-
[Cr(PetA)(ONO)2]BF4 in acetonitrile. 
 
The quantum yield study of light-triggered NO release was performed by following a 
published procedure. (Figure II-D-11)11 The light resource is 451 nm LED with 18 mW 
d-d(LF) 
n-π* π-π* 
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power. A solution of trans-[Cr(PetA)(ONO)2]BF4 ( 0.5 mM) in isobutyronitrile was prepared 
and a 2.5 mL volume of the solution was added into the photolysis Y cell. During the 
photolysis experiment, the solution was purged with medical grade air to transport the NO 
generated to the Sievers Nitric Oxide Analyzer (NOA). Figure II-D-12 shows NO release as 
indicated by signals from a solution of 0.5 mM trans-[Cr(PetA)(ONO)2]BF4 in 
isobutyronitrile. Different irradiation times (1, 2, 2.5 and 3 sec) were applied in this study. 
The quantum yield of NO release can be obtained by plotting the NO produced versus the 
light absorbed;  the slope (0.318) is the quantum yield for NO release Φ(NO) for trans-
[Cr(PetA)(ONO)2]BF4. (Figure II-D-13) 
 
 
Figure II-D-11. Apparatus for measuring NO release quantum yields in solution where 
the purging gas (Medical-grade air) passes first through a solvent purge vessel to reduce 
evaporative losses then through the photolysis "Y" cell.  NO released from the photolysis 
cell is transferred to the Sievers Nitric Oxide Analyzer (NOA, GE model NOA-280i), where 
it is detected via a very sensitive, calibrated, chemiluminescence technique. 
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Figure II-D-12. NOA signals from the 451 nm LED photolysis of trans-
[Cr(PetA)(ONO)2]BF4 in isobutyronitrile at 18 mW power with different irradiation time (1, 
2, 2.5 and 3 sec). 
 
Figure II-D-13. Plot of NO produced versus light absorbed for the 451 nm photolysis 
(18mW) of trans-[Cr(PetA)(ONO)2]BF4 in isobutyronitrile under medical grade air purge.  
The slope (0.318) is the quantum yield for NO release Φ(NO). 
 
1	sec 
 
2	sec 
 
2.5	sec 
 
3	sec 
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E. Upconverting Nanoparticles (UCNPs) 
E -1. Discussion for UCNPs Synthesis 
The 800 nm absorbing Tm-UCNPs and Er-UCNPs were high quality core/shell 
upconverting nanoparticles (Figure II-E-1 & Figure II-E-2) synthesized using the robotic 
Workstation for Automated Nanocrystal Discovery and Analysis (WANDA) of the 
Molecular Foundry at the Lawrence Berkeley National Laboratory.21–23 The host material 
for the 10 nm cores  was NaYF4 with 20% Gd3+ to give hexagonal structures to give higher 
upconversion efficiency and were also doped with the lanthanide ions Yb3+ (30%) and Nd3+ 
(1.0%)..24,25 The XRD spectra of both types of UCNPs showed hexagonal patterns. (Figure 
II-E-3). Additionally, emitter dopant in the Tm-UCNPs was Tm3+ (0.5%)  and in the  Er-
UCNPs was Er3+  (0.5%). The 2 nm thick shells were NaGdF4 doped with Nd (20%) for 
both UCNPs. The shell minimizes surface quenching effects and improves the luminescence 
efficienies. The Nd3+ dopant in these 
NaYF4:Yb/Gd/Nd/Tm(30/20/1/0.5%)@NaGdF4:Nd(20%) and 
NaYF4:Yb/Gd/Nd/Er(30/20/1/0.5%)@NaGdF4:Nd(20%) core-shell nanoparticles has an 
absorption band at ca. 800 nm allowing these UCNPs to be excited at wavelengths (ca. 775-
825 nm, better absorption between 785-800 nm) where the absorption of water is minimal.26 
Energy transfer from the excited Nd3+ to Yb3+ in the core27 is followed by energy migration 
from Yb3+ to Tm3+ or Er3+, respectively,  from which various photoluminescence (PL) bands 
in the UV and visible range are observed. The PL spectra of these Nd doped UCNPs are 
shown in Figure II-E-4. 
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Figure II-E-1. TEM image of NaYF4:Yb/Gd/Nd/Tm(30/20/1/0.5%)@NaGdF4:Nd(20%) 
core-shell nanoparticles. 
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Figure II-E-2. TEM image of NaYF4:Yb/Gd/Nd/Er(30/20/1/0.5%)@NaGdF4:Nd(20%) 
core-shell nanoparticles. 
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Figure II-E-3. The XRD patterns for two cores NaYF4:Yb/Gd/Nd/Tm(30/20/1/0.5%) and 
NaYF4:Yb/Gd/Nd/Er(30/20/1/0.5%). 
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Figure II-E-4. The solid-state up-conversion photoluminescence spectra for core-shell 
Tm-UCNPs and Er-UCNPs under excitation by an 800 nm continuous-wave (CW) laser. 
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E -2. Synthetic Procedure 
The composition of UCNPs was modified from the literature.21–23 The robot known as 
WANDA in Molecular Foundry was applied to prepare these nanoparticles. All solutions 
used in the WANDA glovebox were deaerated. Oleic acid (OA) and 1-octadecene (ODE) 
were heated to 100 0C (no more than 110 0C) separately in three-necked round bottles under 
vacuum and then purged with nitrogen (N2) for deaeration. The deaerating cycle should be 
performed at 1000C for at least three times. The final pressure and temperature in the 
glassware should be around 160 mTorr and room temperature respectively before putting 
into a glove box. For the stock solution, YCl3 (2.43 mmol), YbCl3 (1.50 mmol), NdCl3 (0.05 
mmol), TmCl3 (0.025 mmol), GdCl3 (1.0 mmol), OA (26.834 g) and ODE (15.73 g) were 
mixed in a round bottle and deaerated by following the previous procedure. Then, the 
mixture was heated to 190 0C under N2 atmosphere to make sure all salts dissolved. The 
homogenous stock solution was cooled down to 100 0C and evacuated to 160 mTorr. After 
cooling down to room temperature, the degassed solution was transferred into the WANDA 
glovebox. For the core synthesis, sodium oleate (1.25 mmol), NH4F (20.00 mmol), stock 
solution (4.384 g, 10% of the stock), OA (0.569 g) and ODE (3.5 g) were added into 20 mL 
glass vial and heated to 315 0C with 30 0C/min heating ramp rate and 500.0 rpm stirring rate 
for 40 min. For particle purification, the core solution was transferred to a centrifuge tube 
and ethanol was added to form white colloidal solution. The white precipitate was obtained 
after centrifugation to remove excess OA and ODE, and washed with ethanol for two more 
times. The cores sample was weighed after vacuum drying. 
In order to increase UC luminescence efficiency, NaGdF4 shell doped with 20% Nd was 
grown on the surface of UCNP cores. The Gd/Nd shell stock solution (GdCl3: 3.20 mmol, 
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NdCl3: 0.80 mmol, OA: 7.1539 g, ODE: 9.4664 g) and 0.2 M NaTFA solution (sodium 
trifluoroacetate: 1.0095 g, OA: 9.0592 g, ODE: 21.3050 g) were prepared and degassed by 
following previous procedure. 6 mL ODE and 4 mL OA were added into dried UCNP cores 
and heated to 275 0C in the WANDA glovebox. The automated protocol alternated between 
injections of a 0.2 M NaTFA solution and a Gd/Nd stock solution in a 2:1 mole ratio of 
sodium to gadolinium precursor. One injection was performed every 15 min for a total of 12 
injections (6 injections for each precursor). After the last injection, the reaction was heated 
at 275 °C for an additional 30 min and then cooled down by N2 flow. The core/shell UCNPs 
was purified by following the same procedure of UCNPs cores. 
 
F. [Mn(dpaqNO2)(NO)]BPh4  
These procedures were carried out under reduced lighting. The [Mn(dpaqNO2)(NO)]ClO4 
salt was provided by Professor Hitomi.28 This perchlorate salt (119.3 mg?, 0.195 mmol) was 
dissolved in 3 mL solution of 1:1 acetonitrile/deionized (DI) water that was then added to a 
2 mL volume of acetonitrile in which was dissolved NaBPh4 (66.7 mg, 0.195 mmol). The 
resulting mixture was sonicated for 3 min after which most of the solvent was removed 
under reduced pressure.  The resulting hydrophobic black solid was suspended in aqueous 
solution then collected by filtration, washed with DI water and dried under vacuum. The 
solid was then dissolved in DCM and recrystallized by vapor diffusion of ether to produce 
crystalline black needles of [Mn(dpaqNO2)(NO)]BPh4.  
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G. IgG-modified micro-carriers 
The procedure of polymer micro-emulsion was modified from the literature.29–31 Acid-
terminated PLGA (100 mg) and ~80 µL of a solution of Nd-UCNPs in hexane (~10 mg 
UCNPs) were added into 500 µL DCM, and sonicated for 45 min at room temperature.  A 
14 mg sample of I was dissolved in a mixture of ACN (150 µL) and DCM (400 µL) to form 
a dark purple solution that was then transferred into the PLGA solution, and the mixture was 
sonicated until homogenous. If the volume of as-prepared solution was lower than 1.1 mL, 
more DCM was added. The polymer solution was slowly added into 200 mL of 1 wt% 
polyvinyl alcohol (PVA) aqueous solution contained in a 250 mL half-spherical container 
while the ultrasonic homogenizer was turned to 350 watts for 30 s. A dark brown colloidal 
solution formed immediately. The flask containing the colloidal suspension was fully 
covered with aluminum foil and stirred overnight to evaporate the volatile organic solvents. 
The milky solution was centrifuged to collect a solid, which was washed with 18 megohm 
pure water to remove the PVA. Following particle purification, the brown pellet was re-
suspended in 45 mL pure water and then the 1-micron particles were separated by different 
centrifuge speed (4000 rpm to remove particles < 500 nm and 300 rpm to remove particles 
size > 3 µm). The resulting micro-particles were dried under vacuum and re-suspended in 
0.1 M pH 5.5 MES buffer solution with the concentration of 1 mg/mL. 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDCHCl) (70.94 µmole/1 mg particles) 
and N-hydroxysuccinimide (NHS) (106.87 µmole/1 mg particles) were added into the 
colloidal 2-(N-morpholino)ethanesulfonic acid (MES) solution which was then sonicated at 
room temperature for 30 min. Subsequently, 10 µL IgG solution (11.21 mg/mL) per 1 mg 
micro-particles was added and the mixture stirred overnight. The IgG modified particles 
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were collected by centrifugation and washed with 18 megohm pure water for at least three 
times. IgG concentration was determined with a micro bicinchoninic acid (BCA) assay 
according to the manufacturer’s instructions. After incubation, particles were removed from 
solution with centrifugation to avoid light scattering during absorbance measurements.  
Initially, a beaker was utilized during the emulsion process, however; better yields were 
obtained using a half-spherical glass flash, since there are no corners in the latter and the 
sonic energy is distributed equally preventing settling and allowing more of the PLGA to 
form particles of the correct size. 
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H. Carbon Dots (CDs) 
There are two comprehensive preparation strategies for carbon dots (CDs): bottom-up 
techniques32–37 and top-down techniques38–42. Generally, the bottom-up technique is to 
graphitize carbohydrates or organic carbon sources under high temperature and pressure 
while the top-down technique is to break down and exfoliate bulk graphite via 
electrochemical exfoliation43–51, Hummers’ method52,53 or solvothermal decomposition42,54–
57. In most cases, the latter methods can generate carbon quantum dots (CQDs) and graphene 
quantum dots (GQDs). Here, two top-down methods for GQDs preparation were described. 
 
H-1-1. Electrochemical Exfoliation 
The method of electrochemical exfoliation is modified from the previous literature 
procedure.46 A bulk graphite serves as an anode electrode while a platinum net acts as a 
cathode electrode. The electrolysis was performed in a 0.1M (NH4)2SO4 aqueous solution 
with 10 V DC power supply for one h. The graphite electrode was gradually exfoliated and 
broken down into small pieces of graphite in the beaker. (Figure II-H-1) This preparation 
also generated a lot of carbon particles suspended in the electrolyte. There is no evidence to 
prove if they are graphene-like but the TEM image indicates the distribution of particle size 
is between 1.0 and 4.0 nm. (Figure II-H-2 & Figure II-H-3) Therefore, I prefer to call them 
carbon quantum dots (CQDs). The procedure of purification is that the electrolyte excluding 
massive graphite fragments was decanted into 50 mL centrifuge tubes and then centrifuged 
under 5000 rpm for 20 min. The black precipitate was obtained and resuspended into 18 
megaohm (MΩ) pure water under sonication for 30 min. The black suspension was 
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centrifuged under 5000 rpm for 20 min to obtain purified black precipitate. The black solid 
was dried under vacuum and then suspended in 25 mL DMF with 4 h sonication. The DMF 
solution was kept in a hood overnight to precipitate most of the aggregates. The top 
dispersion solution was used for the characterization of optical property and morphology.  
The UV-vis absorption spectrum shows the same features reported in literature.58  
(Figure II-H-4) Additionally, under 335 nm and 365 nm excitation, the photoluminescence 
(PL) spectrum shows the as-prepared CQDs to have a blue emission that matches the 
published data.51 (Figure II-H-5) The process of electrochemical exfoliation generally 
doesn’t introduce many hydrophilic and electron-withdrawing functional groups such as 
carboxylic acids and amines on the surface of CQDs.  This kind of pristine CQDs usually 
has blue emission and don’t suspend in pure water very well. Additionally, they can’t be 
straightforwardly bonded with other targets that possess common functional groups such as 
carboxylic acids and amines for further application in photosensitizer. Deng et al. utilized 
Billups-Birch reduction to modify pristine graphitic carbon particles with a long chain n-
alkyl carboxylic acid58, which can covalently bond with primary amine functionalized 
compounds via amide coupling. Unfortunately, Dr. Deng’s student, Xue-Huan Song, and I 
can’t repeat their synthetic method. Additionally, the yield of electrochemical preparation 
for CQDs is quite low in our case even though the preparation procedure is relatively simple 
compared with other published methods.33,42,59 
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Figure II-H-1. A bulk graphite under electrolysis in 0.1 M (NH4)2SO4(aq) to generate 
exfoliated graphite. 
 
 
 
Figure II-H-2. The TEM image of purified carbon quantum dots. 
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Figure II-H-3. The size distribution of purified carbon quantum dots (number of particles 
>30). 
 
 
Figure II-H-4. The absorption spectrum of carbon quantum dots in DMF. 
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Figure II-H-5. The emission spectrum of carbon quantum dots in DMF with different 
excitation wavelength (335 nm and 365 nm). 
 
H-1-2. Possible Improvement 
To the best of my knowledge, electrochemical exfoliation is the most easy and feasible 
method to prepare high-quantity CQDs. Therefore, in order to improve this top-down 
strategy, I would like to provide a modified procedure for further study.  
At the beginning of this project, the graphite ingot block was used for electrolysis and 
the yield of CQDs production is very low due to low surface area to interact with electrolyte 
via an intercalation mechanism. Therefore, the shape of graphite electrode is one of 
important factor to increase the production yield and commercial graphite rod would be a 
good candidate with higher surface area.60 Moreover, an acidic electrolyte solution would be 
possible to introduce carboxyl function group on the surface of CQDs for amide coupling 
with targets.61–63 After washing out all electrolyte, long sonication in organic solvent such as 
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DMF or ethanol may exfoliate and break down more graphene nanosheet or graphite 
particles to further increase the preparation yield.64,65  
 
H-2. Hummers’ Oxidation/ Solvothermal Decomposition 
Hummers’ oxidation is a general method to produce graphene/graphene oxide sheets 
from graphite.52 Through this oxidation process, graphene oxide sheets have significant 
defects and can be broken down into small fragments via solvothermal decomposition.42,56 
Gong et al. reported a method to synthesize nitrogen doped graphene quantum dots (N-
GQDs) with high two-photon cross section (48000 Göppert-Mayer units).42 However, the 
synthetic condition can’t be repeated and the yield of N-GQDs production is too low to be 
applied in our photo-triggered drug delivery system. The possible reason could be that the 
graphite powder (325 mesh) we used is not easy to oxidize and created significant defects on 
rigid conjugated sp2 structure. Therefore, a modified method by using graphite nanoparticles 
with high surface area was performed to increase the preparation yield.  
The preparation procedure for N-GQDs was modified from the published method.42,66 
Graphite nanoparticles (15 g, SkySping Nanomaterials) were gradually added into 90 mL 
concentrated H2SO4 mingled with 12.5 g K2S2O8 and 12.5 g P2O5 at 80 0C with gently 
stirring. The mixture was stirred at 80 0C for 4.5 h and then diluted with 500 mL 18MΩ pure 
water at 0 0C. After stirring overnight at room temperature, the diluted solution was 
centrifuged at 13000 rpm for 8 min to obtain a black pellet. The black pellet was suspended 
in 300 mL concentrated H2SO4 at 0 0C and 24 g KMnO4 was slowly added into the mixture 
with vigorous stirring. The solution was heated up to 35 0C for 2 h and then poured into 700 
mL DI water at 0 0C with 2 h stirring. 30% H2O2 was slowly dropped into the acidic solution 
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until bubble ceased and 10 % (v/v) HCl (1L) was well mixed with the solution. After 
centrifugation at 8000 rpm for 30 min, the gray yellowish pellet was collected. The pellet 
was washed with DI water three times and then dried under vacuum. The oxidized carbon 
pellet was re-dispersed into 80 mL dimethylformamide (DMF) and the suspension was 
sonicated for 2 h at least. The post-sonicated solution was transferred to a Teflon-lined 
autoclave and heated to 200 0C for 10 h. After naturally cooling down the temperature of 
solution, the DMF solution was centrifuged at 8000 rpm for 30 min to collect yellow 
solution. The black pellet was re-suspended into clean DMF and sonicated for 4 h. The pale 
yellowish solution was obtained with the same centrifugation condition. High quantity of N-
GQDs can be extracted from the black pellet through by least 10 times of DMF extraction. 
The solution was dried by rotary evaporator and dissolved into DI water. The as-prepared N-
doped GQDs aqueous solution was dialyzed with a 200 MWCO dialysis bag against 18 MΩ 
pure water for 3 days to remove DMF residues, which display blue fluorescence. The pure 
N-doped GQDs was used for further characterization.  
 
H-2-1 Morphological Analysis 
Since size influences the optical property of quantum dots67, the morphology of N-GQDs 
was studied by transmission electron microscopy and atomic force microscopy (AFM). 
Regarding the contrast issue of TEM imaging between the graphene-like particles and 
support films on cupper grids, the TEM grids I used were coated with ultrathin carbon films. 
According to the TEM image, most of N-GQDs are circular shape (Figure II-H-6) and size 
distribution is between 2 and 7 nm (Figure II-H-7). The average size of N-GQDs is 4.04 
nm, which is similar to the literature report.42 Additionally, an AFM scan was performed on 
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a mica substrate by using an Agilent 5500 AFM instrument in tapping. Figure II-H-8 shows 
several N-GQDs were placed on the mica sheet, and Figure II-H-9 is the associated 3D 
image to exhibit height dimension of each N-GQD. The thickness of N-GQDs is between 
0.8 and 3.3 nm. Considering that one layer of graphene is ca. 0.75 nm58,68, N-GQDs have 
one to six layers and the average is three layers (1.48 nm). (Figure II-H-10) 
 
 
Figure II-H-6. The TEM image of N-GQDs on a copper grid supported with an ultrathin 
carbon film. 
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Figure II-H-7. The size distribution of N-GQDs. 
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Figure II-H-8. The 2D AFM topographic image of N-GQDs on a mica sheet. 
 
 
 
Figure II-H-9. The 3D AFM topographic image of N-GQDs on a mica sheet. 
Line	1 
Line	2 Line	3 
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Figure II-H-10. The line-scan height profile of N-GQDs on a mica sheet. 
 
H-2-2 Matrix-assisted Laser Desorption/Ionization - Time-of-flight Mass 
Spectrometry (MALDI-TOF-MS) 
In order to study mass change in the top-down strategy for GQDs preparation, matrix-
assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) 
was applied to this experiment. The MALDI-TOF experiment shows the mass-to-charge 
ratio of N-doped GQDs (740-3250 m/z) is greatly smaller than their starting materials, 
graphite nanoparticles (2000-5000 m/z). (Figure II-H-11) According to the literature69, a 1 
nm of square of graphene has around 38 carbons, which is equal to a molecular weight of 
456. Assuming that as-prepared N-GQDs are only one layer thick and square, their size 
distribution would be between 2-7 nm based on the MALDI-TOF result and matches the 
TEM result (Figure II-H-7). This method can help us quickly predict the particle sizes 
without utilizing expensive electron microscopy. 
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Figure II-H-11. The MALDI-TOF mass spectra of graphite nanoparticles and N-GQDs. 
 
H-2-3 Fourier-transform Infrared (FT-IR) Spectroscopy 
N-GQDs ethanol solution was dropped on a calcium fluoride (CaF2) window and 
gradually evaporated the ethanol. The solid-state FT-IR spectrum shows N-GQDs have a 
broad peak at 3268 cm-1 that represents O-H stretching of carboxylic acid. (Figure II-H-12) 
The peak of 1712 cm-1 in the spectrum is associated with the C=O stretching mode of a 
carboxylic acid. These two evidences prove N-GQDs have the carboxyl functional group. IR 
peaks at 2944, 2925 and 2852 cm-1 reveal N-GQDs also have sp3 C-H bonds while the peak 
at 1620 cm-1 indicates that they have C=C bonds in the structure. Additionally, the multiple 
peaks between 1432 and 1463 cm-1 represent the aromatic C=C bending modes and indicate 
this carbon nanomaterial still maintains aromaticity. 
740 m/z 
2000-5000 m/z 
740-3250 m/z 
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Figure II-H-12. The solid state IR spectrum of N-GQDs on a CaF2 window. 
 
H-2-4 X-ray Photoelectron Spectroscopy (XPS) 
In addition to FT-IR spectroscopy, x-ray photoelectron spectroscopy (XPS) was applied 
to investigate possible functional groups on the surface of N-GQDs. In comparison to the 
XPS survey spectrum of graphite nanoparticles, N-GQDs have tremendously higher 
intensity of N 1s peak (399.5 eV). (Figure II-H-13) The reason could be that dimethyl 
amine decomposed from DMF under high temperature reacts with some functional groups 
such as epoxide on the surface of GQDs under ring-opening mechanism.42 Additionally, 
according to the deconvoluted XPS spectrum of N-GQDs for the C 1s peak (Figure II-H-
14), these carbon nanoparticles have a peak at 285.1 eV representing C-N bonds.70 The peak 
at 283.9 eV is attributed to the abundant C=C bonds in the π- conjugated network after 
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Hummers’ oxidation and solvothermal decomposition.42 Especially, the O-C=O bond (287.8 
eV) is introduced to N-GQDs and can be assigned to carboxyl group based on its FT-IR 
spectrum.70   
 
 
Figure II-H-13. XPS survey scan spectrum of graphite nanoparticles and N-GQDs. 
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Figure II-H-14. C 1s high resolution XPS spectrum of N-GQDs. 
H-2-5 UV-vis Spectroscopy and Photoluminescence Spectroscopy 
The aqueous solution of N-GQDs is pale yellow and has strong green emission under 
365 nm irradiation (Figure II-H-15a). The UV-vis absorption spectrum of N-GQDs 
dispersed in 18 MΩ water shows an peak at 227 nm that is attributed to the π - π* transition 
of C=C bond42 and a peak at 322 nm, which is consistent with the literature data44. (Figure 
II-H-15b) The photoluminescence (PL) spectra present green emission under various 
wavelength excitations (Figure II-H-15b), and the fluorescent quantum yield (QYf) was 
measured by following the literature.58,71 Rhodamine B in ethanol (200 Proof) with 65% 
fluorescent quantum yield (ΦR) acts as a reference. The QYf  (Φx) of N-GQDs was 
calculated according to the following equation: 
  
Gradx and GradR represent the gradient from the plot of integrated emission intensity vs 
absorbance at 365 nm. (Figure II-H-16) nx and nR are the refractive index of solvent I used 
for N-GQDs (water: 1.845) and rhodamine B (ethanol: 1.847). The subscript “x” refers to 
the N-GQDs while “R” refers to the reference. The QYf of N-GQDs is 2.31% that is smaller 
than some of literature reports.42,54,57,58 The possible reason is that N-GQDs have a 
significant amount of carboxylic acid and epoxide groups that serve as nonradiative 
electron-hole recombination centers to decrease the PL efficiency and increase the heat 
losses.57 Therefore, these carbon nanomaterials may have photothermal effects that will be 
described in next section. (H-2-6 Photothermal effect) 
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Figure II-H-17 shows two-photon induced fluorescence spectrum of N-GQDs aqueous 
solution under 800 nm femtosecond laser excitation with 560 mW power, 80 MHz repetition 
rate and 140 fs pulse for 5 s exposure. The reference is fluorescein and the estimated two-
photon cross section is 5 GM.  
 
 
 
 
Figure II-H-15. (a) The photograph show N- GQDs aqueous solution without (left) and 
with (right) UV lamp (365nm) irradiation. (b) The absorption and emission spectra of N-
GQDs aqueous solution. 
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Figure II-H-16. A plot of integrated emission intensity vs absorbance at 365 nm. 
 
 
Figure II-H-17. Two-photon-induced fluorescence spectrum of N-GQD aqueous solution 
with concentration of 264 µg/mL under 800 nm femtosecond laser excitation. 
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H-2-6 Photothermal effect 
Chen et al. have reported that graphene nanoparticles can convert NIR light to heat.59 
However, they didn’t report how they set up the experiment and what the power density of 
laser they used. Therefore, in order to study the photothermal phenomenon, 2 mL aqueous 
solution of N-GQDs with concentration in 2 µg/mL was prepared and added into a designed 
cuvette with a magnetic stir bar. (Figure II-H-18) The whole system wasn’t isolated from 
the environment and the solution was stirred during the measurement. The real-time 
temperature record was performed by using a temperature recorder with two K-type 
thermocouples. One thermocouple was inserted into the sample cell while another was 
inserted into the control cell that only contained pure water. The value of temperature 
increased is the subtraction between two cells.  In comparison to 18 MΩ pure water, the 
temperature of N-GQDs(aq) increase 0.5 0C under 794 nm laser irradiation with a power 
density of 19.95 W/cm2 for 30 min exposure. (Figure II-H-19) 
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Figure II-H-18. The setup for a photothermal experiment with a designed cuvette. 
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Figure II-H-19. The plot of temperature increased vs irradiation time. The sample 
solution (pure water or GQDs(aq)) was added into a designed quartz cell and irradiated by a 
794 nm diode laser for 30 min in an open system.  
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III. Macrophage-Mediated Delivery of Light Activated Nitric Oxide Prodrugs for 
Cancer Therapy with Spatial, Temporal and Concentration Control 
A. Abstract 
Nitric oxide (NO) holds great promise as a treatment for cancer hypoxia; however, 
precise control over its dosage and localization is necessary to assure success. Often, these 
factors are difficult to control due to the short biological half-life of free NO and diffusion 
limitations of NO releasing molecules to areas of tumor hypoxia. Here, we describe a 
method to provide spatial, temporal, and concentration control over NO-based cancer 
therapies by utilizing bone marrow derived murine macrophages (BMMs) as carriers for 
biodegradable polymeric micro-particles containing the photoactivated NO releasing moiety, 
[Mn(NO)dpaqNO2]BPh4, and Nd3+ doped upconverting nanoparticles (Nd-UCNP). Both 
components are activated by tissue penetrating near-infrared (NIR) light allowing for 
simultaneous therapeutic NO delivery and photoluminescence (PL) imaging capabilities 
with a single NIR laser source. The micro-particles were determined to be non-toxic to their 
macrophage hosts in the absence of light and to demonstrate the ability to generate 
intracellularly localized NO upon NIR excitation. Histological sectioning revealed that the 
macrophages penetrate deep into large NIH-3T3/4T1 cocultured tumor spheroids. NIR laser 
excitation of these macrophage treated spheroids led to the release of measurable amounts of 
NO that could be quantified in quasi real-time. Furthermore, the Nd-UCNP PL demonstrated 
macrophage infiltration into the spheroids. Most strikingly, by varying light source intensity, 
we were able to garner control over NO release rates reducing hypoxia inducible factor 1 
alpha (HIF-1α) levels with low doses of NO while demonstrating direct cytoxicity to 
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spheroids with high doses of NO. The use of macrophages as “Trojan Horses” to carry 
micro-particles with a theranostic payload represents a novel approach that overcomes 
challenges often faced with therapeutic administration of NO and offers the potential of 
multiple treatment strategies with a single system.  
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B. Introduction 
In many solid tumors, the rapid rate of tumor cell growth leads to hypoxic areas with 
poor blood supply and low oxygen concentration.1 Such hypoxia serves as a signal to begin 
the wound healing process through the production of prosurvival and proliferative factors 
such as hypoxia-inducible factor 1-α (HIF-1α) and vascular endothelial growth factor 
(VEGF).2,3 While this response to hypoxia is crucial for efficient wound healing, its 
implementation in areas of tumor hypoxia is the cause of problems such as resistance to 
chemotherapy and radiation leading to poor prognosis and reduced survival.3,4 
Nitric oxide (NO) has exhibited significant potential as a cancer therapy; however, its 
effects are highly dosage- and location-dependent.5 Previous reports have indicated that high 
NO concentrations can induce p53 (~300 nM) or nitrosative stress mediated apoptosis 
(>1000 nM).5–7 Low concentrations (hundreds of pM and tens of nM) have been shown to 
produce beneficial shifts in the composition of the tumor microenvironment through the 
reduction of factors such as p-glycoprotein and HIF-1α that have been implicated in 
providing cancer cells with increased resistance to traditional chemotherapeutics like 
doxorubicin as well radiation therapy.8–11 In contrast, intermediate concentrations of NO 
have tumor protective effects through apoptosis resistance caused by the stabilization of 
proteins such as HIF-1α and protein kinase B (Akt-P).5 
Its relatively short lifetime in physiological media and significant systemic side effects 
have made NO difficult to implement as a therapy for cancer without an effective targeting 
strategy.6 One such approach is to use photo-activated NO releasing moieties 
(photoNORMs), since triggering with light provides precise spatial and temporal control of 
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delivery.12,13 However, this methodology is limited by the strong wavelength dependence of 
light transmission through tissue.14 Ultraviolet and shorter visible wavelengths have much 
less tissue penetration than do longer red or (ideally) near-infrared (NIR) wavelengths. The 
ability of NIR light to penetrate deeper into tissue has inspired various approaches to 
designing photoNORM systems including the engineering of molecular compounds that are 
photoactive at longer wavelengths15,16 and the use of antennas for multi-photon sensitization 
of NO release with NIR light.12,17 However, delivering these conjugates to the desired 
physiological targets continues to be challenging.  For example, it is difficult to make such 
delivery to hypoxic areas of tumors, where the vascular structures are poorly developed,18 
via simple diffusion from the blood stream. 
It is well established that tumor hypoxia generates inflammatory signals. These signals 
recruit monocytes from the blood via chemotaxis, and once at the site, these cells 
differentiate into macrophages that are inactivated from their normal roles as immune cells. 
As a result, macrophages can make up 50-70% of a tumor mass in some cases.1,18 With this 
in mind, several recent studies have utilized macrophages as drug carriers19,20 and 
demonstrated the ability to localize drugs in areas of hypoxia at levels difficult to attain with 
conventional delivery methods.18,21–23 While these payloads may be tumorcidal, recent 
research has indicated the importance of being able to control the tumor microenvironment 
to assure long term therapeutic success.24 
Figure III-B-1 shows the present study demonstrates the utility of macrophages as 
carriers of micron-sized, immunoglobulin G (IgG) coated, poly(lactic-co-glycolic acid) 
(PLGA) micro-particles in which one can incorporate different  payloads.  The encapsulated 
payload here included a photoNORM that can be triggered for NO release by NIR light,15 as 
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well as Nd3+ doped upconverting nanoparticles (Nd-UCNPs) to provide imaging capabilities 
under NIR light.25 BALB/c bone marrow derived macrophages (BMMs) were shown to 
phagocytose large numbers of these micro-particle carriers. The use of macrophages allowed 
for far deeper penetration of drug into large NIH-3T3/4T1 cocultured tumor spheroids than 
the micro-particles alone. It is shown that, once carried inside the spheroid by the BMM, the 
photoNORM in the micro-particles can be activated with NIR light. Furthermore, at high 
light intensity, NO concentrations sufficient to cause direct tumor cytotoxicity were 
generated, while at low light intensity, the NO released led to striking changes in the tumor 
microenvironment as evidenced by a significant drop in HIF-1α expression.  
 
 
Figure III-B-1. Macrophage-mediated delivery of micro-particles containing a 
photoNORM and UCNPs for NIR light triggered NO release. 
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C. NIR active photoNORM and bioimaging Nd-UCNPs  
The cell-mediated delivery platform described here consisted of murine bone marrow 
macrophages (BMMs) loaded with polymer-based micro-carriers in which were 
incorporated an NIR sensitive photoNORM and NIR active bioimaging Nd-UCNPs. The 
photoNORM was prepared by metathesis of the water-soluble [Mn(dpaqNO2)(NO)]ClO4  
(dpaqNO2  = 2-[N,N-bis(pyridin-2-ylmethyl)]-amino-N′-5-nitro-quinolin-8-yl-acetamido) with 
sodium tetraphenylborate to give the corresponding, hydrophobic photoNORM 
[Mn(dpaqNO2)(NO)]BPh4 (I). The hydrophobicity was needed to minimize leakage of I from 
the micro-carrier to the medium. This BPh4– salt was further purified by recrystallization to 
obtain black needle crystals. Figure III-C-1 shows the spectrum of I in acetonitrile. Although 
λmax of the longest wavelength band is ~ 650 nm, this absorbance extends to the NIR region 
s (ε: 20.2 M-1cm-1 at 794 nm) and overlaps with the 794 nm diode laser used as the 
excitation source in the present study. (Figure III-C-1 Inset) Direct 794 nm photolysis of I 
in acetonitrile solution does indeed lead to NO release as measured using the Sievers Nitric 
Oxide Analyzer (NOA) with a quantum yield of 0.18. (Figure III-C-2 and Figure III-C-3).  
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Figure III-C-1. Absorption spectrum of [Mn(dpaqNO2)(NO)]BPh4 in acetonitrile and the 
emission spectrum of 794 nm diode laser (Inset). 
 
 
 
 
0.2	sec 
0.4	sec 
0.6	sec 
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Figure III-C-2. NOA signals from the 794 laser photolysis of [Mn(dpaqNO2)(NO)]BPh4 
in acetonitrile at 1.9 W/cm2 power density with different irradiation time (0.2, 0.4 and 0.6 
sec). 
 
Figure III-C-3. Plot of NO detected vs light absorbed. 
 
The Nd-UCNPs were high quality core/shell upconverting nanoparticles (Figure 1, 
bottom) synthesized using the robotic Workstation for Automated Nanocrystal Discovery 
and Analysis (WANDA) of the Molecular Foundry at Lawrence Berkeley National 
Laboratory.26–28 The core host material with 10 nm size was NaYF4 with 20% Gd3+ to give a 
hexagonal structure to give higher upconversion efficiency,29,30 and this was doped with the 
lanthanide ions Yb3+ (30%), Nd (1.0%) and Tm (0.5%). The shell with 2 nm thickness was 
NaGdF4 doped with Nd3+ (20%). The shell minimizes surface quenching effects and 
improves the luminescence efficiency of UCNPs. The Nd3+ dopant in these 
QY(NO	release):	0.18 
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NaYF4:Yb/Gd/Nd/Tm(30/20/1/0.5%)@NaGdF4:Nd(20%) core-shell nanoparticles (Nd-
UCNPs) has an absorption band at ca. 800 nm allowing these materials to be excited at 
wavelengths (ca. 775-825 nm, better absorption: 785-800 nm) where the absorption of water 
is minimal.25 Energy transfer from the excited Nd3+ to Yb3+ in the core,31 followed by 
energy migration from Yb3+ to emitter Tm3+ from which various photoluminescence (PL) 
bands in the UV and visible range are observed. The transmission electron microcopy 
(TEM) and PL spectra of these Nd-UCNPs are shown in Figure III-C-4. 
 
 
 
 
Figure III-C-4. TEM image of NaYF4:Yb/Gd/Nd/Tm(30/20/1/0.5%)@NaGdF4:Nd(20%) 
core-shell nanoparticles. Inset: The upconversion emission spectrum of Nd-UCNPs under 
excitation by an 800 nm continuous-wave (CW) laser. 
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D. Polymer Microencapuslaton 
We encapsulated BPh4 salt of the Mn photoNORM and Nd-UCNPs into PLGA 
microparticles with ca. 1-micron size and spherical shape via micro-emulsion technique 
(Figure III-D-1).32,33 The average loading of the manganese photoNORM is 4.36 ± 0.66 wt% 
determined by inductively coupled plasma atomic emission spectroscopy (ICP-AES). 
Initially, a beaker was utilized during the emulsion process, however; low yields of particles 
were obtained. This was replaced by a half-spherical glass bottle to increase the preparation 
yield of micro-carriers. In a beaker vibration from the homogenizer is unable to reach the 
corners of the vessel allowing PLGA to settle lowering the yield. In a round vessel, there are 
no corners and sonic energy is distributed equally preventing settling and allowing more of 
the PLGA to form particles of the correct size. The spherical particles have the optimal 
shape for phagocytosis (Figure III-D-2).34 Particles range in size between 350 nm and 2 µm. 
(Figure III-D-3 and Figure III-D-4) The PLGA utilized to produce these microcarriers is 
acid terminated. This provides free carboxylates on the surface of micro-carriers that were 
modified with immunoglobulin G (IgG) by amide coupling in 0.1 M pH 5.5 MES buffer 
solution to greatly increase the efficiency of phagocytosis. A bicinchoninic acid (BCA) 
protein assay indicates there is ca. 44 µg of IgG per mg of PLGA microparticles. 
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Figure III-D-1. The preparation of PLGA micro-particles and their surface modification 
with IgG antibody. 
 
 
Figure III-D-2. The SEM image of PLGA microparticles loaded with 
[Mn(dpaqNO2)(NO)]BPh4 (I) and Nd-UCNPs (scale bar = 10 µm). 
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Figure III-D-3. Size distribution of the microparticles determined using ImageJ. 
 
 
Figure III-D-4. Size distribution of the microparticles determined using dynamic light 
scattering.
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E. NO release from photoNORM loaded polymer micro-particles 
Previous studies in these laboratories35–37 have shown that UCNPs can serve as 
photosensitizers that absorb NIR photons and emit visible light to trigger NO release from  
non-NIR sensitive photoNORMs. However, this process requires relatively high power 
irradiation owing to the relatively inefficient multi-photon upconversion mechanism of 
UCNPs and energy transfer from UCNPs to photoNORMs. However, the Mn photoNORM I 
is photosensitive to release NO via direct single-photon excitation at 794 nm, and this allows 
one to overcome the scattering constraints that may be problematic for multiphoton 
excitation in deeper tissue.  However, since the extinction coefficient for I at this wavelength 
is low (20.2 M-1cm-1), it was of interest to see whether the visible light generated by that 
upconversion from the Nd-UCNP would enhance NO release owing to the significantly 
higher extinction coefficients of I in this spectral region. In order to test this possibility, 
micro-particle of two different compositions were prepared. One containing both I and Nd-
UCNPs (PLGA-1), the other containing only the manganese photoNORM I (PLGA-2). Data 
obtained from dynamic light scattering (DLS) showed these two particle groups to be similar 
in average size (~1 micron, Figure III-E-1), while ICP-AES showed the former to have 
somewhat higher loading of I (4.76 wt% vs 3.79 wt% respectively). Particles of both types 
(0.5 mg) were separately suspended in 2.5 mL pH 7.4 phosphate buffered saline (PBS) 
solution and were irradiated with a 794 nm diode laser (at different power settings) while 
stirring and purging with medical grade air. The purge gas was analyzed for NO using the 
NOA for 1.0 second irradiation times at different power densities (in W/cm2).  The NOA 
signals recorded are shown in Figure III-E-2 while Figure III-E-3 plots the quantity of NO 
released from these micro-carriers in response to the different excitation laser power 
densities. (Figure III-E-4) Notably, both plots appear linear, which is consistent with a 
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single photon excitation mechanism for NO release. Additionally, the efficiencies of NO 
release for PLGA-1 and PLGA-2 are 1.63 pmole W-1 cm2 s–1 and 2.06 pmole W-1 cm2 s–1 
respectively. When differences in loading are taken into account, this corresponds to a 37% 
lower NO release from the Nd-UCNP loaded micro-particles. Clearly, the Nd-UCNPs are 
not improving the efficiency of NO release in this case, thus have value primarily for 
imaging purposes. 
 
 
Figure III-E-1. Size distribution of the micro-carriers PLGA-1 and PLGA-2 as 
determined using dynamic light scattering.  
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Figure III-E-2. NOA signals from the 794 laser photolysis of suspensions of PLGA-1 at 
different power densities in W/cm2. 
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Figure III-E-3. NOA signals from the 794 laser photolysis of suspensions of PLGA-2 at 
different power densities in W/cm2. 
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Figure III-E-4. Plots of the NOA detected NO released vs laser power density for the 
794 nm photolysis of PBS suspensions of the micro-carriers PLGA-1 (black) and PLGA-2 
(red). 
 
F. Particle uptake and compatibility 
The goal of these experiments was to determine the number of loaded PLGA micro-
particles that can be phagocytosed into each macrophage. It has been previously shown that 
rigid spheres, about one micron diameter, are readily taken up by this mechanism.38,39 As 
noted above, the micro-particles were also surface modified with a covalently bound layer of 
immunoglobulin G (IgG) to enhanced uptake. Based on the An alamarBlue® cell viability 
assay was used to determine the compatibility of the micro-particles with the cells. Figure 
III-F-1 shows that these particles displayed no significant toxicity for concentrations as high 
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as 100 µg/mL for incubation periods of 24 and 48 h with BMMs. Moderate toxicity was 
observed at higher concentrations. From these results, the incubation concentration of 100 
µg/mL was selected for all further experiments. Analysis of BMMs containing NO-donor 
loaded particles with ICP-AES determined an uptake of 0.667 µg manganese per 1 x 106 
cells. This translates into 263 µg particles or 12.14 nanomole of NO as the photoNORM I. 
BMMs loaded with particles containing NO-donor and UCNPs (BMMp+) were then 
tested to verify internal release of NO using the NO sensor 4-amino-5-methylamino-2',7'-
difluorofluorescein diacetate (DAF-FM),40  which reacts to form a fluorescent compound 
when exposed to intracellular NO. DAF-FM was incubated with macrophages both 
containing and not containing photoNORM loaded micro-particles. Prior to DAF-FM 
incubation, these cells were treated with L-N-nitroarginine methyl ester (L-NAME), a nitric 
oxide synthase (NOS) inhibitor, to reduce any background from biologic production of 
NO.41 Upon 794 nm laser exposure at a power of 13.02 W/cm2 for 90 s, BMMp+ produced a 
visible fluorescence response while macrophages without particles did not. (Figure III-F-2).  
 
Figure III-F-1. Viability of BMMs with various particle incubation concentrations after 
24 and 48 h. 
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Figure III-F-2. BMMp+ irradiated with a 794 nm laser for 90 s. The inset figure is the 
control experiment with BMMs only. NO was detected using 4-amino-5-methylamino-2',7'-
difluorofluorescein diacetate (DAF-FM-2DA) fluorescent reporter (green color). (both 
samples were incubated with L-NG-nitroarginine methyl ester (L-NAME) to inhibit 
endogenous NO generation.) Blue color is 4',6-diamidino-2-phenylindole (DAPI) stain. 
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G. Micro-particle effects on macrophage chemotaxis 
The ability of macrophages to target tissue such as tumors is governed by their ability to 
undergo chemotaxis towards sights of inflammation.1 Thus, it is crucial that the macrophage 
“Trojan Horses” retain this function after drug loading. This question was probed using a 
transendothelial assay (Figure III-G-1).  
 
 
Figure III-G-1. Top: An illustration of macrophage chemotaxis in a transendothelial assay. 
Macrophages are placed on top of the endothelial layer and MCP-1 on the other as a 
chemotaxic agent. Macrophages are attracted to the chemoattractant and traverse the 
endothelial monolayer. These cells are quantified by adding NucBlue® to stain the nuclei of 
Chemoattractant 
Endothelial	Cell 
BMMp+ 24	hrs 
(a) 
(b) 
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cells that have crossed so they can be analyzed by counting cell nuclei with a fluorescent 
microscope. Bottom: A Graph comparing the migration efficiency of macrophages with and 
without particles 
 
First, monolayers of bEnd.3 blood brain barrier (BBB) endothelial cells were grown on 
FluoroBlokTM transwell inserts inside of the wells of a 24-well plate and used as model 
endothelium barriers, since such monolayers are very tight thereby making migration very 
challenging.42 After monolayer confluency, media containing 1 x 105 BMMp+, media 
containing a comparable number of BMMs without particles, and media alone were added to 
the top of separate transwells while monocyte chemoattractant protein-1 (MCP-1) was added 
below. After 24 h, the inserts were stained with NucBlue® allowing for quantification of 
chemotaxis by counting the number of nuclei of cells that had migrated to the bottom of the 
insert and subtracting it from wells that had a confluent bEnd.3 monolayer with no added 
BMMs. Results indicated that (10.4 ± 0.8) x 103 macrophages containing particles vs. (17.1 
± 2.4) x 103 cells without particles had migrated across the endothelium layers. Thus, 
phagocytosis of such micro-particles causes a 39% reduction in chemotaxis in agreement 
with a previous report,23 although in the latter case an even sharper drop in chemotaxis was 
observed without the inclusion of an endothelial monolayer.23 The more efficient barrier 
crossing in the present case may be attributed to using micron-sized rather than nano-sized 
particles. Phagocytosis of particles smaller than 500 nm leads to significant drops in vector 
migration rates due to the lack of asymmetric actin polarization.43 Additionally, exposing 
tumors to ionizing radiation causes increases in inflammation and the release chemotactic 
factors. As shown previously, such treatment may be utilized to enhance overall macrophage 
recruitment and improve therapeutic efficacy if needed.23,44
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      H. Tumor spheroid penetration and NO release 
After traversing the endothelium, macrophages need to be able to follow chemotactic 
gradients arising deep from within the tumor tissue. Tumor spheroids were utilized to mimic 
the 3D tumor environment. Cocultured murine NIH/3T3 fibroblast : 4T1 breast cancer cell  
spheroids with a 5:1 cell seeding ratio similar to those developed previously were employed 
here.45 The incorporation of fibroblasts into tumor spheroids has been reported to induce the 
formation of a tumor stroma which enhances spheroid compactness, helps resist nanoparticle 
penetration and increases the expression of pro-inflammatory cytokines used in leukocyte 
chemotaxis.45,46 Use of this seeding ratio in a hanging drop technique was able to produce 
large spheroids with an average diameter of 962 ± 60 µm ((1.35 ± 0.05) x 105 cells/spheroid) 
after 10 days of incubation with introduction of macrophages on day 7 making them 
considerably larger than spheroids produced with 4T1 cells alone (Figure III-H-1).  
Pimonidazole (PIMO) staining of spheroids revealed a high level of hypoxia throughout the 
spheroid interior. Considering that hypoxia normally occurs 100-150 µm into a tumor,47 this 
is not surprising. It is important to note that spheroids without the fibroblast cells were 
significantly smaller than those with them likely due to macrophage supported tumor 
growth48 (Figure III-H-2).  
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Figure III-H-1. Representative images of tumor spheroids produced with 4T1 cells alone 
(left) or a 5:1 3T3:4T1 coculture method (right) after infiltration with particle loaded 
macrophages. Due to the density of the spheroids, particles cannot be seen in these images. 
 
 
Figure III-H-2. Comparisons of NIH-3T3/4T1 coculture spheroid size after 10 days of 
growth with (right) and without (left) macrophages introduced on day 7. Images represent 
center slices of tumor spheroids stained with DAPI acquired with a confocal microscope. 
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  Macrophages labeled with CellTrackerTM deep red were used to track the chemotaxic 
penetration of BMMp+ into tumor spheroids. Images of tumor spheroid center slices 
indicated deep spheroid penetration (Figure III-H-3).  For the spheroids examined, 
macrophages were unable to reach the center of the spheroid and instead formed a visible 
ring around a center section. Oxygen is required for macrophage chemotaxis, and these 
spheroids are sufficiently large it is likely that the center is a necrotic region where oxygen 
is too low. Flow cytometry of spheroids dissociated with AccumaxTM demonstrated a 
macrophage composition of 0.53 ± 0.4% cell number or 715 ± 540 macrophages per 
spheroid (Figure III-H-4). Assuming macrophages were loaded with particles at a rate as 
shown by ICP, these macrophages brought an estimated 8.7 ± 6.6 picomole of the 
photoNORM into the spheroid. The value of the macrophages as carrier for these micro-
particles was demonstrated using particles labeled with fluorescent IgG. Spheroid slices 
(Figure III-H-5) demonstrated that macrophages with internalized fluorescent particles 
carried their payload into the spheroids but that the micro-particles alone when incubated 
with spheroids were unable to penetrate more than a few cell lengths (Figure III-H-6). 
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Figure III-H-3. The slice of 4T1/NIH-3T3 cocultured breast tumor spheroids incubated 
with BMMs only. Blue is 4',6-diamidino-2-phenylindole (DAPI) and red represents 
macrophages stained with CellTrackerTM deep red. Spheroids was stained with a 
HypoxyprobeTM Red549 to label hypoxia (cyan). 
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Figure III-H-4. Flow Cytometry analysis of macrophage infiltration into tumor spheroids 
(b-d). Macrophages were labeled with CelltrackerTM deep red to allow for their 
identification. Results were subtracted from the proportion of gated cells in the control (a).  
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Figure III-H-5. The slice of 4T1/NIH-3T3 cocultured breast tumor spheroids incubated 
with cy-3-IgG labeled BMMp+ (green spots). Blue is 4',6-diamidino-2-phenylindole (DAPI) 
and red represents macrophages stained with CellTrackerTM deep red. 
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Figure III-H-6. The slice of 4T1/NIH-3T3 cocultured breast tumor spheroids incubated 
with cy-3-IgG labeled micro-particles (green spots). Blue is 4',6-diamidino-2-phenylindole 
(DAPI). 
 
The next question was whether the NO photo-generated within these spheroids can be 
detected externally. To the best of our knowledge, the use of a NOA to measure NO 
diffusion form tumor spheroids has not been reported previously. Five spheroids incubated 
with BMMp+ or BMMs with PLGA-only particles (BMMp-) were put in the corner of a 
custom designed cuvette (Figure III-H-7) with 1 mL Hank’s Balanced Salt Solution 
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(HBSS) solution and excited with the 794 nm diode laser operating at a power density of 
13.1 W/cm2. In typical NOA measurements, the solution is bubbled with the carrier gas and 
stirred allowing the NO generated to swept from the solution to the detector. However, such 
conditions would likely cause spheroid disassembly and cell lysis. To avoid this, the 
spheroids were blanketed with unstirred HBSS solution and irradiated with the laser for 
specified time periods (Figure III-H-8). Subsequent gentle bubbling with medical-grade air 
above the spheroids released most of the NO in solution without disturbing the spheroids.  
This allowed the procedure to be repeated several times on the same sample (Figure III-H-9 
& Figure III-H-10). The NO released from the 6 min (total) photolysis of five spheroids 
invaded by BMMp+ was 13.6 pmol (or 2.72(avg) pmole per spheroid) (Figure III-H-9a), 
while spheroids treated with BMMp- gave no measurable response (Figure III-H-9b). 
Based on spheroid volumes of ~1 µL, NO steady state concentrations in excess of 1 µM are 
being generated, and these are in excess of that needed to induce p53 and nitrosative stress 
mediated apoptosis.5  
 
Figure III-H-7. The custom designed cuvette for the experiment of NO photo-release 
from spheroids 
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Figure III-H-8. The NIH/3T3:4T1 tumor spheroids in 1 mL Hank’s buffered salt solution 
(HBSS) under 794 nm laser irradiation. Inset: the scheme represents that the spheroids can 
be placed at the corner of the cuvette and exposed to NIR laser excitation. 
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Figure III-H-9. (a): NO released from five spheroids infiltrated with BMMp+ in 1 mL 
HBSS solution under 794 nm laser irradiation with 13.1 W/cm2. Down: The control 
experiment of six spheroids loaded with BMMp-. 
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Figure III-H-10. Plot of NO detected vs irradiation time.  
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I. Testing therapeutic efficacy in coculture tumor spheroids  
As mentioned previously, the key to unlocking the full therapeutic potential of nitric 
oxide is garnering spatial, temporal and concentration control of delivery. Spatial and 
temporal control are gained using light as the triggering mechanism, while spatial control is 
strongly enhanced by a localization mechanism such as offered by the use of macrophages.  
Concentration control (dosage) should be achievable by simply changing the amount of light 
delivered to the target. 
For example, Figure III-I-1 illustrates the results of irradiating spheroids containing 
BMMp+ or BMMp- with 794 nm light.  The irradiation times were for 1 to 3 six-minute 
periods with a power density of 13.1 W/cm2. Cell viability was probed after 24 h using a p-
nitrophenyl phosphate (PNPP) assay.49 Irradiation of spheroids containing photoNORM 
loaded macrophages led to 25.7% reduction in tumor viability after 12 min while spheroids 
with macrophages and blank micro-particles demonstrated only a 6.6% drop in cell viability. 
While this reduction in viability from a single round of therapy is somewhat modest, such 
treatment is likely done in several applications. Additionally, the spheroids used in this study 
were based 4T1 breast cancer cells, which are reported to be p53 deficient, so most of the 
damage can be attributed to nitrositive stress. About 50% of cancers have p53 pathways that 
are induced by NO to trigger apoptosis; in such cells, this treatment will likely be much 
more effective.50 
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Figure III-I-1. The viability of spheroids after 6, 12, or 18 min of laser exposure in 6-min 
increments. Viability was measured using a PNPP assay 24 h after spheroid treatment. * =  p 
≤ 0.05 (students t-test) 
 
Experiments utilizing a 735 nm LED with a much lower power density of 0.58 mW/cm2 
for 8.5 h were conducted to assess the effects of low-level NO generation on the levels of 
HIF-1α in tumor spheroids. This factor is upregulated in hypoxia and is correlated with 
tumor cell survival, metastasis, and angiogenesis as well as poor patient prognosis.51 After 
exposure, spheroids were dissociated into a single cell suspension. Cells were then fixed and 
labeled with anti-HIF-1α followed by a fluorescent secondary antibody. Analysis with flow 
cytometry revealed that low level NO treatment resulted in a significant reduction in the 
number of cells expressing HIF-1α from 96.7 ± 0.5 % to 77.7 ± 8.7 % in samples containing 
BMMp+ with and without light exposure respectively (Figure III-I-2).  Spheroids with 
BMMp- failed to show a change in HIF-1α expression with or without light. These data 
agree with previous studies which demonstrated that low levels of NO in hypoxia leads to 
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destabilization of HIF-1α in hypoxia due to its inhibition of cytochrome C oxidase,9,52 a 
critical component of mitochondrial respiration. When cytochrome C oxidase is inactivated 
by NO, oxygen that was going to be used for cellular respiration finds use in nonrespiratory 
oxygen dependent cellular processes including includes the activation of the prolyl 
hydroxylases responsible for the degradation of HIF-1α.52 In a second trial, spheroids 
containing BMMp- and BMMp+ exposed to an LED source for a shorter period of time (7 
h). Unfortunately, the production of a small number of spheroids during this experiment 
limited the number of different conditions that could be tested leading to the exclusion of 
samples without LED exposure. However, it is worth nothing that an even greater reduction 
in the expression of HIF-1α from 90.3 ± 5.1% to 62.2 ± 2.5% in Samples with BMMp- and 
BMMp+ respectively (SI Figure S10).  We hypothesize that this reduction in HIF-1α with a 
smaller exposure time likely indicates that the supply of NO was exhausted between 7 and 
8.5h. Future optimization to identify the precise time required for maximal effect will be 
necessary in order to fully realize the potential of this therapy. 
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 Figure III-I-2. (a) Flow cytometry analysis of dissociated tumor spheroids stained for 
HIF-1α under different treatments. Gated cells correlate with a positive signal from staining. 
(i) and (ii) three runs of analysis for spheroids loaded with BMMp+ with and without 735 
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nm LED exposure at 0.58 mW/cm2 for 8.5 h. (iii) The comparison of (i) black and (ii) red 
for each run. Red and black lines represent particles with and without light exposure 
respectively. (b) The summary of flow cytometry analysis for the control (i) and the NO 
release study (ii). (i) represents spheroids with BMMp- with and without 735nm LED 
irradiation. 
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J. Testing UCNPs for imaging 
Incorporation of an imaging agent has many advantages, most importantly, providing 
information on the location and concentration of the prodrug in the tumor, and this was one 
reason that the Nd-UCNPs were incorporated. Furthermore, the chemotaxic capacities of 
macrophages allow them to hone in inflammation and may provide a mechanism to detect 
hidden metastasis sites an ability which may allow for treatment of these sites in their early 
stages. The Nd-UCNPs are photoactivated by NIR light of the same wavelength as I 
allowing for theranostic capabilities with a single laser source. In order to test this, we 
incubated spheroids with BMMp+ or BMMp-. Spheroids were first labeled with calcein AM 
to provide visualization of their periphery. Figure III-J-1 shows 3D images of these 
spheroids taken with an 810nm laser source from a two-photon confocal microscope.  Weak 
signals were noted on the surface of spheroids after treatment with BMMp+ while those 
treated with BMMp- failed to produce a signal. However, it is clear that emission from the 
Nd-UCNPs is relatively inefficient with the 3W confocal microscope laser and that there is 
room to improve this by optimizing imaging conditions.  
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Figure III-J-1. Z-stack two-photon confocal images (dimensions = 508.4 µm x 508.4 
µm) of live spheroids containing BMMs (a) with blank particles and (b) with UCNPs and 
NO-donor loaded particles. Spheroids were stained with calcein AM (green). Particles were 
identified via two-photon emission (red) from embedded UCNPs with laser excitation at 810 
nm with a pulse energy of 37.5 nJ. Detected signal from UCNPs emission is between 420 – 
460 nm.  
(b) 
(a) 
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K. Summary 
We have successfully demonstrated the use of bone marrow derived macrophages as 
carriers for polymer-based micro-carriers in which a photoNORM I and UCNP have been 
incorporated for therapeutic and imaging applications. These carrier cells were able to load 
large quantities of therapeutics without significant effects on viability. Loaded BMMp+ cells 
maintained most of their chemotaxic ability allowing them to traverse an in vitro BBB 
transendothelial model. These macrophages also demonstrated the ability to deeply penetrate 
large tumor spheroids bringing their cargo with them, a feat which proved impossible for the 
micro-particles alone. Once inside the spheroids, the Nd-UCNPs could be used to visualize 
infiltrated macrophages in live spheroids using the 808 nm laser source of a confocal 
microscope. Photoactivation with a NIR laser at 794 nm released large quantities of NO 
from I as indicated by NOA. The steady state concentration of this NO could be controlled 
by simply changing the intensity of the light. With this in mind, we were able to induce 
therapeutically beneficial effects from two different areas of the NO spectrum. By utilizing a 
laser source over a several minutes of exposure direct cytotoxicity was induced by the high 
levels of NO generated.   Lower power excitation over several hours with a LED induced 
changes in the tumor microenvironment as evidenced by the destabilization of HIF-1α with 
the lower levels of NO generated. Although not explored in the current study, it should be 
noted that targeted NO release in the hypoxic regions of tumors should serve to enhance the 
effectiveness of cancer radiotherapy.53,54 Taken together, macrophage-mediated delivery of 
photoNORMs represents a fresh approach to overcome the hurdles traditionally associated 
with the use of nitric oxide in cancer treatments.    
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Figure III-K-1. The schematic figure summarize the therapeutic functionality of 
photochemical Trojan horse therapy and its potential applications. 
 
L. Materials 
All cell lines were purchased from ATCC (4T1, NIH-3T3, and bEnd.3). All BALB/C 
mice (6-8 weeks old) were purchased from Charles River. Sodium tetraphenylborate, 
sodium trifluoroacetate, sodium oleate, ammonium fluoride, lanthanide chlorides (99.9+%), 
oleic acid (OA) (90%), 1-octadecene (ODE) (90%), poly(vinyl) alcohol (PVA, Mw: 13000-
23000), 4-morpholineethanesulfonic acid (MES, low moisture content, 99+%), 
immunoglobulin G (IgG from mouse serum), N-(3-Dimethylaminopropyl)-N′-
ethylcarbodiimide hydrochloride (EDCHCl, commercial grade), TritonTM X-100 
(BioXtra), Tween® 20 (BioXtra), agarose (BioReagent),  sodium hydroxide (NaOH, ACS 
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reagent grade), sodium acetate (RegentPlus®), purified human plasma fibronectin (1 
mg/mL), and Perfecta3D® 96-well hanging drop plates were purchased from Sigma-
Aldrich. 10X PBS (OmniPur® liquid concentrate) was purchased from EMD Millipore. 
poly(lactic-co-glycolic acid) (5050 DLG 8A, acid terminated) was purchased from 
Lakeshore Biomaterials. 4-Amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-
FM-2DA, Molecular Probes®) was purchased from Life Technologies. N-
hydroxysuccinimide (NHS), fetal bovine serum (FBS), Dulbecco’s Modified Eagle Medium 
high glucose (DMEM), Dulbecco’s Modified Eagle Medium: Nutrient mixture F12 
GlutaMAXTM and high glucose (DMEM/F12), sodium pyruvate solution (100 mM), 
penicillin streptomycin 10,000 U/mL (P/S), trypsin/EDTA (0.25%), Hank’s Balanced Salt 
Solution without calcium and magnesium (HBSS) Dulbecco’s Phosphate Buffered Saline 
without calcium and magnesium (DPBS) NucBlue®, CellTrackerTM  Deep Red, goat 
serum, FITC labeled Goat-anti-rabbit, Rabbit anti-HIF-1α, p-nitrophenyl phosphate (PNPP) 
substrate tablets, calcein AM, micro bicinchoninic acid assay kit, and alamarBlue® was 
purchased from Thermo Fisher Scientific. All TC and Non-TC treated plasticware for cell 
culture, and FluoroblokTM transwell insersts were purchased from Corning. BambankerTM 
cell freezing media was purchased from Bulldog Bio. AccumaxTM was purchased from 
Innovative Cell Technologies. L-N-nitroarginine methyl ester hydrochloride salt (L-NAME) 
was purchased from Caymen Chemical. Murine monocyte colony stimulating factor 1 
(MCSF-1) and murine monocyte chemoattractant protein 1 (MCP-1) were purchased from 
Peprotech. Hypoxyprobe-Red549 Kit containing pimonidazole HCl and mouse DylightTM 
549-Mab was purchased from Hypoxyprobe. Immunoglobulin G labeled with Cyanine 3.5 
(Cy3.5-IgG) was purchased from Jackson Immuno.  
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M. Analytical Instrumentation 
Absorbance spectra were taken on a Shimadzu UV-2401PC. Nitric oxide was measured 
using a General Electric Sievers Nitric Oxide Analyzer NOA 280i. Samples were 
photolyzed with a 3 watt 798 nm SheauPac fiber coupled laser module (actual excitation 
wavelength: 794 nm). XRD spectra were obtained on a Bruker AXS D8 Discover GADDS 
X-Ray diffractometer (XRD). Upconversion emission spectra were obtained on a Horiba 
Jobin Yvon LabRAM ARAMIS automated scanning confocal Raman microscope. DLS data 
were obtained on a Malvern NANO-ZS. TEM images were obtained on a FEI Titan 300 kV 
FEG Transmission electron microscope. SEM images were obtained on a FEI Nova Nano 
650 FEG scanning electron microscope. Confocal images were obtained on a Olympus 
Flowview 1000 Spectral Confocal. Tumor sectioning were performed on a Leica Cryostat 
Microtome. Flow cytometry data were obtained on a FACS Aria high-speed cell sorter. 
 
  
131 
N. Reference 
(1) Murdoch, C.; Giannoudis, A.; Lewis, C. E. Mechanisms Regulating the Recruitment 
of Macrophages into Hypoxic Areas of Tumors and Other Ischemic Tissues. Blood 2004, 
104 (8), 2224–2234. 
(2) Burke, B.; Giannoudis, A.; Corke, K. P.; Gill, D.; Wells, M.; Ziegler-Heitbrock, L.; 
Lewis, C. E. Hypoxia-Induced Gene Expression in Human Macrophages: Implications for 
Ischemic Tissues and Hypoxia-Regulated Gene Therapy. Am. J. Pathol. 2003, 163 (4), 
1233–1243. 
(3) Harris, A. L. Hypoxia — a Key Regulatory Factor in Tumour Growth. Nat. Rev. 
Cancer 2002, 2 (1), 38–47. 
(4) Begg, A. C.; Stewart, F. A.; Vens, C. Strategies to Improve Radiotherapy with 
Targeted Drugs. Nat. Rev. Cancer 2011, 11 (4), 239–253. 
(5) Ridnour, L. A.; Thomas, D. D.; Switzer, C.; Flores-Santana, W.; Isenberg, J. S.; 
Ambs, S.; Roberts, D. D.; Wink, D. A. Molecular Mechanisms for Discrete Nitric Oxide 
Levels in Cancer. Nitric Oxide 2008, 19 (2), 73–76. 
(6) Mocellin, S.; Bronte, V.; Nitti, D. Nitric Oxide, a Double Edged Sword in Cancer 
Biology: Searching for Therapeutic Opportunities. Med. Res. Rev. 2007, 27 (3), 317–352. 
(7) Thomas, D. D.; Espey, M. G.; Ridnour, L. A.; Hofseth, L. J.; Mancardi, D.; Harris, 
C. C.; Wink, D. A. Hypoxic Inducible Factor 1α, Extracellular Signal-Regulated Kinase, and 
p53 Are Regulated by Distinct Threshold Concentrations of Nitric Oxide. Proc. Natl. Acad. 
Sci. U. S. A. 2004, 101 (24), 8894–8899. 
  
132 
(8) Tan, L.; Huang, R.; Li, X.; Liu, S.; Shen, Y.-M. Controllable Release of Nitric Oxide 
and Doxorubicin from Engineered Nanospheres for Synergistic Tumor Therapy. Acta 
Biomater. 2017, 57 (Supplement C), 498–510. 
(9) Mateo, J.; García-Lecea, M.; Cadenas, S.; Hernández, C.; Moncada, S. Regulation of 
Hypoxia-Inducible Factor-1α by Nitric Oxide through Mitochondria-Dependent and -
Independent Pathways. Biochem. J. 2003, 376 (2), 537–544. 
(10) Bonavida, B.; Garban, H. Nitric Oxide-Mediated Sensitization of Resistant Tumor 
Cells to Apoptosis by Chemo-Immunotherapeutics. Redox Biol. 2015, 6, 486–494. 
(11) Yasuda, H. Solid Tumor Physiology and Hypoxia-Induced Chemo/Radio-
Resistance: Novel Strategy for Cancer Therapy: Nitric Oxide Donor as a Therapeutic 
Enhancer. Nitric Oxide 2008, 19 (2), 205–216. 
(12) Weissleder, R. A Clearer Vision for in Vivo Imaging. Nat. Biotechnol. 2001, 19 (4), 
316–317. 
(13) Ford, P. C. Photochemical Delivery of Nitric Oxide. Nitric Oxide 2013, 34, 56–64. 
(14) König, K. Multiphoton Microscopy in Life Sciences. J. Microsc. 2000, 200 (2), 83–
104. 
(15) Hitomi, Y.; Iwamoto, Y.; Kodera, M. Electronic Tuning of Nitric Oxide Release 
from Manganese Nitrosyl Complexes by Visible Light Irradiation: Enhancement of Nitric 
Oxide Release Efficiency by the Nitro-Substituted Quinoline Ligand. Dalton Trans. 2013, 
43 (5), 2161–2167. 
(16) Eroy-Reveles, A. A.; Leung, Y.; Beavers, C. M.; Olmstead, M. M.; Mascharak, P. 
K. Near-Infrared Light Activated Release of Nitric Oxide from Designed Photoactive 
Manganese Nitrosyls:  Strategy, Design, and Potential as NO Donors. J. Am. Chem. Soc. 
2008, 130 (13), 4447–4458. 
  
133 
(17) Ford, P. C. Polychromophoric Metal Complexes for Generating the Bioregulatory 
Agent Nitric Oxide by Single- and Two-Photon Excitation. Acc. Chem. Res. 2008, 41 (2), 
190–200. 
(18) Choi, M.-R.; Stanton-Maxey, K. J.; Stanley, J. K.; Levin, C. S.; Bardhan, R.; Akin, 
D.; Badve, S.; Sturgis, J.; Robinson, J. P.; Bashir, R.; Halas, N. J.; Clare, S. E. A Cellular 
Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors. Nano Lett. 2007, 7 
(12), 3759–3765. 
(19) Doshi, N.; Swiston, A. J.; Gilbert, J. B.; Alcaraz, M. L.; Cohen, R. E.; Rubner, M. 
F.; Mitragotri, S. Cell-Based Drug Delivery Devices Using Phagocytosis-Resistant 
Backpacks. Adv. Mater. 2011, 23 (12), H105–H109. 
(20) Anselmo, A. C.; Mitragotri, S. Cell-Mediated Delivery of Nanoparticles: Taking 
Advantage of Circulatory Cells to Target Nanoparticles. J. Controlled Release 2014, 190, 
531–541. 
(21) Choi, J.; Kim, H.-Y.; Ju, E. J.; Jung, J.; Park, J.; Chung, H.-K.; Lee, J. S.; Lee, J. S.; 
Park, H. J.; Song, S. Y.; Jeong, S.-Y.; Choi, E. K. Use of Macrophages to Deliver 
Therapeutic and Imaging Contrast Agents to Tumors. Biomaterials 2012, 33 (16), 4195–
4203. 
(22) Huang, W.-C.; Shen, M.-Y.; Chen, H.-H.; Lin, S.-C.; Chiang, W.-H.; Wu, P.-H.; 
Chang, C.-W.; Chiang, C.-S.; Chiu, H.-C. Monocytic Delivery of Therapeutic Oxygen 
Bubbles for Dual-Modality Treatment of Tumor Hypoxia. J. Controlled Release 2015, 220 
(Part B), 738–750. 
(23) Huang, W.-C.; Chiang, W.-H.; Cheng, Y.-H.; Lin, W.-C.; Yu, C.-F.; Yen, C.-Y.; 
Yeh, C.-K.; Chern, C.-S.; Chiang, C.-S.; Chiu, H.-C. Tumortropic Monocyte-Mediated 
  
134 
Delivery of Echogenic Polymer Bubbles and Therapeutic Vesicles for Chemotherapy of 
Tumor Hypoxia. Biomaterials 2015, 71 (Supplement C), 71–83. 
(24) Junttila, M. R.; de Sauvage, F. J. Influence of Tumour Micro-Environment 
Heterogeneity on Therapeutic Response. Nature 2013, 501 (7467), 346–354. 
(25) Wang, Y.-F.; Liu, G.-Y.; Sun, L.-D.; Xiao, J.-W.; Zhou, J.-C.; Yan, C.-H. Nd3+-
Sensitized Upconversion Nanophosphors: Efficient In Vivo Bioimaging Probes with 
Minimized Heating Effect. ACS Nano 2013, 7 (8), 7200–7206. 
(26) Levy, E. S.; Tajon, C. A.; Bischof, T. S.; Iafrati, J.; Fernandez-Bravo, A.; Garfield, 
D. J.; Chamanzar, M.; Maharbiz, M. M.; Sohal, V. S.; Schuck, P. J.; Cohen, B. E.; Chan, E. 
M. Energy-Looping Nanoparticles: Harnessing Excited-State Absorption for Deep-Tissue 
Imaging. ACS Nano 2016, 10 (9), 8423–8433. 
(27) Xie, X.; Gao, N.; Deng, R.; Sun, Q.; Xu, Q.-H.; Liu, X. Mechanistic Investigation 
of Photon Upconversion in Nd3+-Sensitized Core–Shell Nanoparticles. J. Am. Chem. Soc. 
2013, 135 (34), 12608–12611. 
(28) Ostrowski, A. D.; Chan, E. M.; Gargas, D. J.; Katz, E. M.; Han, G.; Schuck, P. J.; 
Milliron, D. J.; Cohen, B. E. Controlled Synthesis and Single-Particle Imaging of Bright, 
Sub-10 Nm Lanthanide-Doped Upconverting Nanocrystals. ACS Nano 2012, 6 (3), 2686–
2692. 
(29) Wang, F.; Han, Y.; Lim, C. S.; Lu, Y.; Wang, J.; Xu, J.; Chen, H.; Zhang, C.; Hong, 
M.; Liu, X. Simultaneous Phase and Size Control of Upconversion Nanocrystals through 
Lanthanide Doping. Nature 2010, 463 (7284), 1061–1065. 
(30) Yi, G. S.; Chow, G. M. Synthesis of Hexagonal-Phase NaYF4:Yb,Er and 
NaYF4:Yb,Tm Nanocrystals with Efficient Up-Conversion Fluorescence. Adv. Funct. 
Mater. 2006, 16 (18), 2324–2329. 
  
135 
(31) Zhao, Y.; Zhan, Q.; Liu, J.; He, S. Optically Investigating Nd3+-Yb3+ Cascade 
Sensitized Upconversion Nanoparticles for High Resolution, Rapid Scanning, Deep and 
Damage-Free Bio-Imaging. Biomed. Opt. Express 2015, 6 (3), 838–848. 
(32) Park, T. G.; Yong Lee, H.; Sung Nam, Y. A New Preparation Method for Protein 
Loaded Poly(d,l-Lactic-Co-Glycolic Acid) Microspheres and Protein Release Mechanism 
Study. J. Controlled Release 1998, 55 (2–3), 181–191. 
(33) Zambaux, M. F.; Bonneaux, F.; Gref, R.; Maincent, P.; Dellacherie, E.; Alonso, M. 
J.; Labrude, P.; Vigneron, C. Influence of Experimental Parameters on the Characteristics of 
Poly(lactic Acid) Nanoparticles Prepared by a Double Emulsion Method. J. Controlled 
Release 1998, 50 (1–3), 31–40. 
(34) Champion, J. A.; Katare, Y. K.; Mitragotri, S. Particle Shape: A New Design 
Parameter for Micro- and Nanoscale Drug Delivery Carriers. J. Controlled Release 2007, 
121 (1–2), 3–9. 
(35) Garcia, J. V.; Yang, J.; Shen, D.; Yao, C.; Li, X.; Wang, R.; Stucky, G. D.; Zhao, 
D.; Ford, P. C.; Zhang, F. NIR-Triggered Release of Caged Nitric Oxide Using 
Upconverting Nanostructured Materials. Small 2012, 8 (24), 3800–3805. 
(36) Burks, P. T.; Garcia, J. V.; GonzalezIrias, R.; Tillman, J. T.; Niu, M.; 
Mikhailovsky, A. A.; Zhang, J.; Zhang, F.; Ford, P. C. Nitric Oxide Releasing Materials 
Triggered by Near-Infrared Excitation Through Tissue Filters. J. Am. Chem. Soc. 2013, 135 
(48), 18145–18152. 
(37) Pierri, A. E.; Huang, P.-J.; Garcia, J. V.; Stanfill, J. G.; Chui, M.; Wu, G.; Zheng, 
N.; Ford, P. C. A photoCORM Nanocarrier for CO Release Using NIR Light. Chem. 
Commun. 2015, 51 (11), 2072–2075. 
  
136 
(38) Champion, J. A.; Mitragotri, S. Role of Target Geometry in Phagocytosis. Proc. 
Natl. Acad. Sci. U. S. A. 2006, 103 (13), 4930–4934. 
(39) Beningo, K. A.; Wang, Y. Fc-Receptor-Mediated Phagocytosis Is Regulated by 
Mechanical Properties of the Target. J. Cell Sci. 2002, 115 (4), 849–856. 
(40) Levy, E. S.; Morales, D. P.; Garcia, J. V.; Reich, N. O.; Ford, P. C. Near-IR 
Mediated Intracellular Uncaging of NO from Cell Targeted Hollow Gold Nanoparticles. 
Chem. Commun. 2015, 51 (100), 17692–17695. 
(41) Pfeiffer, S.; Leopold, E.; Schmidt, K.; Brunner, F.; Mayer, B. Inhibition of Nitric 
Oxide Synthesis by NG-Nitro-L-Arginine Methyl Ester (L-NAME): Requirement for 
Bioactivation to the Free Acid, NG-Nitro-L-Arginine. Br. J. Pharmacol. 1996, 118 (6), 
1433–1440. 
(42) Chen, Y.; Liu, L. Modern Methods for Delivery of Drugs across the Blood–brain 
Barrier. Adv. Drug Deliv. Rev. 2012, 64 (7), 640–665. 
(43) Chang, Y.-N.; Guo, H.; Li, J.; Song, Y.; Zhang, M.; Jin, J.; Xing, G.; Zhao, Y. 
Adjusting the Balance between Effective Loading and Vector Migration of Macrophage 
Vehicles to Deliver Nanoparticles. PLOS ONE 2013, 8 (10), e76024. 
(44) Jiang, P.-S.; Yu, C.-F.; Yen, C.-Y.; Woo, C. W.; Lo, S.-H.; Huang, Y.-K.; Hong, J.-
H.; Chiang, C.-S. Irradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for 
Cancer Therapy. PLOS ONE 2015, 10 (9), e0139043. 
(45) Priwitaningrum, D. L.; Blondé, J.-B. G.; Sridhar, A.; van Baarlen, J.; Hennink, W. 
E.; Storm, G.; Le Gac, S.; Prakash, J. Tumor Stroma-Containing 3D Spheroid Arrays: A 
Tool to Study Nanoparticle Penetration. J. Controlled Release 2016, 244 (Part B), 257–268. 
  
137 
(46) Silzle, T.; Kreutz, M.; Dobler, M. A.; Brockhoff, G.; Knuechel, R.; Kunz-
Schughart, L. A. Tumor-Associated Fibroblasts Recruit Blood Monocytes into Tumor 
Tissue. Eur. J. Immunol. 2003, 33 (5), 1311–1320. 
(47) Brown, J. M. Tumor Hypoxia in Cancer Therapy. Methods Enzymol. 2007, 435, 
295–321. 
(48) Sica, A.; Schioppa, T.; Mantovani, A.; Allavena, P. Tumour-Associated 
Macrophages Are a Distinct M2 Polarised Population Promoting Tumour Progression: 
Potential Targets of Anti-Cancer Therapy. Eur. J. Cancer 2006, 42 (6), 717–727. 
(49) Friedrich, J.; Eder, W.; Castaneda, J.; Doss, M.; Huber, E.; Ebner, R.; Kunz-
Schughart, L. A. A Reliable Tool to Determine Cell Viability in Complex 3-D Culture: The 
Acid Phosphatase Assay. J. Biomol. Screen. 2007, 12 (7), 925–937. 
(50) Yerlikaya, A.; Okur, E.; Ulukaya, E. The p53-Independent Induction of Apoptosis 
in Breast Cancer Cells in Response to Proteasome Inhibitor Bortezomib. Tumor Biol. 2012, 
33 (5), 1385–1392. 
(51) Masoud, G. N.; Li, W. HIF-1α Pathway: Role, Regulation and Intervention for 
Cancer Therapy. Acta Pharm. Sin. B 2015, 5 (5), 378–389. 
(52) Hagen, T.; Taylor, C. T.; Lam, F.; Moncada, S. Redistribution of Intracellular 
Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α. Science 2003, 302 (5652), 1975–
1978. 
(53) Mitchell, J. B.; Wink, D. A.; DeGraff, W.; Gamson, J.; Keefer, L. K.; Krishna, M. 
C. Hypoxic Mammalian Cell Radiosensitization by Nitric Oxide. Cancer Res. 1993, 53 (24), 
5845–5848. 
(54) Bourassa, J.; DeGraff, W.; Kudo, S.; Wink, D. A.; Mitchell, J. B.; Ford, P. C. 
Photochemistry of Roussin’s Red Salt, Na2[Fe2S2(NO)4], and of Roussin’s Black Salt, 
  
138 
NH4[Fe4S3(NO)7]. In Situ Nitric Oxide Generation To Sensitize γ-Radiation Induced Cell 
Death1. J. Am. Chem. Soc. 1997, 119 (12), 2853–2860. 
 
IV.  The Application of Graphene Quantum dots (GQDs) in NIR Light-triggered 
Release of Small Molecule Bioregulators 
A. Abstract 
The new nano-carriers with nitrogen doped graphene quantum dots (N-GQDs) as photo-
active cores was developed for photo-triggered nitric oxide (NO) delivery. N-GQDs with 
carboxyl groups (~4 nm) was prepared from graphite nanoparticles (~50 nm) treated with 
Hummers’ oxidation method and solvothermal decomposition process (see Chapter II). 
Through amide coupling with oleylamine, C18-GQDs were synthesized and these were 
assembled with an amphiphilic biotinylated DSPE-PEG.  The result was the formation of  
hydrophilic nano-carriers with lipophilic domains for loading with the hydrophobic NO 
precursor, trans-[PetACr(ONO)2]BPh4.This PetACrONO is UV-visible light sensitive and 
stable in acetonitrile at physiologically relevant temperature (37 0C). Notably, the GQDs-
based nano-carriers loaded with PetACrONO release NO upon 794 nm laser exposure. 
Additionally, the surface of nano-carriers can be modified with cell penetrating peptides 
(CPPs) via biotin-streptavidin-biotin assembly strategy. The preliminary cell study shows 
CPPs-modified GQDs@DSPE-PEG containing PetACrONO can be delivered into HeLa 
cells and NO can be intracellularly uncaged under 794 nm laser irradiation.   
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B. Introduction 
Nitric oxide (NO), a small molecule bioregulator (SMB), has attracted considerable 
attention due to its promising applications in cardiovascular disease1,2, cancer treatment3,4, 
antibacterial activity5–8 and wound healing9. The therapeutic effect of NO pro-drugs greatly 
depends on the concentration, duration and the specific site of NO delivery.10  Nanomolar 
concentrations of NO is a vasodilator and is cytoprotective in cells while micromolar 
concentrations of NO can suppress tumor growth and, when administered in tandem with γ-
radiation, is a radiation sensitizer.3,11–16 Photochemical delivery allows for control over the 
timing, dosage and location of NO release by precisely controlling the intensity and location 
of light irradiation.10 However, there are key challenges associated with using such photo-
activated NO releasing moieties ("photoNORMs").17 One is to activate these precursors with 
tissue penetrating near infrared (NIR) light (700-900 nm), while another is to deliver these 
precursors directly to the target sites such as tumors. 
In order to address the first challenge, several photo-active nanomaterials such as 
upconverting nanoparticles (UCNPs)18–21, carbon quantum dots (CQDs)22–24 and gold 
nanoparticles25 have already been applied to NIR light-triggered SMB delivery system. In 
particular, CQDs possesses unique NIR-responsive photophysical properties such as high 
two-photon cross-section (48000 Göppert-Mayer unit)26,27 and photothermal effect22,24. 
Therefore, compared with UCNPs and gold nanoparticles, this metal-free carbon 
nanomaterial has potential to serve as an alternative NIR photosensitizer. Even though 
several papers discuss CQDs-based applications in NIR-activated SMB release, they still 
have several puzzles left behind their work. Callan and Sortino at el. claimed NO can be 
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uncaged from their carbon quantum dot–NO photoreleaser nanohybrids via an energy 
transfer mechanism under 800 nm two-photon excitation. But, they didn’t have any direct 
evidence to prove it.23 Chen and his co-workers argued that their metal carbonyl-caged 
graphene oxide nanomedicine is able to release carbon monoxide (CO) upon 808 nm 
continuous wavelength (CW) laser irradiation.22 Even though they tried to prove the 
mechanism of CO release is photocatalytic and not photothermal decomposition, they didn’t 
consider that the local heating on graphene oxide nanomaterials (one type of CQDs) may 
have very high temperature to directly decompose Mn-carbonyl molecules. Recently, Liu et. 
al declared ruthenium nitrosyl functionalized graphene quantum dots (GQDs, one type of 
CQDs) have impressive photothermal effect to trigger NO release from ruthenium nitrosyl 
(RuNO) under 808 nm laser exposure.24 This is the first literature to clearly show RuNO 
functionalized GQDs has significant strong photothermal effect in comparison with naked 
GQDs. Unfortunately, the GQDs they prepared may not be graphene-like nanomaterials 
based on their TEM and AFM results, and could be graphite nanoparticles due to their same 
dimension on diameter (~3 nm) and thickness (~3 nm).  
Therefore, in order to understand if PetACrONO, the new photoNORM we synthesized 
(Described in Chapter II), can generate NO in GQDs-based nano-composites under 
photothermal decomposition process, we designed two different carriers: PetACrONO 
functionalized GQDs (PetACrONO-GQDs, Figure IV-B-1) and PetACrONO-loaded 
GQDs@DSPE-PEG (Figure IV-B-2). Trans-[AminoPetACr(ONO)2]+ was designed to 
covalently bond with carboxyl groups on the surface of GQDs in the PetACrONO-GQDs 
system which mimics Liu’s work. In contrast to PetACrONO-GQDs, polymeric nano-
carriers GQDs@DSPE-PEG can encapsulate PetACrONO non-covalently into their 
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lipophilic domains. The latter design may prevent photocatalytic mechanism described in 
Chen’s work due to the long distance between PetACrONO and GQD cores. 
Moreover, to address the second challenge for photochemical SMB delivery, cell-
penetrating peptide, biotinylated TAT peptide, was applied to overcome the barrier of 
cellular membranes and efficiently deliver our nano-carriers inside HeLa cancer cells.28–32  
 
 
 
Figure IV-B-1. The scheme presents PetACrONO covalently bonded on the graphene 
QDs (PetACrONO-GQDs) can release NO under 794 nm laser irradiation. 
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Figure IV-B-2. The scheme presents PetACrONO can be loaded into the lipophilic 
domains of the nano-carrier GQDs@DSPE-PEG and the surface of nano-carrier can 
assemble with biotinlyated TAT peptide to enhance the internalization of cancer cells. 
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C. Preparation of GQDs-based Nanocarriers, GQDs@DSPE-PEG 
Our previous research demonstrated that the hydrophobic UCNPs with oleic acid as a 
surfactant can assemble with the amphiphilic phospholipid-functionalized poly(ethylene 
glycol) (DSPE-PEG 2000 Carboxylic acid) via van der Waals forces to form water-soluble 
nanocarriers with lipid domains for a hydrophobic CO prodrug loading.33 In order to prepare 
this kind of nanocarriers by using the same strategy, the surface of N-GQDs have to be 
modified with oleyl chain to further assemble with a DSPE-PEG. As described previously in 
Chapter II, the surface of N-GQDs possesses carboxylic acid (C=O: 1712 cm-1), which can 
covalently bond with oleylamine. The FT-IR spectra (Figure IV-C-1) proved that the 
carboxylic acid on the N-GQDs was converted to amide (C=O: 1641 cm-1) via amide 
coupling reaction. The following information is the preparation procedure of GQDs-based 
nanocarriers.   
N-GQDs (1.322 mg, assuming 0.11 mmole) was dissolved in 200 proof ethanol by 1-
hour sonication. 21.1 mg N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
(EDCHCl) and 12.7 mg N-hydroxysuccinimide (NHS) were added into N-GQDs solution 
and stirred for one hour at room temperature. Oleylamine (36 µL) was injected into the 
mixture and stirred for at least 8 hours at room temperature. The solution was dried by a 
rotary evaporator and then dissolved into dichloromethane (DCM) by 1-hour sonication. 
Water-soluble impurities and unreacted N-GQDs were removed via solvent extraction from 
the DCM solution. After removed DCM, the oil-like residue was dissolved into hexane and 
dialyzed by using a 1000 MWCO dialysis tube against hexane for at least 3 days. The 
purified oleyl N-GQDs was stored in hexane before using it.  
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Purified Oleyl N-GQDs (24 mg) was dissolved in 2 mL DCM and 21 mg biotinylated  
DSPE-PEG 2000 was added into the DCM solution. The mixture was sonicated for 1 hour 
and dried under vacuum for overnight to form white powder.  The white powder was 
suspended in water and dialyzed by using a 5000MWCO dialysis tube for one day to remove 
excess polymer. The nanocarriers, N-GQDs@DSPE-PEG, was dried under vacuum and 
keep in a freezer before using it. 
 
Figure IV-C-1. The FT-IR spectra of oleylamine, N-GQDs, oleyl N-GQDs. 
 
 
 
1712 1641 
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D. PetACrONOBPh4 loading 
In order to infuse the hydrophobic PetACrONOBPh4 into lipid domain of the 
nanocarriers, the modified procedure was applied.33  
PetACrONOBPh4 (10 mg) was marginally dissolved in 1 mL solution of 40% 
acetonitrile in water and 17 mg N-GQDs@DSPE-PEG was added into the solution. The 
mixture was stirred under dark for 20 hours at room temperature. The particles were 
collected by centrifugation and washed with 50% acetonitrile aqueous solution. The 
morphological study was performed by transmission electron microscopy (Figure IV-D-1). 
The distribution of particle size was measured by ImageJ (Figure IV-D-2) and most of 
particles are between 20 and 70 nm.  
 
 
Figure IV-D-1. The TEM image of PetACrONOBPh4 – loaded N-GQDs@DSPE-PEG. 
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Figure IV-D-2. The size distribution of PetACrONOBPh4 – loaded N-GQDs@DSPE-PEG. 
 
E. NO Release Efficiency 
NO release efficiency of PetACrONOBPh4 - loaded N-GQDs@DSPE-PEG was 
investigated by using the Sievers Nitric Oxide Analyzer (NOA). The nanocarrier was 
suspended in 2 mL pH 7.4 phosphate buffered saline (PBS) solution in a designed cuvette. 
The suspension was stirred during the irradiation with a 794 nm diode laser and NO 
generated from the particles was carried to NOA by using medical air purging. Each peak in 
Figure IV E-1 and Figure IV-E-3 represents NO release under 794 nm laser irradiation. 
Figure IV-E-2 shows that NO release linearly responds to different power density of laser 
with 90-second exposure time. Additionally, under the same power density of irradiation 
(13.02 W/cm2) and different exposure time, NO release efficiency of the nanocarriers is 0.21 
pmole per second irradiation. (Figure IV-E-4) According to a literature report by Chen et. 
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al.22, CO release from the MnCO-GO nanomedicine occurs via a photocatalytic mechanism. 
The graphene oxide nanoparticles absorb energy of NIR light and  “transforms” NIR photon 
into an active electron that can reduce  the manganese CO donor bonded on the surface of 
nanoparticles. They also claimed there is no CO release when the temperature of MnCO-GO 
suspension was increased with 50C by direct heating for 25 min. However, they didn’t 
consider the local heating in the core of the nanomedicine could cause over a temperature 
increase >5 oC. Therefore, for the NIR induced release of NO from GQDs-based 
nanocarriers, photothermal decomposition mechanism should be considered. 
 
 
Figure IV-E-1. Photo-triggered NO released from PetACrONOBPh4 – loaded N-
GQDs@DSPE-PEG suspended in a 2 mL pH 7.4 PBS solution under 794 nm laser 
irradiation with different power density for 90 sec. 
 
13.02	W/cm2	 19.81	W/cm
2	 
 
26.31	W/cm2	 
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Figure IV-E-2. The plot of the amount of NO release vs power density of irradiation.  
 
Figure IV-E-3. Photo-triggered NO released from PetACrONOBPh4 – loaded N-
GQDs@DSPE-PEG suspended in a 2 mL pH 7.4 PBS solution under 794 nm laser 
irradiation with power density of 13.02 W/cm2 for 30, 60, 90, 120 180, 240 and 300 sec 
exposure. 
30	s 
60	s 90	s 120	s 180	s 240	s 300	s 
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Figure IV-E-4. The plot of the amount of NO release vs irradiation time. 
 
F. Biological Study 
HIV-1-Trans-Activator of Transcription (TAT) peptide is a well-known cell-penetrating 
peptide (CPP) that can enter cells in seemingly energy-independent manner.34 It also can 
efficiently deliver cargo with various sizes up to submicron into primary cells under 
receptor-independent process.35  All biological studies were done by Demosthenes Morales 
and Erin Morgan in Professor Reich’s group. In this preliminary study, we demonstrated the 
biotinlyated TAT peptide can be attached on the surface of biotinlyated N-GQDs@DSPE-
PEG via biotin-streptavidin-biotin assembly method.30 Additionally, HeLa cancer cell line 
was applied to study the cell internalization and in vitro NO visualization. According to the 
TEM image (Figure IV-D-1 & Figure IV-D-2), the size of nanocarriers is between 20 and 
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200 nm and shouldn’t be clearly observed by confocal microscopy. Compared with Figure 
IV-F-1a and b, Figure IV-F-1c apparently shows some big particles are inside of cells due to 
particles aggregation. In order to investigate the visualization of intracellular NO release 
from the nanocarriers, four different conditions of cell incubation was operated. All cells 
were treated with a nitric oxide synthase (NOS) inhibitor, L-N-nitroarginine methyl ester (L-
NANE), to inhibit NO generated from cells.36 Figure IV-F-2a and b represent the 
background images without the NO-nanocarriers loading. Most excitingly, after 794 nm 
laser irradiation of cells loaded with NO-nanocarriers with power density of 13.02 W/cm2 
for 2 min, NO was uncaged intracullarly and reacted with the nonfluorescent NO reporter, 4-
amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM-2DA), to form 
fluorescent benzotriazole which has green emission.25 (Figure IV-F-1c) Meanwhile, there is 
negligible fluorescence in the control experiments under dark to show NO only release upon 
laser irradiation. (Figure IV-F-1d) 
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Figure IV-F-1. The bight-filed confocal images of HeLa cells only (a), HeLa cells 
incubated with DAF-FM-2DA (b) and HeLa cells incubated with the NO sensor 4-amino-5-
methylamino-2',7'-difluorofluorescein diacetate (DAF-FM-2DA) and PetACrONOBPh4-
loaded N-GQDs@TAT-DSPE-PEG (c). All trials were treated with a nitric oxide synthase 
(NOS) inhibitor L-N-nitroarginine methyl ester (L-NANE). 
(a) (b) 
(c) 
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Figure IV-F-2. The dark-field confocal images of HeLa cells only (a), HeLa cells 
incubated with DAF-FM-2DA (b), HeLa cells incubated with DAF-FM-2DA and 
PetACrONOBPh4-loaded N-GQDs@TAT-DSPE-PEG under 794 nm laser irradiation with 
power density of 13.02 W/cm2 for 2 min (c), and HeLa cells incubated with DAF-FM-2DA 
and PetACrONOBPh4-loaded N-GQDs@TAT-DSPE-PEG under dark (d). 
 
 
 
 
 
 
(a) (b) 
(c) (d) 
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G. Summary 
We have already successfully synthesized carboxyl modified nitrogen-doped graphene 
quantum dots (N-GQDs). Based on morphological tests (Chapter II Section H), the as-
synthesized N-GQDs are 4 nm in diameter and have 1.4 nm of thickness. Additionally, this 
carbon nanomaterials possess abundant nitrogen in the composition and carboxyl groups on 
the surface. Carboxyl N-GQDs can be coupled with oleylamine to form C18-GQDs and 
further assembled with biotinylated DSPE-PED (2000) to afford hydrophilic GQDs@DSPE-
PEG nano-carriers. This nano-carriers have lipophilic domains that can be loaded with 
hydrophobic trans-[PetACr(ONO)2]BPh4. Our NIR photolysis indicates the amount of NO 
uncaged from PetACrONO-loaded GQDs@DSPE-PEG can linearly respond to 794 nm laser 
excitation with different exposure time and power density. Moreover, the preliminary 
biological study shows the TAT peptide modified nano-carriers containing PetACrONO can 
be delivered into HeLa cancer cells and intracellular NO release triggered by 794 nm laser 
irradiation can be visualized by a NO reporter, DAF-FM-2DA. Since PetACrONO wasn’t 
covalently bonded on the surface of GQDs in this case, photocatalytic process for NO 
uncaging can be ignored but photothermal process may become dominated. 
A novel trans-[AminoPetACrCl2]Cl have been successfully synthesized and also been 
converted to trans-[AminoPetACr(ONO)2]+ proved by ESI-MS. However, we need more 
time to work on the purification method (Chapter II Section D). Once this 
AminoPetACrONO is prepared, it can be covalently bonded with carboxyl groups on the 
surface of GQDs to further study its NO release efficiency under 794 nm exposure. 
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H. Future Work and Possible Improvement 
Although TAT-modified GQDs@DSPE-PEG containing PetACrONO was successfully 
prepared and its preliminary biological exam shows NO can be released inside cells under 
794 nm laser irradiation, the carriers easily aggregate together to form micron size particles 
to greatly lower the production yield of nano size particles. Therefore, it is better to optimize 
the preparation method to avoid this issue.  
In addition to the nano-carrier preparation, we still have to do more biological tests to 
investigate the functionality of TAT peptide to HeLa cancer cells in our nano-carrier system. 
The quantity of the PetACrONO-loaded nano-carrers delivered into cells with or without 
TAT assistance can be determined by ICP-AES. Moreover, one more control experiment 
should be done to show that HeLa cells incubated with L-NAME and DAF-FM-2DA don’t 
have significant green emission after NIR photolysis. The toxicity test for nano-carriers with 
or without PetACrONO have to be performed in the future. 
 
I. Materials 
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDCHCl, 
commercial grade) and oleylamine were purchased from 10X PBS (OmniPur® liquid 
concentrate) was purchased from EMD Millipore. N-hydroxysuccinimide (NHS) was 
purchased from Pierce. 4-Amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-
FM-2DA, Molecular Probes®) was purchased from Life Technologies. L-N-nitroarginine 
methyl ester hydrochloride salt (L-NAME) was purchased from Caymen Chemical. 1,2-
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distearoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl(polyethylene glycol)-2000] 
(ammonium salt) (DSPE-PEG(2000) Biotin) was purchased from Avanti Polar Lipids.  
J. Analytical Instrumentation 
Nitric oxide was measured using a General Electric Sievers Nitric Oxide Analyzer NOA 
280i. Samples were photolyzed with a 3 watt 798 nm SheauPac fiber coupled laser module 
(actual excitation wavelength: 794 nm). TEM images were obtained on a FEI Titan 300 kV 
FEG Transmission electron microscope. Confocal images were obtained on a Olympus 
Flowview 1000 Spectral Confocal. Infrared spectra were taken using a Mattson Research 
Series FTIR.  
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Appendix 
   1. Crystal Information of trans-[Cr(PetA)(Cl)2]Cl (4) 
Table 1.  Crystal data and structure refinement for trans-[Cr(PetA)(Cl)2]Cl (4). 
Identification code  09112014_new_0m 
Empirical formula  C26 H44 Cl3 Cr N4 O2 
Formula weight  603.00 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 27.500(2) Å a= 90°. 
 b = 6.4888(5) Å b= 116.871(4)°. 
 c = 18.2253(13) Å g = 90°. 
Volume 2901.0(4) Å3 
Z 4 
Density (calculated) 1.381 Mg/m3 
Absorption coefficient 0.701 mm-1 
F(000) 1276 
Crystal size 0.200 x 0.150 x 0.050 mm3 
Theta range for data collection 1.660 to 27.135°. 
Index ranges -25<=h<=35, -5<=k<=8, -23<=l<=15 
Reflections collected 9594 
Independent reflections 3205 [R(int) = 0.0316] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7455 and 0.6414 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3205 / 15 / 190 
Goodness-of-fit on F2 1.147 
Final R indices [I>2sigma(I)] R1 = 0.0639, wR2 = 0.1361 
R indices (all data) R1 = 0.0775, wR2 = 0.1425 
Extinction coefficient n/a 
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Largest diff. peak and hole 0.810 and -0.863 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for trans-[Cr(PetA)(Cl)2]Cl (4).  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
__________________________________________________________________________
______  
 x y z U(eq) 
__________________________________________________________________________
______   
C(1) 815(1) 3802(8) 1731(2) 41(1) 
C(2) 1143(1) 5716(8) 1748(2) 42(1) 
C(3) 1215(1) 6138(7) 970(2) 33(1) 
C(4) 1667(1) 7698(7) 1136(2) 32(1) 
C(5) 1713(2) 9481(8) 1579(2) 40(1) 
C(6) 2124(2) 10898(8) 1725(2) 44(1) 
C(7) 2497(2) 10531(8) 1421(2) 44(1) 
C(8) 2464(2) 8734(9) 992(2) 46(1) 
C(9) 2052(1) 7305(8) 848(2) 38(1) 
C(10) -139(1) 2536(7) 1205(2) 31(1) 
C(11) 947(2) 3088(10) 2603(2) 55(2) 
C(12) 714(1) 7074(7) -525(2) 29(1) 
C(13) 1584(2) 8291(9) 4280(3) 62(2) 
Cl(1) -449(1) 7884(2) 139(1) 35(1) 
Cl(2) 0 7478(2) 2500 55(1) 
Cr(1) 0 5000 0 29(1) 
N(1) 218(1) 4279(6) 1224(2) 31(1) 
N(2) 683(1) 6836(6) 272(2) 29(1) 
O(1) 1169(3) 8749(12) 3512(4) 54(1) 
O(2) 1347(2) 7102(10) 3648(4) 54(1) 
__________________________________________________________________________
______ 
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 Table 3.   Bond lengths [Å] and angles [°] for trans-[Cr(PetA)(Cl)2]Cl (4). 
_____________________________________________________  
C(1)-N(1)  1.507(4) 
C(1)-C(2)  1.527(6) 
C(1)-C(11)  1.534(5) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.543(5) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-N(2)  1.511(4) 
C(3)-C(4)  1.522(5) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.383(6) 
C(4)-C(9)  1.402(5) 
C(5)-C(6)  1.387(6) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.390(6) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.384(7) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.394(6) 
C(8)-H(8)  0.9500 
C(9)-H(9)  0.9500 
C(10)-N(1)  1.488(5) 
C(10)-C(12)#1  1.526(5) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(12)-N(2)  1.500(4) 
C(12)-C(10)#1  1.526(5) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(13)-O(2)  1.291(6) 
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C(13)-O(1)  1.380(7) 
C(13)-H(13A)  1.011(9) 
C(13)-H(13B)  1.018(9) 
C(13)-H(13C)  1.005(9) 
Cl(1)-Cr(1)  2.3176(11) 
Cr(1)-N(1)#1  2.085(3) 
Cr(1)-N(1)  2.085(3) 
Cr(1)-N(2)  2.086(3) 
Cr(1)-N(2)#1  2.086(3) 
Cr(1)-Cl(1)#1  2.3176(11) 
N(1)-H(1N)  0.997(10) 
N(2)-H(2N)  0.993(10) 
O(1)-H(2)  1.017(10) 
O(2)-H(2)  1.028(9) 
N(1)-C(1)-C(2) 108.3(4) 
N(1)-C(1)-C(11) 112.3(3) 
C(2)-C(1)-C(11) 111.4(3) 
N(1)-C(1)-H(1) 108.3 
C(2)-C(1)-H(1) 108.3 
C(11)-C(1)-H(1) 108.3 
C(1)-C(2)-C(3) 116.5(4) 
C(1)-C(2)-H(2A) 108.2 
C(3)-C(2)-H(2A) 108.2 
C(1)-C(2)-H(2B) 108.2 
C(3)-C(2)-H(2B) 108.2 
H(2A)-C(2)-H(2B) 107.3 
N(2)-C(3)-C(4) 111.2(3) 
N(2)-C(3)-C(2) 110.4(3) 
C(4)-C(3)-C(2) 111.6(3) 
N(2)-C(3)-H(3) 107.8 
C(4)-C(3)-H(3) 107.8 
C(2)-C(3)-H(3) 107.8 
C(5)-C(4)-C(9) 119.0(4) 
C(5)-C(4)-C(3) 121.6(3) 
C(9)-C(4)-C(3) 119.4(4) 
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C(4)-C(5)-C(6) 121.2(4) 
C(4)-C(5)-H(5) 119.4 
C(6)-C(5)-H(5) 119.4 
C(5)-C(6)-C(7) 119.7(5) 
C(5)-C(6)-H(6) 120.2 
C(7)-C(6)-H(6) 120.2 
C(8)-C(7)-C(6) 119.8(4) 
C(8)-C(7)-H(7) 120.1 
C(6)-C(7)-H(7) 120.1 
C(7)-C(8)-C(9) 120.5(4) 
C(7)-C(8)-H(8) 119.7 
C(9)-C(8)-H(8) 119.7 
C(8)-C(9)-C(4) 119.7(5) 
C(8)-C(9)-H(9) 120.1 
C(4)-C(9)-H(9) 120.1 
N(1)-C(10)-C(12)#1 108.9(3) 
N(1)-C(10)-H(10A) 109.9 
C(12)#1-C(10)-H(10A) 109.9 
N(1)-C(10)-H(10B) 109.9 
C(12)#1-C(10)-H(10B) 109.9 
H(10A)-C(10)-H(10B) 108.3 
C(1)-C(11)-H(11A) 109.5 
C(1)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
C(1)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
N(2)-C(12)-C(10)#1 108.2(3) 
N(2)-C(12)-H(12A) 110.1 
C(10)#1-C(12)-H(12A) 110.1 
N(2)-C(12)-H(12B) 110.1 
C(10)#1-C(12)-H(12B) 110.1 
H(12A)-C(12)-H(12B) 108.4 
O(2)-C(13)-O(1) 51.1(4) 
O(2)-C(13)-H(13A) 122(2) 
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O(1)-C(13)-H(13A) 122(2) 
O(2)-C(13)-H(13B) 144.4(17) 
O(1)-C(13)-H(13B) 99.8(13) 
H(13A)-C(13)-H(13B) 89.5(10) 
O(2)-C(13)-H(13C) 104.6(14) 
O(1)-C(13)-H(13C) 145.6(18) 
H(13A)-C(13)-H(13C) 90.9(10) 
H(13B)-C(13)-H(13C) 89.9(10) 
N(1)#1-Cr(1)-N(1) 180.0 
N(1)#1-Cr(1)-N(2) 85.35(11) 
N(1)-Cr(1)-N(2) 94.65(11) 
N(1)#1-Cr(1)-N(2)#1 94.65(11) 
N(1)-Cr(1)-N(2)#1 85.35(11) 
N(2)-Cr(1)-N(2)#1 180.00(10) 
N(1)#1-Cr(1)-Cl(1) 91.48(11) 
N(1)-Cr(1)-Cl(1) 88.52(11) 
N(2)-Cr(1)-Cl(1) 88.85(10) 
N(2)#1-Cr(1)-Cl(1) 91.15(10) 
N(1)#1-Cr(1)-Cl(1)#1 88.52(11) 
N(1)-Cr(1)-Cl(1)#1 91.48(11) 
N(2)-Cr(1)-Cl(1)#1 91.15(10) 
N(2)#1-Cr(1)-Cl(1)#1 88.85(10) 
Cl(1)-Cr(1)-Cl(1)#1 180.00(4) 
C(10)-N(1)-C(1) 112.5(3) 
C(10)-N(1)-Cr(1) 106.1(2) 
C(1)-N(1)-Cr(1) 114.1(2) 
C(10)-N(1)-H(1N) 109(3) 
C(1)-N(1)-H(1N) 111(3) 
Cr(1)-N(1)-H(1N) 104(3) 
C(12)-N(2)-C(3) 112.9(3) 
C(12)-N(2)-Cr(1) 105.5(2) 
C(3)-N(2)-Cr(1) 117.0(2) 
C(12)-N(2)-H(2N) 108(2) 
C(3)-N(2)-H(2N) 110(2) 
Cr(1)-N(2)-H(2N) 103(2) 
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C(13)-O(1)-H(2) 116.5(9) 
C(13)-O(2)-H(2) 123.6(9) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms: #1 -x,-y+1,-z      
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 Table 4.   Anisotropic displacement parameters  (Å2x 103) for trans-[Cr(PetA)(Cl)2]Cl (4).  
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k 
a* b* U12 ] 
__________________________________________________________________________
____  
 U11 U22  U33 U23 U13 U12 
__________________________________________________________________________
____  
C(1) 15(2)  81(3) 19(2)  16(2) 1(1)  -15(2) 
C(2) 15(2)  85(4) 15(2)  11(2) -1(1)  -19(2) 
C(3) 12(2)  64(3) 16(2)  10(2) 0(1)  -10(2) 
C(4) 11(2)  63(3) 15(2)  10(2) 0(1)  -7(2) 
C(5) 16(2)  70(3) 26(2)  5(2) 3(1)  -8(2) 
C(6) 22(2)  67(3) 27(2)  5(2) -2(2)  -8(2) 
C(7) 21(2)  77(4) 23(2)  13(2) -2(2)  -21(2) 
C(8) 18(2)  92(4) 24(2)  12(2) 7(2)  -11(2) 
C(9) 18(2)  73(3) 20(2)  7(2) 5(1)  -8(2) 
C(10) 19(2)  56(3) 15(2)  8(2) 6(1)  -10(2) 
C(11) 26(2)  108(5) 19(2)  20(2) 0(2)  -21(3) 
C(12) 18(2)  55(3) 14(2)  7(2) 6(1)  -9(2) 
C(13) 54(3)  98(5) 34(2)  0(3) 19(2)  40(3) 
Cl(1) 18(1)  64(1) 22(1)  11(1) 7(1)  -7(1) 
Cl(2) 89(1)  30(1) 19(1)  0 -1(1)  0 
Cr(1) 11(1)  62(1) 11(1)  8(1) 2(1)  -10(1) 
N(1) 15(1)  61(2) 13(1)  8(1) 2(1)  -12(2) 
N(2) 13(1)  59(2) 12(1)  6(1) 3(1)  -8(1) 
O(1) 45(3)  56(3) 51(3)  -23(3) 13(2)  -2(2) 
O(2) 45(3)  56(3) 51(3)  -23(3) 13(2)  -2(2) 
__________________________________________________________________________
____ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for trans-[Cr(PetA)(Cl)2]Cl (4). 
__________________________________________________________________________
______  
 x  y  z  U(eq) 
__________________________________________________________________________
______  
  
H(1) 915 2669 1452 49 
H(2A) 1509 5595 2221 50 
H(2B) 964 6930 1849 50 
H(3) 1322 4814 802 40 
H(5) 1458 9740 1787 48 
H(6) 2151 12113 2032 52 
H(7) 2775 11512 1507 53 
H(8) 2724 8472 794 55 
H(9) 2033 6069 556 46 
H(10A) -146 2423 1742 37 
H(10B) 4 1228 1100 37 
H(11A) 835 4153 2877 82 
H(11B) 1340 2847 2916 82 
H(11C) 750 1807 2573 82 
H(12A) 866 5807 -645 35 
H(12B) 955 8244 -489 35 
H(1N) 110(20) 5530(50) 1440(30) 65(17) 
H(2N) 576(16) 8190(30) 410(20) 31(11) 
H(13A) 1517(13) 8160(70) 4779(12) 100 
H(13B) 1736(15) 9730(30) 4467(15) 100 
H(13C) 1960(8) 7700(60) 4593(16) 100 
H(2) 1031(16) 7570(30) 3101(13) 100 
_______________________________________________________________________
_________ 
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2. Crystal Information of cis-[Cr(PetA)(Cl)2]Cl (5) 
Table 1.  Crystal data and structure refinement for cis-[Cr(PetA)(Cl)2]Cl (5). 
Identification code  b02272017_0m_a 
Empirical formula  C24 H36 Cl3 Cr N4 
Formula weight  538.92 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Trigonal 
Space group  P3221 
Unit cell dimensions a = 12.8928(11) Å a= 90°. 
 b = 12.8928(11) Å b= 90°. 
 c = 13.1562(14) Å g = 120°. 
Volume 1893.9(4) Å3 
Z 3 
Density (calculated) 1.418 Mg/m3 
Absorption coefficient 0.791 mm-1 
F(000) 849 
Crystal size 0.100 x 0.100 x 0.050 mm3 
Theta range for data collection 1.824 to 26.423°. 
Index ranges -5<=h<=16, -16<=k<=12, -16<=l<=16 
Reflections collected 8616 
Independent reflections 2600 [R(int) = 0.0426] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2600 / 0 / 147 
Goodness-of-fit on F2 1.058 
Final R indices [I>2sigma(I)] R1 = 0.0473, wR2 = 0.1190 
R indices (all data) R1 = 0.0574, wR2 = 0.1250 
Absolute structure parameter 0.009(18) 
Extinction coefficient n/a 
Largest diff. peak and hole 1.739 and -0.376 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for cis-[Cr(PetA)(Cl)2]Cl (5).  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
__________________________________________________________________________
______  
 x y z U(eq) 
__________________________________________________________________________
______   
C(1) 3258(5) 10497(5) -267(4) 17(1) 
C(2) 3850(5) 11653(5) 317(4) 17(1) 
C(3) 1432(5) 8474(5) -321(4) 20(1) 
C(4) 1958(5) 7759(5) 159(4) 20(1) 
C(5) 1729(5) 7492(5) 1291(4) 19(1) 
C(6) 2078(5) 6567(5) 1652(4) 22(1) 
C(7) 1266(7) 5579(5) 2215(4) 26(1) 
C(8) 1598(7) 4765(6) 2581(5) 35(2) 
C(9) 2696(7) 4902(7) 2372(5) 36(2) 
C(10) 3486(6) 5882(6) 1790(5) 30(2) 
C(11) 3183(6) 6711(6) 1447(5) 26(1) 
C(12) 1543(6) 8482(6) -1467(5) 26(1) 
Cl(1) 1404(1) 11442(1) 1488(1) 22(1) 
Cl(2) 5200(2) 10000 1667 30(1) 
Cr(1) 1971(1) 10000 1667 14(1) 
N(1) 1997(4) 9729(4) 101(3) 16(1) 
N(2) 3761(4) 11375(4) 1425(3) 16(1) 
_______________________________________________________________________
_________ 
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 Table 3.   Bond lengths [Å] and angles [°] for cis-[Cr(PetA)(Cl)2]Cl (5). 
_____________________________________________________  
C(1)-N(1)  1.499(7) 
C(1)-C(2)  1.501(7) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-N(2)  1.491(7) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-N(1)  1.510(7) 
C(3)-C(12)  1.514(8) 
C(3)-C(4)  1.528(8) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.523(8) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-N(2)#1  1.508(7) 
C(5)-C(6)  1.545(8) 
C(5)-H(5)  1.0000 
C(6)-C(11)  1.369(9) 
C(6)-C(7)  1.390(9) 
C(7)-C(8)  1.402(9) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.364(11) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.390(10) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.383(9) 
C(10)-H(10)  0.9500 
C(11)-H(11)  0.9500 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
Cl(1)-Cr(1)  2.3251(16) 
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Cr(1)-N(1)  2.092(4) 
Cr(1)-N(1)#1  2.092(4) 
Cr(1)-N(2)#1  2.116(5) 
Cr(1)-N(2)  2.116(5) 
Cr(1)-Cl(1)#1  2.3251(16) 
N(1)-H(1)  1.0000 
N(2)-C(5)#1  1.508(7) 
N(2)-H(2)  1.0000 
 
N(1)-C(1)-C(2) 109.6(4) 
N(1)-C(1)-H(1A) 109.7 
C(2)-C(1)-H(1A) 109.7 
N(1)-C(1)-H(1B) 109.7 
C(2)-C(1)-H(1B) 109.7 
H(1A)-C(1)-H(1B) 108.2 
N(2)-C(2)-C(1) 108.8(4) 
N(2)-C(2)-H(2A) 109.9 
C(1)-C(2)-H(2A) 109.9 
N(2)-C(2)-H(2B) 109.9 
C(1)-C(2)-H(2B) 109.9 
H(2A)-C(2)-H(2B) 108.3 
N(1)-C(3)-C(12) 111.5(4) 
N(1)-C(3)-C(4) 111.9(4) 
C(12)-C(3)-C(4) 110.3(5) 
N(1)-C(3)-H(3) 107.6 
C(12)-C(3)-H(3) 107.6 
C(4)-C(3)-H(3) 107.6 
C(5)-C(4)-C(3) 116.5(5) 
C(5)-C(4)-H(4A) 108.2 
C(3)-C(4)-H(4A) 108.2 
C(5)-C(4)-H(4B) 108.2 
C(3)-C(4)-H(4B) 108.2 
H(4A)-C(4)-H(4B) 107.3 
N(2)#1-C(5)-C(4) 110.9(4) 
N(2)#1-C(5)-C(6) 110.1(4) 
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C(4)-C(5)-C(6) 112.1(5) 
N(2)#1-C(5)-H(5) 107.9 
C(4)-C(5)-H(5) 107.9 
C(6)-C(5)-H(5) 107.9 
C(11)-C(6)-C(7) 119.0(6) 
C(11)-C(6)-C(5) 121.4(6) 
C(7)-C(6)-C(5) 119.6(5) 
C(6)-C(7)-C(8) 119.8(7) 
C(6)-C(7)-H(7) 120.1 
C(8)-C(7)-H(7) 120.1 
C(9)-C(8)-C(7) 121.2(7) 
C(9)-C(8)-H(8) 119.4 
C(7)-C(8)-H(8) 119.4 
C(8)-C(9)-C(10) 118.0(6) 
C(8)-C(9)-H(9) 121.0 
C(10)-C(9)-H(9) 121.0 
C(11)-C(10)-C(9) 121.4(7) 
C(11)-C(10)-H(10) 119.3 
C(9)-C(10)-H(10) 119.3 
C(6)-C(11)-C(10) 120.5(6) 
C(6)-C(11)-H(11) 119.7 
C(10)-C(11)-H(11) 119.7 
C(3)-C(12)-H(12A) 109.5 
C(3)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 
C(3)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
N(1)-Cr(1)-N(1)#1 168.6(3) 
N(1)-Cr(1)-N(2)#1 88.64(17) 
N(1)#1-Cr(1)-N(2)#1 83.67(18) 
N(1)-Cr(1)-N(2) 83.67(18) 
N(1)#1-Cr(1)-N(2) 88.64(17) 
N(2)#1-Cr(1)-N(2) 95.6(3) 
N(1)-Cr(1)-Cl(1)#1 94.07(13) 
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N(1)#1-Cr(1)-Cl(1)#1 94.10(13) 
N(2)#1-Cr(1)-Cl(1)#1 87.85(13) 
N(2)-Cr(1)-Cl(1)#1 175.84(14) 
N(1)-Cr(1)-Cl(1) 94.10(13) 
N(1)#1-Cr(1)-Cl(1) 94.06(13) 
N(2)#1-Cr(1)-Cl(1) 175.84(14) 
N(2)-Cr(1)-Cl(1) 87.85(13) 
Cl(1)#1-Cr(1)-Cl(1) 88.84(9) 
C(1)-N(1)-C(3) 111.8(4) 
C(1)-N(1)-Cr(1) 108.1(3) 
C(3)-N(1)-Cr(1) 120.1(3) 
C(1)-N(1)-H(1) 105.2 
C(3)-N(1)-H(1) 105.2 
Cr(1)-N(1)-H(1) 105.2 
C(2)-N(2)-C(5)#1 110.4(4) 
C(2)-N(2)-Cr(1) 105.6(3) 
C(5)#1-N(2)-Cr(1) 118.4(3) 
C(2)-N(2)-H(2) 107.3 
C(5)#1-N(2)-H(2) 107.3 
Cr(1)-N(2)-H(2) 107.3 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x-y+1,-y+2,-z+1/3       
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 Table 4.   Anisotropic displacement parameters  (Å2x 103) for cis-[Cr(PetA)(Cl)2]Cl (5).  
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k 
a* b* U12 ] 
__________________________________________________________________________
____  
 U11 U22  U33 U23 U13 U12 
__________________________________________________________________________
____  
C(1) 17(3)  20(3) 14(2)  3(2) 1(2)  9(2) 
C(2) 16(3)  15(3) 17(3)  6(2) 6(2)  6(2) 
C(3) 21(3)  13(3) 23(3)  2(2) 0(2)  6(2) 
C(4) 25(3)  15(3) 20(3)  -5(2) -1(2)  10(2) 
C(5) 17(3)  14(3) 26(3)  1(2) 0(2)  6(2) 
C(6) 27(4)  15(3) 20(3)  -5(2) -4(2)  9(2) 
C(7) 41(4)  16(3) 19(3)  -3(2) -7(3)  13(3) 
C(8) 52(4)  16(3) 29(3)  -1(3) -6(3)  11(3) 
C(9) 62(5)  26(3) 31(3)  -13(3) -22(3)  30(4) 
C(10) 39(4)  28(4) 33(3)  -15(3) -19(3)  24(3) 
C(11) 31(4)  21(3) 27(3)  -5(3) -4(3)  14(3) 
C(12) 33(4)  19(3) 28(3)  -3(3) -2(3)  14(3) 
Cl(1) 22(1)  24(1) 26(1)  2(1) -1(1)  16(1) 
Cl(2) 15(1)  23(1) 55(2)  7(1) 4(1)  11(1) 
Cr(1) 12(1)  13(1) 16(1)  2(1) 1(1)  6(1) 
N(1) 15(2)  12(2) 21(2)  1(2) -2(2)  7(2) 
N(2) 15(2)  16(2) 16(2)  2(2) 1(2)  8(2) 
__________________________________________________________________________
____ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for cis-[Cr(PetA)(Cl)2]Cl (5). 
__________________________________________________________________________
______  
 x  y  z  U(eq) 
__________________________________________________________________________
______  
  
H(1A) 3254 10665 -1001 21 
H(1B) 3710 10071 -172 21 
H(2A) 4702 12135 115 20 
H(2B) 3451 12121 166 20 
H(3) 560 8058 -152 24 
H(4A) 1632 6987 -206 24 
H(4B) 2835 8203 48 24 
H(5) 852 7146 1414 23 
H(7) 489 5456 2351 31 
H(8) 1048 4105 2983 42 
H(9) 2915 4345 2616 44 
H(10) 4249 5985 1625 36 
H(11) 3747 7384 1066 31 
H(12A) 1262 8996 -1762 40 
H(12B) 1057 7665 -1728 40 
H(12C) 2384 8792 -1654 40 
H(1) 1536 10084 -208 20 
H(2) 4288 11027 1563 19 
_______________________________________________________________________
_________ 
  
179 
3. Crystal Information of trans-[Cr(PetA)(ONO)2]BF4 (6) 
Table 1.  :  Crystal data and structure refinement for trans-[Cr(PetA)(ONO)2]BF4. 
Identification code  06232014_1_0m 
Empirical formula  C25H38BCl2CrF4N6O4 
Formula weight  696.32 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.1893(11) Å a= 80.745(4)°. 
 b = 11.7329(14) Å b= 73.030(4)°. 
 c = 15.259(2) Å g = 79.087(4)°. 
Volume 1535.3(3) Å3 
Z 2 
Density (calculated) 1.506 Mg/m3 
Absorption coefficient 0.613 mm-1 
F(000) 722 
Crystal size 0.200 x 0.100 x 0.050 mm3 
Theta range for data collection 1.779 to 27.301°. 
Index ranges -10<=h<=11, -15<=k<=15, -9<=l<=19 
Reflections collected 11331 
Independent reflections 6835 [R(int) = 0.0247] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7455 and 0.6737 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6835 / 0 / 409 
Goodness-of-fit on F2 1.043 
Final R indices [I>2sigma(I)] R1 = 0.0495, wR2 = 0.1204 
R indices (all data) R1 = 0.0762, wR2 = 0.1343 
Extinction coefficient n/a 
Largest diff. peak and hole 1.069 and -0.974 e.Å-3 
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 Table 2:  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for trans-[Cr(PetA)(ONO)2]BF4. U(eq) is defined as one third of  the 
trace of the orthogonalized Uij tensor. 
_______________________________________________________________________
_________  
 x y z U(eq) 
_______________________________________________________________________
_________   
B(1) 1933(4) 5551(3) 2719(2) 20(1) 
C(1) 9220(4) 2444(3) 5043(2) 25(1) 
C(2) 7602(3) 2924(3) 4948(2) 18(1) 
C(3) 8251(3) 4937(3) 4404(2) 17(1) 
C(4) 7590(3) 6212(3) 4481(2) 18(1) 
C(5) 5157(3) 7619(3) 4533(2) 16(1) 
C(6) 3573(3) 7766(3) 4360(2) 18(1) 
C(7) 6062(3) 8593(3) 4022(2) 18(1) 
C(8) 6072(4) 9031(3) 3120(2) 27(1) 
C(9) 6901(5) 9918(3) 2667(3) 40(1) 
C(10) 7728(5) 10387(3) 3106(3) 41(1) 
C(11) 7742(4) 9955(3) 3995(3) 40(1) 
C(12) 6902(4) 9068(3) 4455(2) 32(1) 
C(13) 6769(3) 5092(3) 257(2) 16(1) 
C(14) 7301(3) 6920(3) 680(2) 17(1) 
C(15) 8397(3) 7386(3) 1082(2) 17(1) 
C(16) 10013(3) 7429(2) 449(2) 16(1) 
C(17) 5642(3) 7256(3) 1221(2) 23(1) 
C(18) 12533(3) 6167(3) -142(2) 15(1) 
C(19) 10842(3) 8295(2) 687(2) 18(1) 
C(20) 10733(4) 8430(3) 1594(2) 24(1) 
C(21) 11536(4) 9212(3) 1781(3) 31(1) 
C(22) 12460(4) 9856(3) 1066(3) 32(1) 
C(23) 12575(4) 9726(3) 167(3) 30(1) 
C(24) 11760(4) 8956(3) -20(2) 24(1) 
C(25) 3302(5) 2454(3) 2422(3) 41(1) 
Cl(1) 4606(1) 2158(1) 1370(1) 38(1) 
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Cl(2) 2677(1) 1194(1) 3114(1) 44(1) 
Cr(1) 5000 5000 5000 10(1) 
Cr(2) 10000 5000 0 10(1) 
F(1) 2521(2) 6452(2) 2927(1) 32(1) 
F(2) 2821(2) 5194(2) 1874(1) 27(1) 
F(3) 1933(2) 4630(2) 3424(1) 26(1) 
F(4) 432(2) 5934(2) 2654(1) 31(1) 
N(1) 7179(3) 4198(2) 5071(2) 15(1) 
N(2) 6034(3) 6439(2) 4316(2) 15(1) 
N(3) 7742(3) 5622(2) 664(2) 13(1) 
N(4) 10917(3) 6216(2) 445(2) 13(1) 
N(5) 5817(3) 4833(2) 3050(2) 22(1) 
N(6) 9367(3) 4007(3) 1892(2) 29(1) 
O(1) 5277(2) 4289(2) 3872(1) 17(1) 
O(2) 5898(3) 4277(2) 2425(1) 26(1) 
O(3) 10285(2) 3867(2) 1062(1) 17(1) 
O(4)      9617(3)     3229(2)     2481(2)         34(1) 
_______________________________________________________________________
_________ 
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 Table 3:   Bond lengths [Å] and angles [°] for trans-[Cr(PetA)(ONO)2]BF4. 
_____________________________________________________  
B(1)-F(1)  1.391(4) 
B(1)-F(2)  1.391(4) 
B(1)-F(4)  1.394(4) 
B(1)-F(3)  1.396(4) 
C(1)-C(2)  1.527(4) 
C(1)-H(1A)  0.9800 
C(1)-H(1B)  0.9800 
C(1)-H(1C)  0.9800 
C(2)-N(1)  1.500(4) 
C(2)-C(6)#1  1.526(4) 
C(2)-H(2A)  1.0000 
C(3)-N(1)  1.487(4) 
C(3)-C(4)  1.514(4) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-N(2)  1.491(4) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-N(2)  1.498(4) 
C(5)-C(7)  1.517(4) 
C(5)-C(6)  1.527(4) 
C(5)-H(5)  1.0000 
C(6)-C(2)#1  1.526(4) 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(12)  1.386(4) 
C(7)-C(8)  1.387(4) 
C(8)-C(9)  1.380(5) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.379(6) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.373(6) 
C(10)-H(10)  0.9500 
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C(11)-C(12)  1.387(5) 
C(11)-H(11)  0.9500 
C(12)-H(12)  0.9500 
C(13)-N(3)  1.494(3) 
C(13)-C(18)#2  1.512(4) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-N(3)  1.503(4) 
C(14)-C(17)  1.518(4) 
C(14)-C(15)  1.538(4) 
C(14)-H(14)  1.0000 
C(15)-C(16)  1.522(4) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-N(4)  1.506(4) 
C(16)-C(19)  1.523(4) 
C(16)-H(16)  1.0000 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-N(4)  1.490(3) 
C(18)-C(13)#2  1.512(4) 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(19)-C(24)  1.387(4) 
C(19)-C(20)  1.392(4) 
C(20)-C(21)  1.390(4) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.386(5) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.375(5) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.387(5) 
C(23)-H(23)  0.9500 
C(24)-H(24)  0.9500 
  
184 
C(25)-Cl(1)  1.741(4) 
C(25)-Cl(2)  1.760(4) 
C(25)-H(25A)  0.9900 
C(25)-H(25B)  0.9900 
Cr(1)-O(1)#1  1.9616(19) 
Cr(1)-O(1)  1.9616(19) 
Cr(1)-N(1)#1  2.071(2) 
Cr(1)-N(1)  2.071(2) 
Cr(1)-N(2)#1  2.075(2) 
Cr(1)-N(2)  2.075(2) 
Cr(2)-O(3)  1.9708(19) 
Cr(2)-O(3)#2  1.9708(19) 
Cr(2)-N(3)  2.074(2) 
Cr(2)-N(3)#2  2.074(2) 
Cr(2)-N(4)#2  2.076(2) 
Cr(2)-N(4)  2.076(2) 
N(1)-H(1)  0.72(4) 
N(2)-H(2)  0.81(4) 
N(3)-H(3)  0.81(3) 
N(4)-H(4)  0.74(3) 
N(5)-O(2)  1.218(3) 
N(5)-O(1)  1.313(3) 
N(6)-O(4)  1.214(3) 
N(6)-O(3)  1.316(3) 
 
F(1)-B(1)-F(2) 109.9(3) 
F(1)-B(1)-F(4) 110.2(3) 
F(2)-B(1)-F(4) 108.0(3) 
F(1)-B(1)-F(3) 108.5(3) 
F(2)-B(1)-F(3) 110.9(3) 
F(4)-B(1)-F(3) 109.4(3) 
C(2)-C(1)-H(1A) 109.5 
C(2)-C(1)-H(1B) 109.5 
H(1A)-C(1)-H(1B) 109.5 
C(2)-C(1)-H(1C) 109.5 
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H(1A)-C(1)-H(1C) 109.5 
H(1B)-C(1)-H(1C) 109.5 
N(1)-C(2)-C(6)#1 110.1(2) 
N(1)-C(2)-C(1) 111.7(2) 
C(6)#1-C(2)-C(1) 110.4(3) 
N(1)-C(2)-H(2A) 108.2 
C(6)#1-C(2)-H(2A) 108.2 
C(1)-C(2)-H(2A) 108.2 
N(1)-C(3)-C(4) 109.3(2) 
N(1)-C(3)-H(3A) 109.8 
C(4)-C(3)-H(3A) 109.8 
N(1)-C(3)-H(3B) 109.8 
C(4)-C(3)-H(3B) 109.8 
H(3A)-C(3)-H(3B) 108.3 
N(2)-C(4)-C(3) 109.2(2) 
N(2)-C(4)-H(4A) 109.8 
C(3)-C(4)-H(4A) 109.8 
N(2)-C(4)-H(4B) 109.8 
C(3)-C(4)-H(4B) 109.8 
H(4A)-C(4)-H(4B) 108.3 
N(2)-C(5)-C(7) 111.9(2) 
N(2)-C(5)-C(6) 110.2(2) 
C(7)-C(5)-C(6) 112.8(2) 
N(2)-C(5)-H(5) 107.2 
C(7)-C(5)-H(5) 107.2 
C(6)-C(5)-H(5) 107.2 
C(2)#1-C(6)-C(5) 116.5(2) 
C(2)#1-C(6)-H(6A) 108.2 
C(5)-C(6)-H(6A) 108.2 
C(2)#1-C(6)-H(6B) 108.2 
C(5)-C(6)-H(6B) 108.2 
H(6A)-C(6)-H(6B) 107.3 
C(12)-C(7)-C(8) 118.4(3) 
C(12)-C(7)-C(5) 120.2(3) 
C(8)-C(7)-C(5) 121.4(3) 
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C(9)-C(8)-C(7) 120.6(3) 
C(9)-C(8)-H(8) 119.7 
C(7)-C(8)-H(8) 119.7 
C(10)-C(9)-C(8) 120.4(4) 
C(10)-C(9)-H(9) 119.8 
C(8)-C(9)-H(9) 119.8 
C(11)-C(10)-C(9) 119.6(3) 
C(11)-C(10)-H(10) 120.2 
C(9)-C(10)-H(10) 120.2 
C(10)-C(11)-C(12) 120.1(4) 
C(10)-C(11)-H(11) 120.0 
C(12)-C(11)-H(11) 120.0 
C(7)-C(12)-C(11) 120.8(3) 
C(7)-C(12)-H(12) 119.6 
C(11)-C(12)-H(12) 119.6 
N(3)-C(13)-C(18)#2 108.6(2) 
N(3)-C(13)-H(13A) 110.0 
C(18)#2-C(13)-H(13A)110.0 
N(3)-C(13)-H(13B) 110.0 
C(18)#2-C(13)-H(13B)110.0 
H(13A)-C(13)-H(13B)108.3 
N(3)-C(14)-C(17) 112.3(2) 
N(3)-C(14)-C(15) 109.6(2) 
C(17)-C(14)-C(15) 110.4(2) 
N(3)-C(14)-H(14) 108.2 
C(17)-C(14)-H(14) 108.2 
C(15)-C(14)-H(14) 108.2 
C(16)-C(15)-C(14) 115.1(2) 
C(16)-C(15)-H(15A) 108.5 
C(14)-C(15)-H(15A) 108.5 
C(16)-C(15)-H(15B) 108.5 
C(14)-C(15)-H(15B) 108.5 
H(15A)-C(15)-H(15B)107.5 
N(4)-C(16)-C(15) 109.4(2) 
N(4)-C(16)-C(19) 111.9(2) 
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C(15)-C(16)-C(19) 113.2(2) 
N(4)-C(16)-H(16) 107.4 
C(15)-C(16)-H(16) 107.4 
C(19)-C(16)-H(16) 107.4 
C(14)-C(17)-H(17A) 109.5 
C(14)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17B)109.5 
C(14)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17C)109.5 
H(17B)-C(17)-H(17C)109.5 
N(4)-C(18)-C(13)#2 109.3(2) 
N(4)-C(18)-H(18A) 109.8 
C(13)#2-C(18)-H(18A)109.8 
N(4)-C(18)-H(18B) 109.8 
C(13)#2-C(18)-H(18B)109.8 
H(18A)-C(18)-H(18B)108.3 
C(24)-C(19)-C(20) 118.7(3) 
C(24)-C(19)-C(16) 119.3(3) 
C(20)-C(19)-C(16) 122.0(3) 
C(21)-C(20)-C(19) 120.2(3) 
C(21)-C(20)-H(20) 119.9 
C(19)-C(20)-H(20) 119.9 
C(22)-C(21)-C(20) 120.3(3) 
C(22)-C(21)-H(21) 119.9 
C(20)-C(21)-H(21) 119.9 
C(23)-C(22)-C(21) 119.8(3) 
C(23)-C(22)-H(22) 120.1 
C(21)-C(22)-H(22) 120.1 
C(22)-C(23)-C(24) 119.9(3) 
C(22)-C(23)-H(23) 120.0 
C(24)-C(23)-H(23) 120.0 
C(19)-C(24)-C(23) 121.1(3) 
C(19)-C(24)-H(24) 119.5 
C(23)-C(24)-H(24) 119.5 
Cl(1)-C(25)-Cl(2) 113.2(2) 
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Cl(1)-C(25)-H(25A) 108.9 
Cl(2)-C(25)-H(25A) 108.9 
Cl(1)-C(25)-H(25B) 108.9 
Cl(2)-C(25)-H(25B) 108.9 
H(25A)-C(25)-H(25B)107.8 
O(1)#1-Cr(1)-O(1) 180.0 
O(1)#1-Cr(1)-N(1)#1 90.06(9) 
O(1)-Cr(1)-N(1)#1 89.94(9) 
O(1)#1-Cr(1)-N(1) 89.94(9) 
O(1)-Cr(1)-N(1) 90.07(9) 
N(1)#1-Cr(1)-N(1) 180.0 
O(1)#1-Cr(1)-N(2)#1 94.51(9) 
O(1)-Cr(1)-N(2)#1 85.49(9) 
N(1)#1-Cr(1)-N(2)#1 86.28(10) 
N(1)-Cr(1)-N(2)#1 93.72(10) 
O(1)#1-Cr(1)-N(2) 85.49(9) 
O(1)-Cr(1)-N(2) 94.51(9) 
N(1)#1-Cr(1)-N(2) 93.72(10) 
N(1)-Cr(1)-N(2) 86.28(10) 
N(2)#1-Cr(1)-N(2) 180.0 
O(3)-Cr(2)-O(3)#2 180.00(8) 
O(3)-Cr(2)-N(3) 93.41(9) 
O(3)#2-Cr(2)-N(3) 86.59(9) 
O(3)-Cr(2)-N(3)#2 86.59(9) 
O(3)#2-Cr(2)-N(3)#2 93.41(9) 
N(3)-Cr(2)-N(3)#2 180.0 
O(3)-Cr(2)-N(4)#2 89.45(9) 
O(3)#2-Cr(2)-N(4)#2 90.55(9) 
N(3)-Cr(2)-N(4)#2 85.83(9) 
N(3)#2-Cr(2)-N(4)#2 94.17(9) 
O(3)-Cr(2)-N(4) 90.55(9) 
O(3)#2-Cr(2)-N(4) 89.45(9) 
N(3)-Cr(2)-N(4) 94.17(9) 
N(3)#2-Cr(2)-N(4) 85.83(9) 
N(4)#2-Cr(2)-N(4) 180.0 
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C(3)-N(1)-C(2) 113.4(2) 
C(3)-N(1)-Cr(1) 105.17(17) 
C(2)-N(1)-Cr(1) 117.48(18) 
C(3)-N(1)-H(1) 108(3) 
C(2)-N(1)-H(1) 110(3) 
Cr(1)-N(1)-H(1) 102(3) 
C(4)-N(2)-C(5) 113.8(2) 
C(4)-N(2)-Cr(1) 105.01(17) 
C(5)-N(2)-Cr(1) 117.02(17) 
C(4)-N(2)-H(2) 103(2) 
C(5)-N(2)-H(2) 108(2) 
Cr(1)-N(2)-H(2) 109(2) 
C(13)-N(3)-C(14) 113.5(2) 
C(13)-N(3)-Cr(2) 105.55(17) 
C(14)-N(3)-Cr(2) 117.49(17) 
C(13)-N(3)-H(3) 107(2) 
C(14)-N(3)-H(3) 107(2) 
Cr(2)-N(3)-H(3) 106(2) 
C(18)-N(4)-C(16) 113.6(2) 
C(18)-N(4)-Cr(2) 105.28(17) 
C(16)-N(4)-Cr(2) 115.15(17) 
C(18)-N(4)-H(4) 108(2) 
C(16)-N(4)-H(4) 103(2) 
Cr(2)-N(4)-H(4) 112(2) 
O(2)-N(5)-O(1) 113.3(2) 
O(4)-N(6)-O(3) 114.0(3) 
N(5)-O(1)-Cr(1) 121.69(18) 
N(6)-O(3)-Cr(2) 120.13(18) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1    #2 -x+2,-y+1,-z       
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 Table 4:   Anisotropic displacement parameters  (Å2x 103) for trans-
[Cr(PetA)(ONO)2]BF4. The anisotropic displacement factor exponent takes the form:  -2p2[ 
h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
_______________________________________________________________________
_______  
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________________
_______  
B(1) 20(2)  27(2) 14(2)  -1(1) -4(1)  -5(2) 
C(1) 16(2)  26(2) 34(2)  -6(1) -9(1)  1(1) 
C(2) 14(1)  20(2) 21(2)  -5(1) -5(1)  -1(1) 
C(3) 10(1)  24(2) 17(1)  -1(1) -2(1)  -4(1) 
C(4) 14(1)  22(2) 20(2)  1(1) -3(1)  -9(1) 
C(5) 16(1)  19(2) 16(1)  -1(1) -5(1)  -5(1) 
C(6) 18(2)  19(2) 18(1)  0(1) -6(1)  -4(1) 
C(7) 20(2)  16(2) 17(1)  -5(1) 0(1)  -3(1) 
C(8) 34(2)  27(2) 20(2)  1(1) -4(1)  -10(2) 
C(9) 47(2)  35(2) 32(2)  8(2) -1(2)  -15(2) 
C(10) 42(2)  20(2) 49(2)  -4(2) 10(2)  -15(2) 
C(11) 36(2)  37(2) 50(2)  -19(2) -1(2)  -19(2) 
C(12) 37(2)  39(2) 27(2)  -7(2) -7(2)  -17(2) 
C(13) 11(1)  23(2) 15(1)  -4(1) -5(1)  -4(1) 
C(14) 15(1)  18(2) 20(1)  -3(1) -7(1)  -3(1) 
C(15) 15(1)  17(2) 22(2)  -8(1) -5(1)  -2(1) 
C(16) 17(1)  15(1) 20(1)  -2(1) -8(1)  -2(1) 
C(17) 15(2)  23(2) 31(2)  -6(1) -5(1)  -2(1) 
C(18) 11(1)  20(2) 15(1)  -3(1) -3(1)  -6(1) 
C(19) 17(1)  12(1) 27(2)  -2(1) -10(1)  -1(1) 
C(20) 28(2)  21(2) 26(2)  -4(1) -12(1)  -7(1) 
C(21) 34(2)  31(2) 37(2)  -11(2) -15(2)  -10(2) 
C(22) 30(2)  19(2) 54(2)  -10(2) -18(2)  -5(1) 
C(23) 27(2)  18(2) 42(2)  3(2) -6(2)  -9(1) 
C(24) 25(2)  20(2) 27(2)  0(1) -7(1)  -6(1) 
C(25) 36(2)  31(2) 51(2)  -11(2) -2(2)  -6(2) 
Cl(1) 36(1)  41(1) 38(1)  -2(1) -7(1)  -12(1) 
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Cl(2) 49(1)  49(1) 31(1)  -6(1) -4(1)  -5(1) 
Cr(1) 9(1)  16(1) 6(1)  -1(1) -2(1)  -4(1) 
Cr(2) 9(1)  14(1) 9(1)  -1(1) -4(1)  -4(1) 
F(1) 41(1)  36(1) 25(1)  -7(1) -14(1)  -13(1) 
F(2) 33(1)  34(1) 14(1)  -6(1) -3(1)  -5(1) 
F(3) 24(1)  33(1) 17(1)  5(1) -6(1)  -2(1) 
F(4) 19(1)  40(1) 31(1)  12(1) -9(1)  -6(1) 
N(1) 13(1)  20(1) 12(1)  -1(1) -4(1)  -3(1) 
N(2) 14(1)  20(1) 10(1)  -3(1) -2(1)  -3(1) 
N(3) 13(1)  17(1) 10(1)  0(1) -5(1)  -6(1) 
N(4) 13(1)  17(1) 11(1)  -1(1) -4(1)  -3(1) 
N(5) 20(1)  31(2) 13(1)  -1(1) -4(1)  -6(1) 
N(6) 28(2)  40(2) 17(1)  1(1) -6(1)  -1(1) 
O(1) 18(1)  24(1) 9(1)  -1(1) -3(1)  -6(1) 
O(2) 28(1)  38(1) 13(1)  -7(1) -4(1)  -7(1) 
O(3) 17(1)  21(1) 12(1)  0(1) -5(1)  -3(1) 
O(4) 34(1)  45(2) 19(1)  9(1) -9(1)  -6(1) 
_______________________________________________________________________
_______ 
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 Table 5:   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for trans-[Cr(PetA)(ONO)2]BF4. 
_______________________________________________________________________
_________  
 x  y  z  U(eq) 
_______________________________________________________________________
_________  
  
H(1A) 9969 2860 4568 38 
H(1B) 9451 1609 4968 38 
H(1C) 9279 2554 5654 38 
H(2A) 7577 2828 4313 22 
H(3A) 8397 4757 3769 21 
H(3B) 9266 4770 4538 21 
H(4A) 7512 6405 5103 22 
H(4B) 8275 6710 4021 22 
H(5) 4987 7649 5207 20 
H(6A) 3136 8606 4348 22 
H(6B) 3713 7539 3740 22 
H(8) 5502 8717 2813 32 
H(9) 6903 10207 2048 48 
H(10) 8285 11006 2794 49 
H(11) 8327 10264 4296 48 
H(12) 6903 8783 5074 39 
H(13A) 6723 5527 -349 19 
H(13B) 5708 5133 667 19 
H(14) 7423 7290 30 20 
H(15A) 7936 8184 1244 21 
H(15B) 8476 6888 1660 21 
H(16) 9912 7691 -191 20 
H(17A) 4957 6970 948 35 
H(17B) 5399 8108 1202 35 
H(17C) 5499 6906 1863 35 
H(18A) 13141 6525 150 18 
H(18B) 12549 6612 -753 18 
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H(20) 10107 7986 2088 28 
H(21) 11451 9306 2402 37 
H(22) 13014 10386 1196 38 
H(23) 13211 10164 -325 36 
H(24) 11831 8880 -642 29 
H(25A) 2397 2998 2304 49 
H(25B) 3791 2850 2762 49 
H(1) 7170(40) 4290(30) 5530(30) 26(11) 
H(2) 6230(40) 6420(30) 3770(30) 22(9) 
H(3) 7610(40) 5330(30) 1200(20) 13(8) 
H(4) 10940(30) 6060(30) 930(20) 5(8) 
_______________________________________________________________________
_________ 
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 Table 6:  Torsion angles [°] for trans-[Cr(PetA)(ONO)2]BF4. 
________________________________________________________________  
N(1)-C(3)-C(4)-N(2) -57.1(3) 
N(2)-C(5)-C(6)-C(2)#1 72.7(3) 
C(7)-C(5)-C(6)-C(2)#1 -161.4(2) 
N(2)-C(5)-C(7)-C(12) -96.6(3) 
C(6)-C(5)-C(7)-C(12) 138.4(3) 
N(2)-C(5)-C(7)-C(8) 83.5(3) 
C(6)-C(5)-C(7)-C(8) -41.4(4) 
C(12)-C(7)-C(8)-C(9) 0.1(5) 
C(5)-C(7)-C(8)-C(9) 180.0(3) 
C(7)-C(8)-C(9)-C(10) -0.4(6) 
C(8)-C(9)-C(10)-C(11) 1.0(6) 
C(9)-C(10)-C(11)-C(12) -1.3(6) 
C(8)-C(7)-C(12)-C(11) -0.5(5) 
C(5)-C(7)-C(12)-C(11) 179.7(3) 
C(10)-C(11)-C(12)-C(7) 1.1(6) 
N(3)-C(14)-C(15)-C(16) 73.3(3) 
C(17)-C(14)-C(15)-C(16) -162.6(3) 
C(14)-C(15)-C(16)-N(4) -76.9(3) 
C(14)-C(15)-C(16)-C(19) 157.6(2) 
N(4)-C(16)-C(19)-C(24) 94.7(3) 
C(15)-C(16)-C(19)-C(24) -141.2(3) 
N(4)-C(16)-C(19)-C(20) -84.1(3) 
C(15)-C(16)-C(19)-C(20) 40.1(4) 
C(24)-C(19)-C(20)-C(21) -0.2(5) 
C(16)-C(19)-C(20)-C(21) 178.6(3) 
C(19)-C(20)-C(21)-C(22) -0.5(5) 
C(20)-C(21)-C(22)-C(23) 0.4(5) 
C(21)-C(22)-C(23)-C(24) 0.3(5) 
C(20)-C(19)-C(24)-C(23) 0.9(5) 
C(16)-C(19)-C(24)-C(23) -177.9(3) 
C(22)-C(23)-C(24)-C(19) -1.0(5) 
C(4)-C(3)-N(1)-C(2) 170.9(2) 
C(4)-C(3)-N(1)-Cr(1) 41.2(3) 
  
195 
C(6)#1-C(2)-N(1)-C(3) -178.6(2) 
C(1)-C(2)-N(1)-C(3) 58.4(3) 
C(6)#1-C(2)-N(1)-Cr(1) -55.4(3) 
C(1)-C(2)-N(1)-Cr(1) -178.4(2) 
C(3)-C(4)-N(2)-C(5) 170.1(2) 
C(3)-C(4)-N(2)-Cr(1) 40.8(2) 
C(7)-C(5)-N(2)-C(4) 54.6(3) 
C(6)-C(5)-N(2)-C(4) -179.0(2) 
C(7)-C(5)-N(2)-Cr(1) 177.46(18) 
C(6)-C(5)-N(2)-Cr(1) -56.1(3) 
C(18)#2-C(13)-N(3)-C(14) 171.3(2) 
C(18)#2-C(13)-N(3)-Cr(2) 41.2(2) 
C(17)-C(14)-N(3)-C(13) 58.7(3) 
C(15)-C(14)-N(3)-C(13) -178.2(2) 
C(17)-C(14)-N(3)-Cr(2) -177.51(19) 
C(15)-C(14)-N(3)-Cr(2) -54.4(3) 
C(13)#2-C(18)-N(4)-C(16) -168.4(2) 
C(13)#2-C(18)-N(4)-Cr(2) -41.5(2) 
C(15)-C(16)-N(4)-C(18) -178.8(2) 
C(19)-C(16)-N(4)-C(18) -52.6(3) 
C(15)-C(16)-N(4)-Cr(2) 59.7(3) 
C(19)-C(16)-N(4)-Cr(2) -174.04(19) 
O(2)-N(5)-O(1)-Cr(1) -179.08(19) 
O(4)-N(6)-O(3)-Cr(2) 177.1(2) 
________________________________________________________________  
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4. Crystal Information of  NitroPetA (3”) Ligand 
Table 1.  Crystal data and structure refinement for NitroPetA (3”). 
Identification code  hpj20150627-2-3 
Empirical formula  C24 H34 N6 O4 
Formula weight  470.57 
Temperature  100.01(10) K 
Wavelength  1.54184 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.1135(5) Å a= 104.275(6)°. 
 b = 8.5554(6) Å b= 99.129(6)°. 
 c = 10.6673(6) Å g = 101.428(6)°. 
Volume 601.79(7) Å3 
Z 1 
Density (calculated) 1.298 Mg/m3 
Absorption coefficient 0.737 mm-1 
F(000) 252 
Crystal size 0.15 x 0.08 x 0.05 mm3 
Theta range for data collection 4.383 to 65.046°. 
Index ranges -8<=h<=8, -10<=k<=10, -12<=l<=12 
Reflections collected 8603 
Independent reflections 2019 [R(int) = 0.0271] 
Completeness to theta = 67.684° 98.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.88862 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2019 / 0 / 163 
Goodness-of-fit on F2 1.078 
Final R indices [I>2sigma(I)] R1 = 0.0420, wR2 = 0.1088 
R indices (all data) R1 = 0.0438, wR2 = 0.1106 
Extinction coefficient n/a 
Largest diff. peak and hole 0.315 and -0.190 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for NitroPetA (3”).  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
__________________________________________________________________________
______  
 x y z U(eq) 
__________________________________________________________________________
______   
O(1) 4332(2) 8356(2) -1058(1) 37(1) 
O(2) 1792(2) 8068(2) -187(1) 39(1) 
N(1) 3484(2) 7978(2) -219(1) 27(1) 
N(2) 323(2) 7337(2) 6277(1) 25(1) 
N(3) 1883(2) 6156(2) 3868(1) 23(1) 
C(2) 4528(2) 7356(2) 785(1) 22(1) 
C(6) 4436(2) 6104(2) 2549(1) 22(1) 
C(8) 3322(2) 5282(2) 3411(2) 23(1) 
C(7) 3493(2) 6761(2) 1635(1) 22(1) 
C(3) 6479(2) 7361(2) 818(2) 26(1) 
C(4) 7409(2) 6710(2) 1736(2) 29(1) 
C(10) 1237(2) 8400(2) 5536(2) 28(1) 
C(9) 2786(2) 7696(2) 4934(2) 27(1) 
C(5) 6398(2) 6086(2) 2582(2) 25(1) 
C(11) -1528(2) 7682(2) 6594(2) 27(1) 
C(13) -2372(2) 6528(2) 7364(2) 24(1) 
C(12) -1349(3) 9480(2) 7365(2) 33(1) 
__________________________________________________________________________
______ 
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 Table 3.   Bond lengths [Å] and angles [°] for NitroPetA (3”). 
_____________________________________________________  
O(1)-N(1)  1.2272(17) 
O(2)-N(1)  1.2267(18) 
N(1)-C(2)  1.471(2) 
N(2)-C(10)  1.4694(19) 
N(2)-C(11)  1.476(2) 
N(2)-H(2)  0.89(2) 
N(3)-C(8)  1.4581(19) 
N(3)-C(9)  1.462(2) 
N(3)-H(3)  0.90(2) 
C(2)-C(7)  1.383(2) 
C(2)-C(3)  1.383(2) 
C(6)-C(8)  1.516(2) 
C(6)-C(7)  1.390(2) 
C(6)-C(5)  1.394(2) 
C(8)-H(8)  1.0000 
C(8)-C(13)#1  1.521(2) 
C(7)-H(7)  0.9500 
C(3)-H(3A)  0.9500 
C(3)-C(4)  1.384(2) 
C(4)-H(4)  0.9500 
C(4)-C(5)  1.381(2) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(10)-C(9)  1.512(2) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(5)-H(5)  0.9500 
C(11)-H(11)  1.0000 
C(11)-C(13)  1.527(2) 
C(11)-C(12)  1.525(2) 
C(13)-C(8)#1  1.521(2) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
  
199 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
 
O(1)-N(1)-C(2) 118.67(13) 
O(2)-N(1)-O(1) 123.18(13) 
O(2)-N(1)-C(2) 118.14(12) 
C(10)-N(2)-C(11) 113.75(12) 
C(10)-N(2)-H(2) 107.5(12) 
C(11)-N(2)-H(2) 107.8(12) 
C(8)-N(3)-C(9) 112.67(12) 
C(8)-N(3)-H(3) 107.7(11) 
C(9)-N(3)-H(3) 109.2(11) 
C(7)-C(2)-N(1) 118.27(13) 
C(3)-C(2)-N(1) 118.69(13) 
C(3)-C(2)-C(7) 123.03(14) 
C(7)-C(6)-C(8) 121.08(13) 
C(7)-C(6)-C(5) 118.53(14) 
C(5)-C(6)-C(8) 120.16(13) 
N(3)-C(8)-C(6) 112.14(12) 
N(3)-C(8)-H(8) 108.1 
N(3)-C(8)-C(13)#1 111.86(12) 
C(6)-C(8)-H(8) 108.1 
C(6)-C(8)-C(13)#1 108.45(12) 
C(13)#1-C(8)-H(8) 108.1 
C(2)-C(7)-C(6) 118.89(13) 
C(2)-C(7)-H(7) 120.6 
C(6)-C(7)-H(7) 120.6 
C(2)-C(3)-H(3A) 121.2 
C(2)-C(3)-C(4) 117.67(14) 
C(4)-C(3)-H(3A) 121.2 
C(3)-C(4)-H(4) 119.8 
C(5)-C(4)-C(3) 120.34(14) 
C(5)-C(4)-H(4) 119.8 
N(2)-C(10)-H(10A) 109.5 
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N(2)-C(10)-H(10B) 109.5 
N(2)-C(10)-C(9) 110.73(13) 
H(10A)-C(10)-H(10B) 108.1 
C(9)-C(10)-H(10A) 109.5 
C(9)-C(10)-H(10B) 109.5 
N(3)-C(9)-C(10) 110.77(13) 
N(3)-C(9)-H(9A) 109.5 
N(3)-C(9)-H(9B) 109.5 
C(10)-C(9)-H(9A) 109.5 
C(10)-C(9)-H(9B) 109.5 
H(9A)-C(9)-H(9B) 108.1 
C(6)-C(5)-H(5) 119.2 
C(4)-C(5)-C(6) 121.52(14) 
C(4)-C(5)-H(5) 119.2 
N(2)-C(11)-H(11) 107.6 
N(2)-C(11)-C(13) 110.22(12) 
N(2)-C(11)-C(12) 114.55(13) 
C(13)-C(11)-H(11) 107.6 
C(12)-C(11)-H(11) 107.6 
C(12)-C(11)-C(13) 109.08(13) 
C(8)#1-C(13)-C(11) 117.17(13) 
C(8)#1-C(13)-H(13A) 108.0 
C(8)#1-C(13)-H(13B) 108.0 
C(11)-C(13)-H(13A) 108.0 
C(11)-C(13)-H(13B) 108.0 
H(13A)-C(13)-H(13B) 107.2 
C(11)-C(12)-H(12A) 109.5 
C(11)-C(12)-H(12B) 109.5 
C(11)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y+1,-z+1       
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 Table 4.   Anisotropic displacement parameters  (Å2x 103) for NitroPetA (3”).  The 
anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* 
b* U12 ] 
__________________________________________________________________________
____  
 U11 U22  U33 U23 U13 U12 
__________________________________________________________________________
____  
O(1) 56(1)  37(1) 27(1)  18(1) 19(1)  14(1) 
O(2) 33(1)  56(1) 37(1)  24(1) 7(1)  17(1) 
N(1) 35(1)  27(1) 22(1)  9(1) 8(1)  7(1) 
N(2) 29(1)  25(1) 24(1)  10(1) 11(1)  8(1) 
N(3) 24(1)  24(1) 24(1)  8(1) 11(1)  7(1) 
C(2) 27(1)  21(1) 18(1)  6(1) 6(1)  6(1) 
C(6) 26(1)  21(1) 18(1)  4(1) 7(1)  6(1) 
C(8) 25(1)  28(1) 22(1)  11(1) 9(1)  10(1) 
C(7) 20(1)  24(1) 22(1)  7(1) 9(1)  7(1) 
C(3) 27(1)  25(1) 26(1)  5(1) 13(1)  2(1) 
C(4) 20(1)  32(1) 34(1)  6(1) 9(1)  5(1) 
C(10) 34(1)  23(1) 30(1)  9(1) 16(1)  7(1) 
C(9) 31(1)  25(1) 28(1)  9(1) 14(1)  6(1) 
C(5) 24(1)  27(1) 24(1)  5(1) 2(1)  8(1) 
C(11) 33(1)  26(1) 27(1)  10(1) 14(1)  9(1) 
C(13) 29(1)  26(1) 24(1)  9(1) 13(1)  10(1) 
C(12) 40(1)  26(1) 38(1)  11(1) 20(1)  9(1) 
__________________________________________________________________________
____ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for NitroPetA (3”). 
__________________________________________________________________________
______  
 x  y  z  U(eq) 
__________________________________________________________________________
______  
  
H(8) 4292 5302 4208 28 
H(7) 2160 6800 1593 26 
H(3A) 7159 7795 232 32 
H(4) 8749 6692 1784 35 
H(10A) 1846 9534 6139 33 
H(10B) 217 8483 4824 33 
H(9A) 3545 8522 4579 33 
H(9B) 3707 7472 5628 33 
H(5) 7056 5635 3201 31 
H(11) -2494 7428 5736 32 
H(13A) -1298 6550 8087 29 
H(13B) -3364 6994 7782 29 
H(12A) -454 9750 8230 50 
H(12B) -2646 9619 7493 50 
H(12C) -830 10226 6868 50 
H(3) 1050(30) 5470(20) 4161(18) 27(5) 
H(2) 1170(30) 7530(20) 7040(20) 30(5) 
_______________________________________________________________________
_________ 
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5. Crystal Information of trans-[Cr(NitroPetA)(Cl)2]Cl (4”) 
Table 1.  Crystal data and structure refinement for trans-[Cr(NitroPetA)(Cl)2]Cl (4”). 
Identification code  f07252014_3rd_0m 
Empirical formula  C24 H34 Cl3 Cr N6 O4 
Formula weight  628.92 
Temperature  107(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 6.7988(8) Å a= 69.310(4)°. 
 b = 9.1567(12) Å b= 84.726(4)°. 
 c = 12.3814(15) Å g = 80.948(4)°. 
Volume 711.56(15) Å3 
Z 1 
Density (calculated) 1.468 Mg/m3 
Absorption coefficient 0.725 mm-1 
F(000) 327 
Crystal size 0.250 x 0.100 x 0.050 mm3 
Theta range for data collection 1.759 to 26.301°. 
Index ranges -8<=h<=8, -6<=k<=11, -15<=l<=15 
Reflections collected 4806 
Independent reflections 2887 [R(int) = 0.0179] 
Completeness to theta = 25.242° 99.7 %  
Absorption correction Multi scan 
Max. and min. transmission 0.7454 and 0.6619 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2887 / 1 / 186 
Goodness-of-fit on F2 1.041 
Final R indices [I>2sigma(I)] R1 = 0.0662, wR2 = 0.1982 
R indices (all data) R1 = 0.0778, wR2 = 0.2113 
Extinction coefficient n/a 
Largest diff. peak and hole 2.544 and -0.549 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for trans-[Cr(NitroPetA)(Cl)2]Cl (4”).  U(eq) is defined as one third of  the trace 
of the orthogonalized Uij tensor. 
__________________________________________________________________________
______  
 x y z U(eq) 
__________________________________________________________________________
______   
C(1) 5530(7) 6663(5) 5508(4) 21(1) 
C(2) 5894(6) 7376(5) 4214(4) 19(1) 
C(3) 6764(6) 9832(5) 2689(3) 19(1) 
C(4) 7518(7) 11411(5) 2468(4) 21(1) 
C(5) 6076(7) 12659(5) 2803(4) 22(1) 
C(6) 6824(9) 14259(5) 2243(4) 35(1) 
C(7) 8040(7) 8920(5) 2000(4) 23(1) 
C(8) 7213(8) 8588(5) 1164(4) 27(1) 
C(9) 8420(8) 7724(5) 552(4) 30(1) 
C(10) 10399(8) 7210(6) 754(5) 35(1) 
C(11) 11237(8) 7570(7) 1578(5) 40(1) 
C(12) 10066(8) 8415(6) 2214(5) 34(1) 
Cl(1) 7730(1) 9419(1) 6138(1) 21(1) 
Cl(2A) 811(3) 6238(3) 4941(2) 15(1) 
Cr(1) 5000 10000 5000 13(1) 
N(1) 4114(5) 7805(4) 5910(3) 16(1) 
N(2) 6683(5) 8897(4) 3945(3) 15(1) 
N(3) 7481(8) 7333(5) -308(4) 40(1) 
O(1) 5643(8) 7743(6) -427(4) 58(1) 
O(2) 8509(7) 6572(5) -834(3) 49(1) 
Cl(2B) 624(13) 6691(11) 5231(8) 15(1) 
_______________________________________________________________________
_________ 
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 Table 3.   Bond lengths [Å] and angles [°] for trans-[Cr(NitroPetA)(Cl)2]Cl (4”). 
_____________________________________________________  
C(1)-N(1)  1.494(5) 
C(1)-C(2)  1.514(6) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-N(2)  1.487(5) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-N(2)  1.488(5) 
C(3)-C(7)  1.522(6) 
C(3)-C(4)  1.536(6) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.531(6) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-N(1)#1  1.496(5) 
C(5)-C(6)  1.529(6) 
C(5)-H(5)  1.0000 
C(6)-H(6A)  0.9800 
C(6)-H(6B)  0.9800 
C(6)-H(6C)  0.9800 
C(7)-C(8)  1.365(7) 
C(7)-C(12)  1.401(7) 
C(8)-C(9)  1.407(7) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.369(8) 
C(9)-N(3)  1.461(7) 
C(10)-C(11)  1.371(8) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.404(7) 
C(11)-H(11)  0.9500 
C(12)-H(12)  0.9500 
Cl(1)-Cr(1)  2.3136(10) 
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Cl(2A)-Cl(2B)  0.631(10) 
Cr(1)-N(1)  2.080(3) 
Cr(1)-N(1)#1  2.080(3) 
Cr(1)-N(2)#1  2.080(3) 
Cr(1)-N(2)  2.080(3) 
Cr(1)-Cl(1)#1  2.3136(10) 
N(1)-C(5)#1  1.496(5) 
N(1)-H(1)  0.898(10) 
N(2)-H(2)  0.83(6) 
N(3)-O(2)  1.218(6) 
N(3)-O(1)  1.254(7) 
 
N(1)-C(1)-C(2) 109.0(3) 
N(1)-C(1)-H(1A) 109.9 
C(2)-C(1)-H(1A) 109.9 
N(1)-C(1)-H(1B) 109.9 
C(2)-C(1)-H(1B) 109.9 
H(1A)-C(1)-H(1B) 108.3 
N(2)-C(2)-C(1) 109.0(3) 
N(2)-C(2)-H(2A) 109.9 
C(1)-C(2)-H(2A) 109.9 
N(2)-C(2)-H(2B) 109.9 
C(1)-C(2)-H(2B) 109.9 
H(2A)-C(2)-H(2B) 108.3 
N(2)-C(3)-C(7) 111.8(3) 
N(2)-C(3)-C(4) 111.1(3) 
C(7)-C(3)-C(4) 110.5(3) 
N(2)-C(3)-H(3) 107.8 
C(7)-C(3)-H(3) 107.8 
C(4)-C(3)-H(3) 107.8 
C(5)-C(4)-C(3) 116.5(3) 
C(5)-C(4)-H(4A) 108.2 
C(3)-C(4)-H(4A) 108.2 
C(5)-C(4)-H(4B) 108.2 
C(3)-C(4)-H(4B) 108.2 
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H(4A)-C(4)-H(4B) 107.3 
N(1)#1-C(5)-C(6) 111.7(4) 
N(1)#1-C(5)-C(4) 109.8(3) 
C(6)-C(5)-C(4) 109.2(4) 
N(1)#1-C(5)-H(5) 108.7 
C(6)-C(5)-H(5) 108.7 
C(4)-C(5)-H(5) 108.7 
C(5)-C(6)-H(6A) 109.5 
C(5)-C(6)-H(6B) 109.5 
H(6A)-C(6)-H(6B) 109.5 
C(5)-C(6)-H(6C) 109.5 
H(6A)-C(6)-H(6C) 109.5 
H(6B)-C(6)-H(6C) 109.5 
C(8)-C(7)-C(12) 119.3(4) 
C(8)-C(7)-C(3) 120.0(4) 
C(12)-C(7)-C(3) 120.6(4) 
C(7)-C(8)-C(9) 118.8(5) 
C(7)-C(8)-H(8) 120.6 
C(9)-C(8)-H(8) 120.6 
C(10)-C(9)-C(8) 122.7(5) 
C(10)-C(9)-N(3) 119.6(4) 
C(8)-C(9)-N(3) 117.7(5) 
C(9)-C(10)-C(11) 118.4(5) 
C(9)-C(10)-H(10) 120.8 
C(11)-C(10)-H(10) 120.8 
C(10)-C(11)-C(12) 120.3(5) 
C(10)-C(11)-H(11) 119.9 
C(12)-C(11)-H(11) 119.9 
C(7)-C(12)-C(11) 120.4(5) 
C(7)-C(12)-H(12) 119.8 
C(11)-C(12)-H(12) 119.8 
N(1)-Cr(1)-N(1)#1 180.0 
N(1)-Cr(1)-N(2)#1 94.25(13) 
N(1)#1-Cr(1)-N(2)#1 85.75(13) 
N(1)-Cr(1)-N(2) 85.75(13) 
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N(1)#1-Cr(1)-N(2) 94.25(13) 
N(2)#1-Cr(1)-N(2) 180.0 
N(1)-Cr(1)-Cl(1)#1 88.85(10) 
N(1)#1-Cr(1)-Cl(1)#1 91.15(10) 
N(2)#1-Cr(1)-Cl(1)#1 88.81(10) 
N(2)-Cr(1)-Cl(1)#1 91.18(10) 
N(1)-Cr(1)-Cl(1) 91.15(10) 
N(1)#1-Cr(1)-Cl(1) 88.85(10) 
N(2)#1-Cr(1)-Cl(1) 91.19(10) 
N(2)-Cr(1)-Cl(1) 88.81(10) 
Cl(1)#1-Cr(1)-Cl(1) 180.0 
C(1)-N(1)-C(5)#1 113.3(3) 
C(1)-N(1)-Cr(1) 105.3(2) 
C(5)#1-N(1)-Cr(1) 116.8(2) 
C(1)-N(1)-H(1) 109(3) 
C(5)#1-N(1)-H(1) 107(3) 
Cr(1)-N(1)-H(1) 106(3) 
C(2)-N(2)-C(3) 113.4(3) 
C(2)-N(2)-Cr(1) 105.3(2) 
C(3)-N(2)-Cr(1) 116.2(2) 
C(2)-N(2)-H(2) 110(4) 
C(3)-N(2)-H(2) 109(4) 
Cr(1)-N(2)-H(2) 103(4) 
O(2)-N(3)-O(1) 123.6(5) 
O(2)-N(3)-C(9) 118.2(5) 
O(1)-N(3)-C(9) 118.1(4) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+2,-z+1       
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 Table 4.   Anisotropic displacement parameters  (Å2x 103) for trans-[Cr(NitroPetA)(Cl)2]Cl 
(4”).  The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 
2 h k a* b* U12 ] 
__________________________________________________________________________
____  
 U11 U22  U33 U23 U13 U12 
__________________________________________________________________________
____  
C(1) 27(2)  15(2) 22(2)  -8(2) 5(2)  -4(2) 
C(2) 23(2)  14(2) 22(2)  -10(2) 3(2)  -4(2) 
C(3) 22(2)  20(2) 16(2)  -8(2) 4(2)  -3(2) 
C(4) 27(2)  17(2) 19(2)  -7(2) 7(2)  -4(2) 
C(5) 33(2)  14(2) 16(2)  -4(2) 5(2)  -2(2) 
C(6) 58(3)  20(2) 24(2)  -7(2) 12(2)  -10(2) 
C(7) 32(2)  16(2) 21(2)  -7(2) 10(2)  -7(2) 
C(8) 40(3)  20(2) 21(2)  -7(2) 6(2)  -5(2) 
C(9) 54(3)  19(2) 15(2)  -4(2) 3(2)  -9(2) 
C(10) 43(3)  27(2) 34(3)  -12(2) 16(2)  -5(2) 
C(11) 31(3)  41(3) 53(3)  -27(3) 12(2)  -2(2) 
C(12) 32(3)  33(3) 40(3)  -21(2) 7(2)  -3(2) 
Cl(1) 18(1)  24(1) 23(1)  -11(1) -4(1)  -2(1) 
Cr(1) 14(1)  12(1) 15(1)  -6(1) 1(1)  -3(1) 
N(1) 18(2)  12(2) 17(2)  -7(1) 3(1)  -3(1) 
N(2) 15(2)  15(2) 18(2)  -7(1) 1(1)  -3(1) 
N(3) 66(3)  30(2) 23(2)  -12(2) -3(2)  3(2) 
O(1) 71(3)  63(3) 50(3)  -36(2) -27(2)  18(2) 
O(2) 79(3)  42(2) 33(2)  -25(2) 5(2)  0(2) 
__________________________________________________________________________
____ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for trans-[Cr(NitroPetA)(Cl)2]Cl (4”). 
__________________________________________________________________________
______  
 x  y  z  U(eq) 
__________________________________________________________________________
______  
  
H(1A) 4962 5666 5698 25 
H(1B) 6805 6427 5902 25 
H(2A) 6865 6647 3938 23 
H(2B) 4633 7556 3817 23 
H(3) 5376 10064 2410 23 
H(4A) 8751 11200 2897 26 
H(4B) 7883 11862 1635 26 
H(5) 4737 12723 2503 26 
H(6A) 5915 15059 2463 52 
H(6B) 6876 14545 1401 52 
H(6C) 8161 14198 2506 52 
H(8) 5847 8936 997 33 
H(10) 11174 6619 332 42 
H(11) 12615 7246 1721 48 
H(12) 10653 8647 2792 40 
H(2) 7820(80) 8730(60) 4190(40) 20(12) 
H(1) 2890(30) 7850(60) 5670(40) 19(12) 
_______________________________________________________________________
_________ 
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6. Crystal Information of trans-[Cr(AminoPetA)(Cl)2]BF4 (5”) 
Table 1.  Crystal data and structure refinement for trans-[Cr(AminoPetA)(Cl)2]BF4 (5”). 
Identification code  b10102014_0m 
Empirical formula  C28 H44 B Cl2 Cr F4 N8 
Formula weight  702.42 
Temperature  107(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 31.812(4) Å a= 90°. 
 b = 6.4411(9) Å b= 125.256(6)°. 
 c = 19.781(3) Å g = 90°. 
Volume 3309.9(8) Å3 
Z 4 
Density (calculated) 1.410 Mg/m3 
Absorption coefficient 0.563 mm-1 
F(000) 1468 
Crystal size 0.250 x 0.200 x 0.100 mm3 
Theta range for data collection 2.062 to 27.411°. 
Index ranges -39<=h<=39, -8<=k<=6, -13<=l<=25 
Reflections collected 6333 
Independent reflections 3680 [R(int) = 0.0280] 
Completeness to theta = 25.242° 99.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7455 and 0.6590 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3680 / 2 / 215 
Goodness-of-fit on F2 0.989 
Final R indices [I>2sigma(I)] R1 = 0.0427, wR2 = 0.0959 
R indices (all data) R1 = 0.0607, wR2 = 0.1051 
Extinction coefficient n/a 
Largest diff. peak and hole 0.493 and -0.387 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for trans-[Cr(AminoPetA)(Cl)2]BF4 (5”).  U(eq) is defined as one third of  the 
trace of the orthogonalized Uij tensor. 
__________________________________________________________________________
______  
 x y z U(eq) 
__________________________________________________________________________
______   
B(1) 0 7064(7) 7500 42(1) 
C(1) 635(1) 1953(4) -392(1) 20(1) 
C(2) 1102(1) 912(4) 1841(1) 23(1) 
C(3) 799(1) -933(4) 1822(1) 21(1) 
C(4) -91(1) -2285(4) 1140(1) 20(1) 
C(5) 928(1) -1345(4) 2675(2) 28(1) 
C(6) 1139(1) 1135(4) 1111(1) 20(1) 
C(7) 1567(1) 2593(4) 1298(2) 26(1) 
C(8) 1894(1) 1980(5) 1094(2) 32(1) 
C(9) 2279(1) 3309(5) 1215(2) 43(1) 
C(10) 2324(1) 5248(5) 1544(2) 47(1) 
C(11) 2007(1) 5839(5) 1760(2) 45(1) 
C(12) 1625(1) 4532(4) 1638(2) 36(1) 
C(13) 1728(1) 7690(6) 9479(2) 49(1) 
C(14) 1411(1) 5944(6) 9333(2) 70(1) 
Cl(1) 415(1) -2939(1) 3(1) 19(1) 
Cr(1) 0 0 0 13(1) 
F(1) 395(1) 6436(5) 7342(2) 38(1) 
F(2) 265(1) 5359(5) 7653(2) 38(1) 
F(3) 271(1) 8272(3) 8188(1) 55(1) 
N(1) 634(1) 1790(3) 354(1) 16(1) 
N(2) 238(1) -571(3) 1197(1) 16(1) 
N(3) 2606(1) 2642(6) 1014(2) 62(1) 
N(4) 1971(1) 9117(6) 9618(2) 75(1) 
_______________________________________________________________________
_________ 
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 Table 3.   Bond lengths [Å] and angles [°] for trans-[Cr(AminoPetA)(Cl)2]BF4 (5”). 
_____________________________________________________  
B(1)-F(2)#1  1.309(5) 
B(1)-F(2)  1.309(5) 
B(1)-F(3)  1.359(3) 
B(1)-F(3)#1  1.359(3) 
B(1)-F(1)#1  1.516(3) 
B(1)-F(1)  1.516(3) 
C(1)-N(1)  1.479(3) 
C(1)-C(4)#2  1.507(3) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-C(3)  1.519(3) 
C(2)-C(6)  1.522(3) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-N(2)  1.490(3) 
C(3)-C(5)  1.510(3) 
C(3)-H(3)  1.0000 
C(4)-N(2)  1.480(3) 
C(4)-C(1)#2  1.507(3) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-H(5A)  0.9800 
C(5)-H(5B)  0.9800 
C(5)-H(5C)  0.9800 
C(6)-N(1)  1.493(3) 
C(6)-C(7)  1.513(3) 
C(6)-H(6)  1.0000 
C(7)-C(8)  1.374(4) 
C(7)-C(12)  1.380(4) 
C(8)-C(9)  1.397(4) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.378(5) 
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C(9)-N(3)  1.379(4) 
C(10)-C(11)  1.355(5) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.383(4) 
C(11)-H(11)  0.9500 
C(12)-H(12)  0.9500 
C(13)-N(4)  1.128(5) 
C(13)-C(14)  1.425(5) 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
Cl(1)-Cr(1)  2.3056(6) 
Cr(1)-N(2)#2  2.0602(19) 
Cr(1)-N(2)  2.0603(19) 
Cr(1)-N(1)  2.0628(18) 
Cr(1)-N(1)#2  2.0629(18) 
Cr(1)-Cl(1)#2  2.3055(6) 
F(2)-F(2)#1  1.424(7) 
N(1)-H(5)  0.81(3) 
N(2)-H(2)  0.84(3) 
N(3)-H(3A)  0.8800 
N(3)-H(3B)  0.8800 
 
F(2)#1-B(1)-F(2) 65.9(4) 
F(2)#1-B(1)-F(3) 131.5(2) 
F(2)-B(1)-F(3) 107.34(19) 
F(2)#1-B(1)-F(3)#1 107.35(19) 
F(2)-B(1)-F(3)#1 131.5(2) 
F(3)-B(1)-F(3)#1 110.1(4) 
F(2)#1-B(1)-F(1)#1 47.4(2) 
F(2)-B(1)-F(1)#1 103.2(3) 
F(3)-B(1)-F(1)#1 93.86(16) 
F(3)#1-B(1)-F(1)#1 103.78(15) 
F(2)#1-B(1)-F(1) 103.2(3) 
F(2)-B(1)-F(1) 47.4(2) 
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F(3)-B(1)-F(1) 103.78(15) 
F(3)#1-B(1)-F(1) 93.85(16) 
F(1)#1-B(1)-F(1) 149.1(4) 
N(1)-C(1)-C(4)#2 109.20(18) 
N(1)-C(1)-H(1A) 109.8 
C(4)#2-C(1)-H(1A) 109.8 
N(1)-C(1)-H(1B) 109.8 
C(4)#2-C(1)-H(1B) 109.8 
H(1A)-C(1)-H(1B) 108.3 
C(3)-C(2)-C(6) 116.6(2) 
C(3)-C(2)-H(2A) 108.1 
C(6)-C(2)-H(2A) 108.1 
C(3)-C(2)-H(2B) 108.1 
C(6)-C(2)-H(2B) 108.1 
H(2A)-C(2)-H(2B) 107.3 
N(2)-C(3)-C(5) 112.30(19) 
N(2)-C(3)-C(2) 109.73(18) 
C(5)-C(3)-C(2) 110.5(2) 
N(2)-C(3)-H(3) 108.1 
C(5)-C(3)-H(3) 108.1 
C(2)-C(3)-H(3) 108.1 
N(2)-C(4)-C(1)#2 109.12(18) 
N(2)-C(4)-H(4A) 109.9 
C(1)#2-C(4)-H(4A) 109.9 
N(2)-C(4)-H(4B) 109.9 
C(1)#2-C(4)-H(4B) 109.9 
H(4A)-C(4)-H(4B) 108.3 
C(3)-C(5)-H(5A) 109.5 
C(3)-C(5)-H(5B) 109.5 
H(5A)-C(5)-H(5B) 109.5 
C(3)-C(5)-H(5C) 109.5 
H(5A)-C(5)-H(5C) 109.5 
H(5B)-C(5)-H(5C) 109.5 
N(1)-C(6)-C(7) 111.46(19) 
N(1)-C(6)-C(2) 110.51(18) 
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C(7)-C(6)-C(2) 112.20(19) 
N(1)-C(6)-H(6) 107.5 
C(7)-C(6)-H(6) 107.5 
C(2)-C(6)-H(6) 107.5 
C(8)-C(7)-C(12) 119.6(2) 
C(8)-C(7)-C(6) 118.5(2) 
C(12)-C(7)-C(6) 121.9(2) 
C(7)-C(8)-C(9) 120.8(3) 
C(7)-C(8)-H(8) 119.6 
C(9)-C(8)-H(8) 119.6 
C(10)-C(9)-N(3) 122.0(3) 
C(10)-C(9)-C(8) 118.5(3) 
N(3)-C(9)-C(8) 119.5(3) 
C(11)-C(10)-C(9) 120.7(3) 
C(11)-C(10)-H(10) 119.6 
C(9)-C(10)-H(10) 119.6 
C(10)-C(11)-C(12) 121.0(3) 
C(10)-C(11)-H(11) 119.5 
C(12)-C(11)-H(11) 119.5 
C(11)-C(12)-C(7) 119.4(3) 
C(11)-C(12)-H(12) 120.3 
C(7)-C(12)-H(12) 120.3 
N(4)-C(13)-C(14) 176.3(5) 
C(13)-C(14)-H(14A) 109.5 
C(13)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
C(13)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
N(2)#2-Cr(1)-N(2) 180.0 
N(2)#2-Cr(1)-N(1) 85.90(7) 
N(2)-Cr(1)-N(1) 94.10(7) 
N(2)#2-Cr(1)-N(1)#2 94.10(7) 
N(2)-Cr(1)-N(1)#2 85.90(7) 
N(1)-Cr(1)-N(1)#2 180.0 
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N(2)#2-Cr(1)-Cl(1)#2 91.17(6) 
N(2)-Cr(1)-Cl(1)#2 88.82(6) 
N(1)-Cr(1)-Cl(1)#2 89.29(6) 
N(1)#2-Cr(1)-Cl(1)#2 90.71(6) 
N(2)#2-Cr(1)-Cl(1) 88.82(6) 
N(2)-Cr(1)-Cl(1) 91.18(6) 
N(1)-Cr(1)-Cl(1) 90.71(6) 
N(1)#2-Cr(1)-Cl(1) 89.29(6) 
Cl(1)#2-Cr(1)-Cl(1) 180.0 
B(1)-F(2)-F(2)#1 57.04(19) 
C(1)-N(1)-C(6) 113.56(18) 
C(1)-N(1)-Cr(1) 105.37(13) 
C(6)-N(1)-Cr(1) 117.27(14) 
C(1)-N(1)-H(5) 105.7(18) 
C(6)-N(1)-H(5) 107.6(17) 
Cr(1)-N(1)-H(5) 106.6(18) 
C(4)-N(2)-C(3) 113.63(18) 
C(4)-N(2)-Cr(1) 105.79(13) 
C(3)-N(2)-Cr(1) 116.84(14) 
C(4)-N(2)-H(2) 108.5(16) 
C(3)-N(2)-H(2) 106.6(16) 
Cr(1)-N(2)-H(2) 104.9(16) 
C(9)-N(3)-H(3A) 120.0 
C(9)-N(3)-H(3B) 120.0 
H(3A)-N(3)-H(3B) 120.0 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x,y,-z+3/2    #2 -x,-y,-z       
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 Table 4.   Anisotropic displacement parameters  (Å2x 103) for trans-
[Cr(AminoPetA)(Cl)2]BF4 (5”).  The anisotropic displacement factor exponent takes the 
form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
__________________________________________________________________________
____  
 U11 U22  U33 U23 U13 U12 
__________________________________________________________________________
____  
B(1) 34(2)  23(2) 51(3)  0 14(2)  0 
C(1) 19(1)  22(1) 24(1)  2(1) 14(1)  -2(1) 
C(2) 16(1)  26(1) 20(1)  -2(1) 6(1)  -3(1) 
C(3) 18(1)  24(1) 17(1)  1(1) 8(1)  2(1) 
C(4) 22(1)  20(1) 19(1)  1(1) 13(1)  -4(1) 
C(5) 25(1)  37(2) 19(1)  3(1) 10(1)  1(1) 
C(6) 13(1)  20(1) 22(1)  2(1) 7(1)  -1(1) 
C(7) 15(1)  26(1) 24(1)  6(1) 4(1)  -4(1) 
C(8) 20(1)  38(2) 33(1)  10(1) 12(1)  -3(1) 
C(9) 18(1)  61(2) 36(2)  20(2) 8(1)  -6(1) 
C(10) 24(1)  48(2) 39(2)  17(1) 1(1)  -18(1) 
C(11) 30(1)  31(2) 38(2)  6(1) -1(1)  -11(1) 
C(12) 24(1)  27(1) 35(2)  1(1) 5(1)  -5(1) 
C(13) 39(2)  61(2) 43(2)  18(2) 21(1)  -2(2) 
C(14) 55(2)  61(2) 54(2)  12(2) 8(2)  -18(2) 
Cl(1) 20(1)  16(1) 23(1)  -1(1) 13(1)  0(1) 
Cr(1) 13(1)  13(1) 15(1)  -1(1) 8(1)  -1(1) 
F(1) 42(1)  37(1) 41(1)  -11(1) 27(1)  4(1) 
F(2) 42(1)  37(1) 41(1)  -11(1) 27(1)  4(1) 
F(3) 62(1)  71(1) 46(1)  -14(1) 40(1)  4(1) 
N(1) 16(1)  15(1) 18(1)  -1(1) 9(1)  -1(1) 
N(2) 16(1)  16(1) 17(1)  -1(1) 10(1)  0(1) 
N(3) 32(1)  88(2) 73(2)  14(2) 34(1)  -13(2) 
N(4) 64(2)  77(2) 89(3)  18(2) 48(2)  -19(2) 
__________________________________________________________________________
____ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for trans-[Cr(AminoPetA)(Cl)2]BF4 (5”). 
__________________________________________________________________________
______  
 x  y  z  U(eq) 
__________________________________________________________________________
______  
  
H(1A) 776 665 -460 24 
H(1B) 854 3130 -330 24 
H(2A) 1456 824 2353 28 
H(2B) 944 2193 1878 28 
H(3) 900 -2182 1648 25 
H(4A) -85 -2319 1647 24 
H(4B) 41 -3629 1093 24 
H(5A) 844 -118 2868 42 
H(5B) 1297 -1647 3059 42 
H(5C) 729 -2536 2652 42 
H(6) 1222 -266 998 24 
H(8) 1859 637 869 38 
H(10) 2580 6180 1622 56 
H(11) 2049 7170 1998 54 
H(12) 1403 4966 1788 43 
H(14A) 1311 5982 9717 106 
H(14B) 1603 4662 9420 106 
H(14C) 1102 5985 8762 106 
H(2) 163(9) 510(40) 1343(15) 11(6) 
H(5) 573(9) 2950(40) 436(15) 16(7) 
H(3A) 2852 3464 1095 74 
H(3B) 2568 1395 804 74 
__________________________________________________________________________
______  
 
 
